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ABSTRACT 
During development, neurons migrate to their correct position and extend 
axons to their appropriate targets to form functional neuronal networks. Both these 
processes require the combination of many molecular signals. The hindbrain is a 
powerful model to uncover specific roles of these signals in axon guidance and 
neuronal migration. I have used the hindbrain model to investigate roles for specific 
isoforms of the vascular endothelial growth factor (VEGF-A) and enzymes that 
modify heparan sulfate proteoglycans (HSPGs) in motor neuron migration and 
cranial nerve development. 
VEGF-A is a potent angiogenic signal that has been described to also have 
functions during nervous system development. VEGFA is an alternatively spliced 
gene and its three main isoforms are termed VEGF121, VEGF165 and VEGF189. 
VEGF165 can bind the transmembrane receptor neuropilin 1 (NRP1) to regulate axon 
guidance, neuronal migration and neuronal survival, whilst VEGF121 is unable to 
signal through NRP1. Using in situ ligand-binding assays, I show that VEGF189 can 
also bind NRP1 in vivo, similar to VEGF165 and unlike VEGF121. Furthermore, I 
show that VEGF189 can promote NRP1-dependent migration of facial branchiomotor 
(FBM) neurons similar to VEGF165, and also has similar functions in retinal ganglion 
cell guidance at the optic chiasm and neuronal survival in the nose. 
 HSPGs are extracellular matrix proteins that interact with various signalling 
proteins, including VEGF-A, but also fibroblast growth factors (FGFs) and their 
receptors. I found that the HSPG modifying enzymes HS6ST1 and HS6ST2 
cooperate during cranial axon guidance, while HS2ST is required for normal FBM 
neuron migration. Furthermore, I demonstrated that HS2ST is dispensable for 
VEGF/NRP1-dependent FBM neuron migration, but promotes a novel pathway 
involving FGF-induced migration of these neurons.  
Finally, I investigated the suitability of genetic tools to study FBM neuron 
migration and cranial axon guidance. 
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Chapter 1 INTRODUCTION 
 
1.1 DEVELOPMENT OF THE HINDBRAIN 
1.1.1 Hindbrain patterning and development 
1.1.1.1 Development of the hindbrain 
During early embryonic development the process of gastrulation initiates 
early morphogenetic movements that result in the specification of the endoderm, 
mesoderm and ectoderm (Holtfreter, 1943; Holtfreter, 1944). During gastrulation 
cells must migrate collectively in a process known as convergent-extension, where 
cells first converge and then slide over each other creating a narrow axis that leads to 
the elongation of the embryo (Keller et al., 1992; Wallingford et al., 2002). 
Following gastrulation the process of neurogenesis is initiated, through which new 
neurons can be generated to populate the different areas of the brain (reviewed in 
(Gotz and Huttner, 2005; Paridaen and Huttner, 2014). The hindbrain is one of these 
areas, and also described as the oldest area of the brain (Jimenez-Guri and Pujades, 
2011). 
During early development, several swellings arise in the anterior part of the 
neural tube, which will generate the forebrain, midbrain and hindbrain. In 
vertebrates, all cranial motor neurons are located in the brainstem, where they form 
distinct motor nuclei, whilst their axons extend out to control the muscles in the head 
and neck (reviewed by (Cordes, 2001; Guthrie, 2007). Depending on their positional 
arrangement in the hindbrain and synaptic target, cranial motor neurons are arranged 
in three groups, somatic motor (SM), visceral motor (VM), and branchiomotor (BM) 
neurons.  
 
1.1.1.2 Segmentation of the hindbrain 
The hindbrain is divided into 8 compartments known as rhombomeres (r), 
which provide positional information and specific signals that promote the 
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differentiation of neurons (Lumsden and Keynes, 1989). Rhombomere segmentation 
of the hindbrain is mostly conserved across different vertebrate species (Gilland and 
Baker, 1993). Rhombomere identity of the hindbrain is established by the segmental 
expression of transcription factors and secreted signals as well as inter-rhombomere 
interactions, which together fine-tune the final two-segment periodicity. One key 
signal in hindbrain structural specificity is Krox20, a zinc finger transcription factor 
that is expressed in early development in r3 and r5 and is important for the 
development of odd numbered rhombomeres (Wilkinson et al., 1989). In Krox20-
null mice, the hindbrain lacks r3 and r5, thus it has a reduced length and lacks motor 
neurons that would originate in those rhombomeres (Schneider-Maunoury et al., 
1993; Swiatek and Gridley, 1993). The leucine zipper transcription factor Kreisler is 
expressed early in r5 and r6 (Cordes and Barsh, 1994). Mice lacking Kreisler 
develop an aberrant r5 and lack motor neurons that are generated at that level 
(McKay et al., 1994; McKay et al., 1997). These transcription factors are key in 
hindbrain development and act upstream of Hox genes, which are also expressed in a 
segmented fashion across rhombomeres.  
Vertebrate Hox genes are related to the Drosophila HOM genes and their 
discovery was key in discovering common patterning mechanisms across species 
(Carrasco et al., 1984; McGinnis et al., 1984). There are 39 Hox genes in the mouse, 
divided into four clusters (Hoxa, Hoxb, Hoxc and Hoxd). Correct segmentation and 
rhombomere identity results from the combined level and timed expression of 
different Hox gene clusters (Cordes, 2001; Guthrie, 2007). The midbrain-hindbrain 
boundary (isthmus) is controlled by fibroblast growth factor 8 (FGF8), which 
determines the start of Hox gene expression as well as the boundary between r1 and 
r2 (Reifers et al., 1998; Irving and Mason, 1999). Moreover, r4 expresses Hoxb1 at 
higher levels than other Hox gene clusters, thus Hoxb1-null mice have correct 
segmentation but lose r4 identity, which initially results in abnormal facial 
branchiomotor (FBM) neuron migration from r4 to r5 and later the facial nucleus is 
lost (Goddard et al., 1996; Studer et al., 1996). Hoxa1 is also expressed on r4 before 
Hoxb1 expression, and Hoxa1;Hoxb1 double mutants completely lack migrating 
FBM neurons, indicating that these Hox genes act together to specify r4 identity 
(Gavalas et al., 1998).  
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1.1.1.3 Neuronal specificity in the hindbrain and spinal cord 
The patterning of the hindbrain requires the rhombomere anterior-posterior 
code and integration with dorsoventral signals. Sonic hedgehog (SHH) is a signal 
derived from the floorplate and notochord that forms a ventral (high) to dorsal (low) 
gradient to specify neuronal progenitor classes in the spinal cord (Figure 1.1) 
(reviewed in (Jessell, 2000; Price and Briscoe, 2004). SHH is defined as a 
morphogen, for its ability to induce different effects depending on its concentration, 
a term that defines other signals with similar properties (Turing, 1952; Wolpert, 
1969). Several groups have shown that transplanting the notochord and/or expressing 
SHH ectopically leads to the differentiation of floorplate, ventral interneurons and 
motor neurons in a concentration dependent manner (Watterson et al., 1954; Marti et 
al., 1995; Roelink et al., 1995; Ericson et al., 1996). SHH gradient promotes neuronal 
differentiation in a dose dependent manner by controlling expression of essential 
homoedomain proteins at specific dorsoventral levels (Ericson et al., 1997a; Briscoe 
et al., 2000). These homoedomain proteins are divided into class I and class II 
proteins, which mutually repress each other and respond to SHH concentrations 
differently. The expression of class I proteins are repressed at specific SHH 
concentrations, whilst the class II proteins need SHH signalling and are also induces 
by specific SHH concentrations (Briscoe et al., 2000). Targeting transcription factors 
downstream of SHH increases the specificity of different population of neurons in 
the spinal cord and hindbrain.  
In the hindbrain, VM and BM neurons originate from neural progenitors 
expressing the homeobox genes Nkx2.2 and Nkx2.9 (Figure 1.2) (Ericson et al., 
1997b; Briscoe et al., 1999). Furthermore, Nkx6.1 and Nkx6.2 are expressed in BM 
and VM neuron precursors, but are not required for neuronal differentiation. 
However, Nkx6.1 single and Nkx6.1;Nkx6.2 double mutants have abnormal neuronal 
migration and axon guidance, whilst Nkx6.2-null mice are viable and have no motor 
neuron defects (Muller et al., 2003; Pattyn et al., 2003a; Chandrasekhar, 2004).  
 All postmitotic motor neurons express Isl1, whilst VM and BM neurons also 
express Tbx20 as well as the homeobox genes Phox2a and Phox2b (Ericson et al., 
 
19 
1992; Pattyn et al., 1997; Kraus et al., 2001). Interestingly, Phox2b expression is 
observed before Phox2a in BM neurons, whilst Phox2a is expressed before Phox2b 
in some SM neurons (oculomotor and trochlear) (Figure 1.2). Phox2a-null mice fail 
to form oculomotor and trochlear motor neurons, while in Phox2b mutants BM 
progenitors do not differentiate into motor neurons (Pattyn et al., 1997; Pattyn et al., 
2000). Moreover, Nkx genes and Hoxb1 together regulate the expression of Phox2b 
in the hindbrain, which determines the differentiation of Nkx2.2-positive precursors 
into BM or serotonergic neurons (Pattyn et al., 2003b). Furthermore, one study 
generated two knock-in mice replacing the Phox2b and Phox2a coding sequence 
with one another and showed there was only a partial rescue of single mutant 
phenotypes, which indicates these two genes are not functionally analogous 
(Coppola et al., 2005). 
 
1.1.1.4 Organisation of motor neurons in the hindbrain  
BM and VM neurons are found only in the hindbrain, while SM neurons are 
present in the hindbrain and midbrain. Motor nuclei in the hindbrain can be 
composed of more than one type of neuron. In mice, the vagus (X) and cranial 
accessory (XI) motor nuclei occupy r7 and r8, whilst the abducens (VI) nerve 
extends from somata in r5. The trochlear (IV) nucleus lies in r1; the trigeminal (V) 
nucleus spans r1-r3; the facial (VII) nucleus contains both BM and VM neurons 
along r4 and r5 level; the glossopharyngeal (IX) nucleus occupies r6; and the 
oculomotor (III) nucleus is contained in the midbrain.  
Cranial motor axons converge and exit the brainstem through the cranial 
nerves (reviewed by (Cordes, 2001; Guthrie, 2007). All BM and VM axons exit the 
hindbrain dorsally, while all SM neurons, except the trochlear axons, exit from the 
basal plate of the neural tube (Lumsden and Keynes, 1989). SM neurons give rise to 
the hypoglossal (XII) nerve, which innervates the tongue muscles. SM neurons also 
form the trochlear (IV), abducens (VI) and oculomotor (III) nerves that project to the 
muscles of the eye. VM neurons control the salivary and lacrimal glands through 
branches of the facial (VII) nerve that innervate parasympathetic ganglia. VM 
neurons also project to visceral organs and smooth muscle. BM neuron axons merge 
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to form the glossopharyngeal (IX), vagus (X), trigeminal (V), and facial (VII) cranial 
nerves that innervate muscles in the face, jaw, larynx that derive from the brachial 
arches.  
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Figure 1.1 Ventral neural tube patterning by SHH 
A graded concentration of SHH induces the specification of neuronal progenitors in 
the spinal cord. The notochord and floorplate express SHH which diffused from the 
ventral spinal cord to more dorsal areas that will be presented with low 
concentrations of SHH. V3-1 indicates the different classes of interneurons. MN, 
motor neurons; N, notochord; FP, floorplate. Adapted from (Jessell, 2000; Price and 
Briscoe, 2004). 
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Figure 1.2 Specification of motor neuron type in the hindbrain. 
The expression of key transcriptional factors for the determination of motor neuron 
types in the mouse E10.5 hindbrain. Pax6 is expressed in the domain where somatic 
motor (sm) neurons are born. Phox2b is expressed in the domains where visceral 
motor (vm) and branchiomotor (bm) neurons are born. Expression of these genes is 
essential for the specification and development of the different motor neuron types. 
Nkx2.2 is expressed in the same domain as Phox2b. Adapted from (Cordes, 2001). 
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1.1.2 Facial branchiomotor (FBM) neurons 
1.1.2.1 Neuronal migration 
In the early nineteenth century Santiago Ramon y Cajal and Wilhelm His 
used histology on embryonic brains to describe the migration of neurons in along 
glial guide cells (reviewed in (Sidman and Rakic, 1973; Bentivoglio and Mazzarello, 
1999). Neuronal migration can occur in two axes in the CNS, radial and migration. 
Radial migration takes place in an apical-basal direction and many neurons use radial 
glial as guide cells. The correct development and layering of the cerebral cortex is 
dependent on radial migration (Hatten, 1999). Tangential migration occurs along the 
dorsa-ventral axes. One example of tangential migration involves the migration of 
interneurons migrated form the cerebral cortex to the olfactory bulb, and from the 
ganglionic eminences into the cortex (Marin et al., 2010). 
 
1.1.2.2 FBM neuron development  
The FBM neurons are a powerful model to study neuronal migration and 
axon guidance in the hindbrain. FBM neurons are born on the ventricular side of the 
hindbrain at the r4 level and their axons form the facial nerve. The cell bodies of 
FBM neurons migrate caudally and laterally, away from the floor plate, to form one 
facial nucleus on each side of the midline at r6 level in mice, and r6/7 level in 
zebrafish (reviewed by (Chandrasekhar, 2004; Wanner et al., 2013). In chicks, the 
migration of FBM neurons is negligible (Jacob and Guthrie, 2000), although when a 
chick r4 is transplanted into the mouse, the chick r4-derived FBM neurons migrate 
into mouse r5/6 (Studer, 2001). FBM axons exit the hindbrain through r4 and as cell 
bodies continue to migrate the motor axons are positioned along the migratory 
stream. During their caudal migration, mouse FBM neurons first move along the 
ventricular surface (Figure 1.3), while in zebrafish initial caudal migration is 
influenced by the laminin rich r4/5 boundary, which briefly changes the orientation 
of migration towards the pial surface (Grant and Moens, 2010). After caudal 
migration is completed, FBM neurons in mice also migrate radially from the 
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ventricular to the pial side of the hindbrain where they reach their final location 
(Figure 1.3). 
 
1.1.2.3 Molecular control of FBM neuron migration in mice 
FBM neuron migration is regulated by several growth factors with 
chemoattractive effects (summarised in Table 1.1). For example, vascular endothelial 
growth factor (VEGF-A) signalling through neuropilin 1 (NRP1) guides FBM 
neurons from r4 to r6 in the mouse hindbrain. FBM neurons normally migrate in an 
organised stream and form paired nuclei on each side of the midline on the pial side 
of the hindbrain, but in Nrp1-null mice they migrate in disorganised streams and 
form misplaced, dumbbell shaped nuclei (Schwarz et al., 2004). Consistent with a 
role in chemoattraction, Vegfa is expressed in r6 where the facial nuclei form, and 
VEGF164-soaked beads attract migrating FBM neurons in a hindbrain explant assay 
(Schwarz et al., 2004). VEGF expression at the final destination may also promote 
motor neuron survival, but this has not yet been demonstrated formally. The finding 
that the class 3 semaphorin Sema3a-/- mice show normal FBM migration, whilst 
Vegfa120/120 mice lacking VEGF164 phenocopy the FBM defects seen in Nrp1-null 
mice suggests that VEGF is the NRP1 ligand that controls FBM migration (Schwarz 
et al., 2004). In contrast, the same study shows that SEMA3A, but not VEGF164 
signalling through NRP1 is required for correct facial nerve guidance. The 
extracellular matrix protein reelin, which is known to control radial migration 
(reviewed by (Zhao and Frotscher, 2010) resulting in inverted neuronal layers 
(Caviness and Sidman, 1973; D'Arcangelo et al., 1995) and is also expressed at the 
final target of migrating FBM neurons. Mice null for reelin or its receptor Dab1 also 
have FBM neuron migration defects and form abnormal facial nuclei (Rossel et al., 
2005).  
WNTs also have an important chemoattractive function during FBM neuron 
migration, and several components of the planar cell polarity (PCP) have been 
implicated in FBM neuron migration. The PCP pathway is responsible for the 
inducing an orientation/polarity in cells that is perpendicular to the apical-basal axis, 
and consequently very important for cell movement/migration and tissue 
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morphogenesis (reviewed in (Axelrod and McNeill, 2002). Wnt5a is expressed in the 
hindbrain during FBM neuron migration in a rostral-caudal gradient-like pattern 
where expression increases from r4 to r6 (Vivancos et al., 2009). Moreover, beads 
soaked in WNT5A or WNT7A attract migrating FBM neurons in a hindbrain explant 
assay. Interestingly, mice null for Wnt5a or its receptor Frizzled 3 (Fz3) have 
defective FBM neuron migration, while FBM neurons migrate normally in Wnt7a 
mutants (Vivancos et al., 2009). Furthermore, the same study showed that the 
cytoplasmic protein SCRB1 and the membrane protein VANGL2, two components 
of the WNT/PCP pathway, are also required during FBM neuron migration 
(Vivancos et al., 2009). In Scrib1 mutants FBM neurons fail to migrate out of r4, and 
in two different Vangl2 mouse mutants FBM neurons were unable to migrate 
caudally (Vivancos et al., 2009; Glasco et al., 2012).  
The atypical cadherins CELSR1-3, part of the PCP signalling pathway, are 
also important for FBM neuron migration. CELSR1 is expressed in neuronal 
precursors but not migrating FBM neurons, while CELSR2 and CELSR3 are 
expressed more broadly in the hindbrain. FBM neurons in Celsr1 mutant mice fail to 
migrate caudally and remain in r4 or sometimes migrate into r3/2 (Qu et al., 2010). 
Moreover, Celsr2 single and Celsr2;Celsr3 double mutants show early and excessive 
lateral migration of FBM neuron around r5/6 (Qu et al., 2010). These defects are 
very similar to those observed in Fz3-null mice, another integral part of the PCP 
pathway. 
Several signalling molecules have been associated with FBM migration, and 
yet the downstream signal transducers controlling the cytoskeleton changes required 
for migration have not been fully characterised. Mice carrying a mutation in non-
muscle myosin heavy chain (NMHCIIB) have abnormal FBM neuron migration as a 
consequence of defective actomyosin contractility (Ma et al., 2004). In these 
mutants, the facial nuclei form as protrusions in the 4th ventricle. Furthermore, some 
downstream effectors of the PCP pathway, important for cytoskeletal control, have 
also been shown to play a part in FBM neuron migration. Inhibitors of ROCK, JNK 
and Myosin II induce abnormal migration of FBM neurons in a hindbrain explant 
assay (Vivancos et al., 2009). 
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1.1.2.4 Molecular control of FBM neuron migration in zebrafish 
FBM neuron migration in zebrafish differs to mice but several PCP pathway 
components have also been shown to be important during zebrafish FBM neuron 
migration (summarised in Table 1.1) (Wanner et al., 2013). Similar to mice, Celsr2 
and Fz3a are also required for distinct functions during FBM migration. Both genes 
are expressed in the neuroepithelium, which maintains FBM neurons migrating along 
the pial surface of the hindbrain. Mutations these genes result in abnormal caudal and 
radial FBM migration (Wada et al., 2006). Knockdown of Prikle1b leads to defective 
FBM neuron polarisation, which results in abnormal cell protrusions and an aberrant 
axis of cell elongation both necessary during directed migration (Mapp et al., 2010). 
Zebrafish Vangl2 mutants (trilobite) are also unable to maintain stable cell 
protrusions, which results in abnormal FBM neuronal caudal migration (Jessen et al., 
2002). Nshl1b is expressed in FBM neuron membrane protrusions and interacts with 
Prickle1b. Mutations in Nshl1b leads to defective caudal migration through a cell 
autonomous function interacting with other components of the PCP pathway (Walsh 
et al., 2011).  
Moreover, additional signalling pathways, including SDF1/CXCR4/CXCR7 
and MET/HGF1/HGF2, are important during FBM migration in zebrafish, but have 
not yet been described to have a role in mouse (Sapede et al., 2005; Cubedo et al., 
2009; Elsen et al., 2009). Knockdown of Sdf1a, Cxcr4 or Cxcr7 leads to varying 
levels of defective FBM neuron caudal migration (Sapede et al., 2005; Cubedo et al., 
2009). Hgf1 or Hgf2 single knockdown also results in abnormal caudal migration, 
whilst simultaneous knockdown of both genes (Hgf1/Hgf2) leads to almost complete 
failure of FBM neurons to migrate caudally (Elsen et al., 2009).  
Zebrafish FBM neuron migration requires ‘pioneer’ neurons and their trailing 
axons to lead the bulk of migrating FBM neurons (Wanner and Prince, 2013). Using 
laser ablation techniques, researchers showed that without this FBM neuron 
‘pioneer’ population, other FBM neurons are unable to migrate out of r4 into r5. The 
later stage of FBM neuron migration from r5 to r6 depends on a physical interaction 
between migrating neurons and the medial longitudinal fasciculus (MLF), a bundle 
of axons that extends alongside FBM neurons (Wanner and Prince, 2013). The 
adhesion molecule CDH2 (N-cadherin) is essential for the cell-cell interactions 
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between FBM neurons and both the ‘pioneer’ neurons and the MLF (Wanner and 
Prince, 2013). Unfortunately, the type of live imaging experiments performed in the 
zebrafish to demonstrate the role of the pioneer population are difficult to perform in 
the mouse. Therefore, the pioneer model has not yet been tested in the mouse.   
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Figure 1.3 Migration of FBM neurons in the hindbrain. 
Schematic representation of a E12.5 hindbrain showing the position of the trigeminal 
(V), abducens (VI), hypoglossal (XII) and facial (VII) motor nuclei. The schematic 
shows the two stages of FBM migration, tangential and radial migration. During 
tangential migration, FBM neurons move from r4 to r6 along the ventricular side (v); 
when they reach r6, they migrate radially from the ventricular to the pial (p) side of 
the hindbrain. The diagram on the right is a transverse section through the hindbrain. 
Dotted lines show exit point for trigeminal and facial axons. Adapted from (Schwarz 
et al., 2004). 
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Gene/molecule Animal/Experiment Phenotype (reference) 
Nrp1/Vegfa Mouse KO and 
hindbrain explants 
Defective FBM neuron radial migration 
leading to dumbbell shaped facial 
nucleus. VEGF164 or VEGF188 soaked 
beads attract migrating FBM neurons in 
hindbrain explants (Schwarz et al., 2004; 
Tillo et al., 2015). 
Dab/reelin Mouse KO Disorganise and scattered facial nucleus 
(Rossel et al., 2005). 
Wnt5a Wnt7a 
Fz3 
Mouse KO and 
hindbrain explants 
Wnt5a and Fz3 knockout mice have 
defective FBM neuron migration. Wnt5a 
or Wnt7a soaked beads attract migrating 
FBM neurons in hindbrain explants 
(Vivancos et al., 2009). 
Vangl2 Mouse KO FBM neurons fail to migrate from r4 
(Vivancos et al., 2009; Glasco et al., 
2012). 
Scrib1 Mouse KO; Zebrafish 
mutants 
Defective FBM neuron caudal migration 
(Wada et al., 2005; Vivancos et al., 
2009). 
Celsr1-3 Mouse KO Celsr1-/- mice fail to migrate from r4. 
Celsr2-/- and Celsr2-/-;Celsr3-/- show 
uncontrolled lateral migration around 
r5/6 (Qu et al., 2010). 
NMHCIIB Mouse KO Reduced size of facial nucleus and 
nucleus forms as a protrusion in the 4th 
ventricle (Ma et al., 2004). 
Hgf1/2 Zebrafish Morpholino Defective caudal migration, most neurons 
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knockdown fail to migrate in Hgf1/2 double 
knockdown. Milder phenotype in single 
knockdown (Elsen et al., 2009). 
Cdh2 Zebrafish Morpholino 
knockdown and 
mutants 
FBM neurons fail to migrate out of r4. 
Occasionally there is fusion of FBMs at 
the midline (Stockinger et al., 2011). 
Cxcr4 Cxcr7 
Sdf1a 
Zebrafish Morpholino 
knockdown  
Sdf1a knockdown leads to defective 
caudal migration. Cxcr4 knockdown also 
leads to defective caudal migration with 
neurons spread over r4-6. Cxcr7 
knockdown neurons cluster in r5. 
Cxcr7/Cxcr4 double knockdown leads 
also to clustering around r4-5. (Sapede et 
al., 2005; Cubedo et al., 2009). 
Dcsh1/Fat4 Mouse KO Defective polarity and tangential 
migration of FBM neurons. (Zakaria et 
al., 2014). 
Laminin!1 Zebrafish mutants Defective caudal migration. Some 
neurons exit the neuroepithelium through 
the basement membrane (Paulus and 
Halloran, 2006). 
Table 1.1 Mutations affecting facial branchiomotor neuron development 
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1.2 MOLECULAR CONTROL OF CNS PATTERNING 
1.2.1 Vascular endothelial growth factor (VEGF) 
1.2.1.1 VEGF family 
The vascular endothelial growth factor (VEGF) family of secreted 
glycoproteins includes cysteine knot proteins that are termed VEGF-A, VEGF-B, 
VEGF-C, VEGF-D and PGF (PlGF) (Ferrara et al., 2003). The VEGFs are best 
known as growth and patterning factors for blood vessels and lymphatic vessels. In 
addition, they are important for neuronal development. For example, VEGF-C 
regulates murine neurogenesis as well as axon guidance, and it can also act as a 
neurotrophic factor (Calvo et al., 2011; Piltonen et al., 2011; Kwon et al., 2013). 
VEGF-A, the most widely studied family member, is essential for blood vascular 
development, but also regulates neuronal migration, birth, survival and axon 
guidance (e.g. (Jin et al., 2002; Zhu et al., 2003; Schwarz et al., 2004; Cariboni et al., 
2011; Erskine et al., 2011; Mackenzie and Ruhrberg, 2012).  
 
1.2.1.2 VEGF-A isoforms 
VEGF-A exists in several different isoforms that arise through alternative 
splicing of the VEGFA gene, which comprises 8 exons (Tischer et al., 1991). This 
splicing results in the inclusion or exclusion of exons 6 and/or 7, which encode 
domains that enhance binding to heparin in vitro and heparan sulfate proteoglycans 
in vivo (Figure 3.1; (Houck et al., 1991; Park et al., 1993). The major and most 
studied human isoforms are VEGF189, VEGF165 and VEGF121, whilst their murine 
homologues, encoded by the Vegfa gene, are one aa shorter and termed VEGF188, 
VEGF164 and VEGF120 (Figure 1.4). Due to their varying ability to bind heparin in 
the extracellular matrix (ECM), the VEGF isoforms are differentially distributed in 
the environment. The longest isoforms VEGF189 is found bound to the ECM and 
therefore poorly diffusible, whilst VEGF121 is very diffusible and VEGF165 has 
intermediate characteristics, and this property allows them to form growth factor 
gradients (Park et al., 1993; Ruhrberg et al., 2002).  
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Furthermore, in cooperation with the exon 8-encoded domain, the exon 6/7-
encoded domains are also essential for binding to the non-tyrosine kinase receptors 
of the neuropilin family, NRP1 and NRP2 (Soker et al., 1998; Gluzman-Poltorak et 
al., 2000). The sequence for VEGF165 contains both exons 7 and 6, which enables 
high affinity binding to NRP1 (Gluzman-Poltorak et al., 2000; Parker et al., 2012). 
VEGF189 is also predicted to bind NRP1, given that it contains the exon 7 and 8 
domains (Vintonenko et al., 2011), but prior to my PhD research, this not yet been 
demonstrated in vivo. Even though VEGF121 does not contain exons 6 or 7, it still 
maintains the exon 8 domain, but it can only weakly interact with NRP1, resulting in 
a low affinity of NRP1 for VEGF121 in vitro (Jia et al., 2006; Parker et al., 2012). 
Accordingly, VEGF121 is not believed to bind NRP1 with high specificity, although 
this idea has been contested in one in vitro study using cultured endothelial cells (Pan 
et al., 2007). As part of my aims, I have investigated further the NRP1 binding 
properties of the major VEGF isoforms, and my results are discussed in detail in 
Chapter 3. 
 
1.2.1.3 Receptor kinase receptors for VEGF-A 
VEGF-A binds to two transmembrane tyrosine kinase receptors termed 
VEGFR1 (FLT1) and VEGFR2 (KDR, FLK1). VEGFR1 and VEGFR2 are 
transmembrane glycoproteins of 180 and 200 kDa, respectively. The role of these 
receptors has been mainly described in the context of vascular development, and 
mice lacking either VEGFR1 or VEGFR2 are embryonic lethal around E8.5 (Fong et 
al., 1995; Shalaby et al., 1995). VEGFR2 can also be recruited into plexin/neuropilin 
receptor complexes to modulate signalling response induced by semaphorins in 
neurons (Bellon et al., 2010). 
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Figure 1.4  Major human VEGF-A isoforms and receptors. 
The Vegfa gene encodes can be alternatively spliced and encodes for 3 major 
isoforms termed VEGF189, VEGF165 and VEGF121 in humans. This diagram indicated 
the number of exons in each isoform. The yellow section indicates the VEGF exons 
that can promote binding to heparin in vitro and heparin sulfate proteoglycans 
(HSPGs) in vivo. Red arrows indicate specific sites for receptor binding. The VEGF 
specific tyrosine kinase receptors VEGFR1 and VEGFR2 can bind to all isoforms 
through exons 3 and 4 respectively. The non-tyrosine kinase receptor Neuropilin 1 
(NRP1) is known to bind VEGF165 through its heparin binding domains and exon 8, 
whilst it is still not known if it can also bind VEGF189.  
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1.2.2 Semaphorins and neuropilins 
1.2.2.1 Semaphorins 
The semaphorins (SEMA) belong to a large family of glycoproteins that 
includes both secreted and membrane-bound forms; they are categorised into 8 
classes, with invertebrates using classes 1, 2 and 5 and vertebrates using classes 3-7 
(Zhou et al., 2008) To convey their signals, semaphorins bind transmembrane 
receptors of the plexin (PLXN) family or composite receptors consisting of a plexin 
as a signal transducing and a neuropilin as a ligand-binding co-receptor. Although 
initially discovered due to their function as chemorepellents in axon guidance (He 
and Tessier-Lavigne, 1997; Kolodkin et al., 1997), members of the semaphorin 
classes 1, 3, 4 and 5 have also been implicated in dendrite patterning (Polleux et al., 
2000), vascular growth and function (Arese et al., 2011) and synapse development 
(Tran et al., 2009; Tillo et al., 2012).  
 
1.2.2.2 Neuropilins 
The interaction of VEGF-A with the single transmembrane protein NRP1 was 
initially identified in human umbilical vein derived endothelial cells (HUVEC) 
(Gitay-Goren et al., 1996) and later in tumour cell lines (Soker et al., 1998). 
Interestingly, at this time, NRP1 had already been identified in the nervous system as 
an adhesion protein (Takagi et al., 1987) and as receptor for the class 3 semaphorin 
family (He and Tessier-Lavigne, 1997; Kolodkin et al., 1997). A second member of 
the neuropilin family was identified later and termed NRP2 (Chen et al., 1997). 
NRP2 shares 44% homology at the aa level with NRP1 and has a similar domain 
structure comprised of a large N-terminal extracellular domain (835 aa for NRP1, 
844 for NRP2), a short membrane-spanning domain (23 aa for NRP1, 25 for NRP2) 
and a small cytoplasmic domain (44 aa for NRP1, 42 for NRP2). 
The neuropilin extracellular part contains two coagulation factor V/VIII 
homology domains, termed b1 and b2, and they mediate binding to different 
members of the VEGF family (Figure 1.5). Both neuropilins can bind VEGF-A, but 
NRP1 has a much higher affinity than NRP2 for VEGF-A. Whilst NRP1 is a receptor 
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for SEMA3A, NRP2 preferentially binds SEMA3F (Chen et al., 1997; He and 
Tessier-Lavigne, 1997; Kolodkin et al., 1997; Gluzman-Poltorak et al., 2000). 
The neuropilin extracellular part contains two complement-binding homology 
domains, termed a1 and a2, which are essential for binding to the SEMA domain 
present in all members of the semaphorin family. The cytoplasmic neuropilin tail 
contains a PDZ-domain binding motif; in the case of NRP1, this motif binds synectin 
(GIPC1), which bridges NRP1 and a myosin 6-driven cell transport machinery for 
endocytic trafficking (Figure 1.5) (Lanahan et al., 2010; Schwarz and Ruhrberg, 
2010; Lanahan et al., 2013; Raimondi and Ruhrberg, 2013). 
Due to the variety of structural domains present on both sides of the cell 
membrane that allow neuropilins to interact with several ligands, they are able to 
modulate a number of different signalling pathways to control neuronal and vascular 
cell behaviour. 
Different hypotheses exist for how NRP1 acts in endothelial cells: it was originally 
proposed to enhance VEGFR2 affinity for VEGF165 (Whitaker et al., 2001) and 
promote VEGFR2 clustering (Soker et al., 2002), but current research is focused on 
its role in VEGFR2 trafficking by endocytosis (Salikhova et al., 2008; Lanahan et al., 
2013). All models agree that VEGF165 binding to NRP1 promotes complex formation 
between NRP1 and VEGFR2 via a VEGF165 bridge. This pathway appears to be 
particular important for arteriogenesis (Lanahan et al., 2013). Mice lacking the NRP1 
cytoplasmic domain (Nrp1cyto/cyto) do not have general defects in assembling blood 
vessel networks, with the exception of a subtle arteriovenous patterning defect in the 
developing retina (Fantin et al., 2011) and impaired VEGFR2-dependent 
arteriogenesis due to abnormal VEGFR2 trafficking (Lanahan et al., 2013). Whether 
the cytoplasmic tail of NRP1 might signal in neural development has so far only 
been explored in gonadotropin hormone releasing hormone (GnRH) neurons; in 
these cells, VEGF164 signalling through NRP1 enhances survival independently of 
VEGFR2 through an unknown co-receptor, and the NRP1 cytoplasmic tail does not 
appear to play a role in this process (Cariboni et al., 2011). NRP1 also promotes 
angiogenesis through unknown adhesion ligands in a VEGF-independent pathway, 
but the role of this pathway in neuronal development remains to be defined (Shimizu 
et al., 2000; Raimondi et al., 2014).   
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Figure 1.5 Neuropilin 1 structure and ligand binding. 
SEMA3A can bind NRP1 through a1/a2 domains whilst VEGF165 can bind through 
b1/b2 domains. The b1/b2 domain is also available for heparin binding. The 
cytoplasmic domain of NRP1 contains a sequence of 3 amino acids that allows the 
binding of the protein GIPC/Synectin through its PDZ-binding motif. Adapted from 
(Schwarz and Ruhrberg, 2010). 
  
 
37 
1.2.3 Neuropilin and VEGF-A signalling in the vascular system 
1.2.3.1 Vascular development 
During development the cardiovascular system is the first organ system to 
assemble in vertebrates. A cardiovascular system is essential to provide other organs 
with blood and nutrients during development (Risau and Flamme, 1995). Initially 
vessels are assembled from single cell precursors in a process termed vasculogenesis. 
These single blood vessels then begin to sprout through filopodia processes and lead 
to the formation of a complex vascular plexus network in a process termed 
angiogenesis (Ruhrberg, 2003; Carmeliet, 2005). Vessel sprouts are made up of 
endothelial stalk cells, which proliferate and form the lumen of blood vessels, and 
endothelial tip cells, which guide the growing sprouts (Gerhardt et al., 2003).  
VEGF signals through NRP1 and VEGR2 complexes to control different 
aspects of vascular development. VEGF requires VEGFR2 for a wide variety of 
functions during vascular development such as promoting survival, proliferation and 
migration of endothelial cells (Clauss et al., 1990; Praloran et al., 1991; Guerrin et 
al., 1995). VEGR2 mutants are embryonic lethal as they are unable to form blood 
vessels through vasculogenesis early in development (Shalaby et al., 1995). 
Following vasculogenesis, VEGR2 is important during angiogenesis to sense a 
concentration of diffusing VEGF and promote the extension of tip cell filopodia 
(Figure 1.6) (Ruhrberg et al., 2002; Gerhardt et al., 2003).  
During angiogenesis NRP1 is expressed in endothelial cells as well as in 
other cell types including tissue macrophages and neural progenitors that secrete 
VEGF in the brain (Figure 1.6) (Haigh et al., 2003; Fantin et al., 2010; Fantin et al., 
2013). NRP1 mutant mice have reduced vessel growth and are embryonic lethal, 
whilst overexpressing NRP1 results in increased vessel growth, leakiness of vessels 
and also embryonic lethality (Kitsukawa et al., 1995; Kawasaki et al., 1999). 
Defective vessel sprouting and vessel patterning has also been observed in zebrafish 
knockdown of NRP1 homologues (Nrp1a; Nrp1b) (Lee et al., 2002; Martyn and 
Schulte-Merker, 2004). NRP1 and VEGFR2 form complexes in cultured endothelial 
cells for the binding of VEGF165 (Whitaker et al., 2001; Soker et al., 2002). However, 
genetic experiments demonstrate that NRP1 is essential during sprouting 
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angiogenesis to control tip cell filopodia whilst it does not play a role in cell 
proliferation (Figure 1.6) (Fantin et al., 2013).  
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Figure 1.6 NRP1 and VEGR2 distribution and function in the brain during 
angiogenesis 
VEGFR2 is expressed in stalk and tip cells whilst NRP1 is only expressed in tip 
cells. Neural progenitors secrete VEGF-A, which is required for both tip cell 
extension (signalling via NRP1+VEGR2 complex) and stalk cell proliferation 
(signalling via VEGR2). Adapted from (Fantin et al., 2013). 
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1.2.4 Neuropilin and semaphorin signalling in the nervous system 
1.2.4.1 Axon guidance 
One of the crucial mechanisms available to modulate a wide variety of 
neuronal responses is the idea that a small number of ligands act through a large 
combination of receptors and co-receptors. For example, individual semaphorins 
have differential affinities for NRP1 and/or NRP2, and both receptors have 
preferential interactions with members of the signal-transducing plexin family. Thus, 
several different semaphorin-plexin-neuropilin ternary signalling complex 
combinations act in axonal growth cones to modulate attraction and repulsion during 
axon path finding (Zhou et al., 2008). 
A variety of neuron subtypes in the developing CNS have been used to study 
the function of these combinations. SEMA3C can bind both neuropilins in axons 
projecting from neurons in the dorsal root ganglia (Takahashi et al., 1998). However, 
other class 3 semaphorins bind preferentially to either NRP1 or NRP2. Thus, 
SEMA3A predominantly binds to NRP1, whilst axons expressing NRP2 more 
typically respond to SEMA3F (Kitsukawa et al., 1997; Taniguchi et al., 1997; Chen 
et al., 2000; Giger et al., 2000; Sahay et al., 2003). Interestingly, in the case of spinal 
motor neurons, the SEMA3A/NRP1 and SEMA3F/NRP2 pathways cooperate to 
control axon pathfinding. In this case, the fasciculation of lateral motor column 
(LMC) nerve axons and their timing of limb invasion are regulated by 
SEMA3A/NRP1 signalling, whereas SEMA3F/NRP2 signalling guides a medial 
subset of LMC axons into the ventral compartment of the limb (Huber et al., 2005). 
Neuropilins also preferentially recruit certain plexin co-receptors. Most 
commonly, PLXNA4 is co-receptor for NRP1 for axon sensing of SEMA3A, whilst 
PLXNA3 interacts mainly with NRP2 to mediate SEMA3F signalling (Cheng et al., 
2001; Suto et al., 2005; Yaron et al., 2005). For example, axons from the 
visceromotor branch of the facial nerve (FVM) are organised by SEMA3A signalling 
through the NRP1/PLXNA4 complex (Chauvet et al., 2007; Schwarz et al., 2008), 
whereas, axon pruning in the infrapyramidal tract is regulated by SEMA3F signalling 
through NRP2/PLXNA3 (Giger et al., 2000; Cheng et al., 2001; Bagri et al., 2003; 
Sahay et al., 2003). Both mechanisms may synergistically pattern other neuronal 
subtypes, as disruption of either the SEMA3A/NRP1/PLXNA4 or the 
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SEMA3F/NRP2/PLXNA3 complex causes fasciculation and guidance defects of 
cranial nerves (Chauvet et al., 2007; Schwarz et al., 2008). Moreover, the combined 
loss of both plexins causes a significantly more severe phenotype, suggesting that 
SEMA3A and SEMA3F cooperate to regulate cranial nerve development (Chauvet et 
al., 2007; Schwarz et al., 2008).  
In addition to the typical preference of NRP1 for PLXNA4 and NRP2 for 
PLXNA3 (Giger et al., 2000; Sahay et al., 2003), other combinations also occur, as 
demonstrated by the analysis of trochlear axon patterning (Yaron et al., 2005). In this 
system, axons are guided by SEMA3F/NRP2 signalling, but PLXNA4 can 
compensate for the loss of PLXNA3, and only the combined loss of both plexins 
recapitulates the guidance defects observed in Sema3f-null mice (Yaron et al., 2005). 
SEMA3E is the only class 3 semaphorin known to bind directly to a plexin, 
PLXND1, without requiring a neuropilin as a ligand-binding subunit (Gu et al., 
2005). Thus, the axons of striatonigral and corticofugal neurons are repelled by 
SEMA3E via PLXND1 signalling (Chauvet et al., 2007). However, NRP1 can still 
bind to the receptor complex, which can alter the axon response to SEMA3E. The 
extracellular domains of NRP1 and PLXND1 are able to associate, and this 
interaction is required for NRP1 to convert SEMA3E/PLXND1-mediated repulsion 
into attraction (Chauvet et al., 2007). Specifically, SEMA3E attracts subiculo-
mammilary axons expressing both PLXND1 and NRP1, which project from the 
hippocampus to the hypothalamus (Chauvet et al., 2007). 
Even though SEMA3 signalling through neuropilins is best known for roles 
in axon repulsion, some SEMA3 proteins elicit chemoattractive responses. The 
ability to stimulate either axon repulsion or attraction was initially demonstrated for 
different compartments of the same neuron; thus, SEMA3A functions as a 
chemorepellent for their axons but have chemoattractive functions for the apical 
dendrites of cortical pyramidal neurons (Polleux et al., 2000). Furthermore, SEMA3F 
can also act as a chemoattractant for cerebellar granule sprouting axons (Ding et al., 
2007). In both situations, increased intracellular cyclic GMP levels are believed to 
convert repulsive into attractive responses (Polleux et al., 2000). 
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1.2.4.2 Neuronal migration 
Semaphorin signalling through neuropilins can also guide migrating neuronal 
subtypes both during tangential or radial migration (MarÌn and Rubenstein, 2003; 
Tamamaki et al., 2003; Chen et al., 2008; Ito et al., 2008).  
The progenitors of GABAergic cortical interneurons migrate tangentially 
from the ganglionic eminence, where they are generated, around the striatum and 
into the cortex (Tamamaki et al., 2003). Both SEMA3A and SEMA3F are expressed 
in the developing striatum, and this region contains excess neurons in Nrp2-null 
embryos, suggesting a role for semaphorin signalling in their migration. Due to early 
embryonic lethality of Nrp1-null mutants, a dominant negative form of NRP1 was 
used to show impairment in the migration of cortical interneurons in a similar 
manner to NRP2 loss (Tamamaki et al., 2003). In addition, both neuropilins are 
involved in positioning cortical interneurons within the correct layer of the 
embryonic cortex (Tamamaki et al., 2003). SEMA3F signals through NRP2-
expressing interneurons to guide them dorsally into the intermediate zone, whilst 
SEMA3A guides NRP1-expressing interneurons into the more medial layers of the 
subplate and cortical plate (Tamamaki et al., 2003). 
NRP1 also plays a key role in the organisation of the mammalian cortex, 
which relies on radial migration of cortical neurons. In contrast to its repulsive role 
for other types of migrating neurons, SEMA3A is a chemoattractant for migrating 
cortical neurons (Chen et al., 2008). Knockdown of NRP1 impairs the migration of 
cortical neurons to the outer layers of the cortex, in a process that requires PLXNA2 
and PLXNA4 to act as co-receptors (Chen et al., 2008). Cortical neurons also fail to 
extend neurites correctly in the Nrp1-null brain, raising the possibility that migration 
and projection rely on similar downstream signalling transduction pathways (Polleux 
et al., 2000; Chen et al., 2008). 
Semaphorin signalling through neuropilins also guides the tangential 
migration of lateral olfactory tract neurons across the telencephalon. Thus, lateral 
olfactory tract neurons migrate towards the ganglionic eminence and then change 
direction and spread laterally along the interface between the cortex and ganglionic 
eminence to guide lateral olfactory tract axons (Ito et al., 2008). The mantle layer of 
the ganglionic eminence expresses SEMA3F, and in Sema3f-/- mice many lateral 
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olfactory tract neurons continue to migrate ectopically towards the ganglionic 
eminence and do not adopt the lateral migratory path (Ito et al., 2008).  
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1.2.5 Neuropilin and VEGF-A signalling in the nervous system 
1.2.5.1 Axon guidance 
NRP1 was also found to regulate axon guidance in the CNS, where it 
promotes the growth of retinal ganglion cell (RGC) axons across the diencephalic 
commissure known as the optic chiasm (Erskine et al., 2011). In this system, 
semaphorins do not play any role in axon guidance. Instead, VEGF-A promotes the 
growth of RGC axons to project contralaterally across the optic chiasm (Erskine et 
al., 2011). For this guidance event to proceed correctly, VEGF-A is expressed at the 
chiasm midline, and RGCs destined to project contralaterally express NRP1 (Erskine 
et al., 2011). Thus, Nrp1-null and Vegfa120/120 mice that express only the non-NRP1 
binding VEGF120 at the expense of other isoforms have excessive ipsilateral 
projections in the optic chiasm. Furthermore, the NRP1-binding isoform VEGF165 
stimulates extension and turning of cultured RGC axons (Erskine et al., 2011). 
VEGF signalling in the optic chiasm cooperates with other guidance systems. Thus, a 
small population of ipsilaterally projecting axons expresses the EphB1 receptor and 
is repelled by the ephrin B2 ligand at the optic chiasm (Nakagawa et al., 2000; 
Williams et al., 2003). Furthermore, SLITs are expressed around the diencephalon 
and act as axon chemorepellents through ROBO2 to define the boundaries through 
which RGC axons should travel to form the optic chiasm (Plump et al., 2002).  
During spinal cord development, neurons in the dorsal spinal cord project 
their axons across the floor plate, which expresses attractive molecules such as 
Netrin and sonic hedgehog (SHH), and floor plate bone morphogenic proteins 
(BMPs) that are essential for axons to form a correct commissure (Kennedy et al., 
1994; Augsburger et al., 1999; Charron et al., 2003). The floor plate also expresses 
VEGF, which signals as a chemoattractant to FLK1-expressing commissural axons 
(Ruiz de Almodovar et al., 2011). Thus, the floorplate-specific knockdown of Vegfa 
or the knockdown of Flk1 in the spinal cord region where the commissural neurons 
originate caused defasciculation of the axons and they failed to cross the floorplate 
(Ruiz de Almodovar et al., 2011). Moreover, VEGF-induced axon attraction is 
blocked by FLK, but not NRP1 inhibition in vitro (Ruiz de Almodovar et al., 2011). 
The spinal cord commissural axons also require repulsive signals from SLITs to 
extend past the floor plate after crossing the midline (Long et al., 2004). 
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1.2.5.2 Neuronal migration 
Even though facial axons require SEMA3A/NRP1 to extend correctly, 
VEGF164 signals through NRP1 to control FBM neuron migration (section 1.1.2.3; 
(Taniguchi et al., 1997; Schwarz et al., 2004). VEGF also promotes the tangential 
migration of cerebellar granule cells from the external granule cells layer to the 
Purkinje cell layer (Ruiz de Almodovar et al., 2010). Thus, mice with hypomorphic 
levels of VEGF expression display delayed cerebellar granule cell migration, whilst 
ectopic expression of VEGF also disturbs migration, suggesting that VEGF gradients 
are important to guide these cells (Ruiz de Almodovar et al., 2010). The granule cells 
do not express either neuropilin, but FLK1; accordingly, mice with a granule cell 
specific knockout of Flk1 have similar migration defects to those caused by 
disrupting VEGF levels, and anti-FLK1 treatment perturbs the guidance of their 
axons in vitro (Ruiz de Almodovar et al., 2010).  
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1.3 THE ROLE OF HSPG IN NERVOUS SYSTEM PATTERNING 
1.3.1 Heparan sulfate proteoglycan structure 
1.3.1.1 Heparan sulfate structure and core proteins 
Heparan sulfate proteoglycans (HSPGs) are membrane-bound glycoproteins 
related to heparin. HSPGs are present in virtually all cells, whilst heparin is only 
released from connective tissue-type mast cells. Heparin is release at the site of 
vascular injury and made up of a Serglycin core protein. On the other hand, HSGPs 
consist of one core protein and at least one covalently linked HS chain and can have 
one of 17 different core proteoglycans that have been described to date (reviewed by 
(Kreuger and Kjellen, 2012; Xu and Esko, 2014). They are grouped into three main 
families of transmembrane-associated (syndecan 1-4, betaglycan, CD44v3), 
Glycosylphosphatidylinositol (GPI)-linked (glypican 1-6), and secreted (perlecan, 
agrin, collagen XVIII) HSPGs. The tissue-dependent expression of each core protein 
correlates with its physiological role. The structure of each HS chain is dependent on 
a wide number of specific modifying enzymes that are expressed in a cell specific 
manner. Altogether, these account for the huge diversity of potential HSPG isoforms 
(reviewed by (Lindahl and Hook, 1978; Hook et al., 1984; Iozzo, 1998; Esko and 
Lindahl, 2001; Esko and Selleck, 2002). 
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1.3.2 Heparan sulfate biosynthesis 
1.3.2.1 Heparan sulfate chain initiation 
Proteoglycans are an assorted class of glycoproteins composed of 
unbranched, long glycosaminoglycan (GAG) chains covalently bonded to a core 
protein serine residue. All GAGs share an initiating tetrasaccharide core, xylose-
galactose-galactose-gluconic acid (Xyl-Gal-Gal-GlcA), which is common to 
chondroitin sulfate, heparan sulfate (HS), dermatan sulfate and heparin. 
Subsequently, disaccharides are added to this core to elongate the chain in patterns 
that are unique to each class of proteoglycans (Prydz and Dalen, 2000). HS is 
composed of repeating disaccharide units made up of uronic acid (GlcA, or L-
iduronic acid (IdoA) and a glucosamine derivative (N-sulfated glucosamine (GlcNS), 
or N-acetylglucosamine (GlcNAc)). 
 
1.3.2.2 Heparan sulfate chain polymerisation 
A GlcNAc residue is first attached to one end of the initial tetrasaccharide 
structure by the exostosin-like (EXTL) family of glycosyltransferases, whereby three 
members of the EXTL family have the capacity to initiate HS polymerisation (Kim 
et al., 2001), although some studies using Drosophila and zebrafish have shown that 
EXTL3 is the primary enzyme required for this process in vivo (Han et al., 2004; 
Holmborn et al., 2012). Following the initial steps, the essential enzymes EXT1 and 
EXT2 polymerise the rest of the HS chain. Individually, the two exostosins have 
very low activity, thus require translocation from the endoplasmic reticulum to the 
Golgi apparatus where they function optimally as a heterodimer (McCormick et al., 
2000; Senay et al., 2000). The EXT1/2 complex sequentially transfers GlcNAc and 
GlcA residues to elongate the HS chain (Lidholt and Lindahl, 1992). 
 
1.3.2.3 Heparan sulfate chain modification 
During polymerisation, the HS chain undergoes a number of modifications in 
the Golgi apparatus by epimerase and sulfotransferases. HS modifications must 
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occur in a particular sequence, evidence shows that the product of one reaction is a 
necessary substrate for the next modifying enzyme (Hook et al., 1975; Jacobsson and 
Lindahl, 1980; Riesenfeld et al., 1982a). The first and prerequisite modification to 
the HS chain is the removal of N-acetyl groups from selected GlcNAc residues and 
their replacement with sulfate. N-sulfation can only take place in N-deacetylated 
GAGs, hence N-deacetylation is key to maintain normal sulfation in HS (Riesenfeld 
et al., 1982a; Riesenfeld et al., 1982b). The four members of the family of N-
deacetylase/N-sulfotransferase (NDST) modifiers carry out both reactions (Orellana 
et al., 1994; Aikawa and Esko, 1999; Aikawa et al., 2001). NDST1 has a lower ratio 
of N-deacetylase/N-sulfotransferase activity than NDST2 (Forsberg et al., 1999; 
Humphries et al., 1999), but both family members are ubiquitously expressed in 
tissues that have been implicated in HS formation (Kusche-Gullberg et al., 1998; 
Toma et al., 1998). In contrast, NDST3 is a more active N-acetylase, and NDST4 
acts mostly as an N-sulfotransferase, and their expression pattern is restricted to 
specific tissues (Aikawa et al., 2001). The relative expression of each enzyme in a 
tissue-specific manner results in varying degrees of N-sulfation of the HS chain 
(Pikas et al., 2000). 
Epimerases are responsible for an isomerisation reaction that leads to the 
change in position of two groups at a chiral carbon. A single C5-epimerase 
isomerises multiple D-GlcA residues that are attached to a GlcNS unit and turns 
them into the 5’ epimer L-IdoA (Li et al., 1997). Epimerisation can lead to various 
IdoA conformations, which add another element of complexity to the HS structure 
and leads to varying ligand specificity. Epimerases do not modify O-sulfated GlcA, 
or any GlcA adjacent to O-sulfated GlcNS, suggesting these are active after NDST 
modifications, but before any O-sulfation (Hagner-McWhirter et al., 2000).  
The ability of HSPGs to interact with other protein ligands is determined by 
the number of O-sulfate groups available (Kreuger and Kjellen, 2012). All of the O-
sulfotransferases are expressed and function in a cell specific manner. The 2-O-
sulfotransferase, encoded by a single gene (Hs2st), transfers a sulfate group to a C-2 
in hexuronic acid residues. The enzyme prefers to sulfate IdoA, but can also transfer 
a sulfate group to GlcA. Most HS chains contain some amount of IdoA C-2-sulfated 
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residues, and the variable number of IdoA residues adds complexity to HSPG 
structure (Safaiyan et al., 2000; Wilson et al., 2002).  
The next enzymes to modify HSPGs are the three members of the 6-O-
sulfotransferase family (HS6ST). All three HS6STs have been shown to sulfate both 
GlcNAc and GlcNS (Smeds et al., 2003), although they have selective preferences 
for different uronic acid isomers attached to the target GlcNS (Habuchi et al., 2000; 
Jemth et al., 2003). Finally the seven members of the 3-O-sulftotransferase (HS3ST) 
family modify the structure of HSPGs (Kreuger and Kjellen, 2012). HS3STs modify 
HS motifs important for the interaction with other proteins, such as those in 
glycoprotein gD of the herpes simplex virus (Petitou et al., 2003), antithrombin 
(Petitou et al., 2003) and the chemokine cyclophilin B (Vanpouille et al., 2007). 
Another family of HSPG modifiers are the heparan sulfate 6-O-endo-
sulfatases (SULF). Sulfatases are extracellular enzymes that hydrolyse sulfates from 
the C-6 position of glucosamine, but before their discovery it was thought that HS 
structure was not changed after it localised to the cell surface (Nagamine et al., 
2012). There are two members of this enzyme family, SULF1, which was first 
described in quail (QSULF1), and SULF2 (Dhoot et al., 2001; Morimoto-Tomita et 
al., 2002). Interestingly, they seem to have a similar role, but are expressed 
differently across cell types and generate organ-specific sulfation patterns in the 
mouse (Nagamine et al., 2012). 
Altogether these modifications allow for huge heterogeneity in HSPG 
structure, and, accordingly, their expression is both spatially and temporally 
regulated depending on their role in specific physiological responses (Lindahl et al., 
1998; Esko and Lindahl, 2001). 
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Figure 1.7 Heparan sulfate biosynthesis 
In the first stage of heparan sulfate synthesis a tetrasaccharide linker (xylose-
galactose-galactose-gluconic acid (Xyl-Gal-Gal-GlcA) is attached to a serine and a 
glycine residue. A functional EXT1-EXT2 dimer then elongates the sugar chain by 
adding GlcNAc and GlcA disaccharide elements. These chains are then modified by 
a number of processes including epimerisation and sulfations to synthesise a wide 
variety of HS. The order of modifications is not always sequential; some 
modifications are dependent on previous steps whilst others occur independently. 
Adapted from (Hacker et al., 2005). 
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1.3.3 HSPG gene targeting 
1.3.3.1 Mutants targeting heparan sulfate core proteins 
Various mouse models are available to study the role of HSPGs during 
development (summarised in Table 1.2). I will discuss below the phenotypes caused 
by null mutations. All syndecan 1-4 (Sdc) knockout mice are viable after birth, but 
have various developmental defects (Alexander et al., 2000; Echtermeyer et al., 
2001; Reizes et al., 2001; Li et al., 2002) (Professor Michael Simons, personal 
communication). Syndecans 1, 2 and 4 are expressed and required in endothelial 
cells, while syndecan 3 is expressed in the endothelial cells but Sdc3-null mice are do 
not have any endothelial phenotypes (Echtermeyer et al., 2001; Gotte et al., 2002; Li 
et al., 2002; Patterson et al., 2005; Noguer et al., 2009). Sdc3-null mice show 
enhanced long-term potentiation in the hippocampus (Kaksonen et al., 2002) and 
develop abnormal cortical laminar organisation due to impaired neuronal migration 
(Hienola et al., 2006).  
 So far mutants for glypicans (Gpc) 1,3 and 4 have been published, and none 
are embryonic lethal (Cano-Gauci et al., 1999; Tang et al., 2010). Mice carrying the 
Gpc1-null allele have reduced brain size due to impaired neurogenesis (Jen et al., 
2009), whilst Gpc3-null mice have a multitude of developmental defects including 
cardiac and vascular defects (Ng et al., 2009), and Gpc4-null mice have a defective 
excitatory synapse formation in the hippocampus (Allen et al., 2012).  
Targeting the extracellular matrix perlecan (Hspg2) or agrin (Agn) alleles 
leads to embryonic lethal mutations in mice. Deletion of Hspg2 results in a multitude 
of defects, including neuromuscular junctions lacking acetylcholinesterase, cephalic 
abnormalities and cardiac outflow tract malformations (Arikawa-Hirasawa et al., 
1999; Arikawa-Hirasawa et al., 2002; Costell et al., 2002). Agrin is essential for 
neuronal development and Agn-/- mice have smaller brains, reduced size, density and 
number of acetylcholine receptors in muscles, as well as abnormal synapse number 
and assembly in the CNS (Gautam et al., 1996; Serpinskaya et al., 1999; Gingras et 
al., 2007; Ksiazek et al., 2007).  
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1.3.3.2 Mutants targeting heparan sulfate biosynthesis 
Most of the enzymes required for HSPG synthesis have also been targeted to 
generate knockout mouse models. Unsurprisingly, targeting essential steps in HS 
biosynthesis results leads to more severe defects than targeting individual HS core 
proteins. For example, mice null for Ext1 or Ext2, which cannot polymerise HS 
chains, will die during gestation around E6-7.5 (Lin et al., 2000; Stickens et al., 
2005). A floxed allele of Ext1 is also available, which when targeted with CRE 
recombinase will delete Ext1 and will consequently not form any functional EXT1/2 
heterodimers. Nestin-Cre targeting of floxed Ext1 results in complete penetrance 
brain structure malformations as well as midline axon guidance defects (Inatani et 
al., 2003). 
The Ndst1-null mutation causes perinatal lethality and mice have abnormal 
forebrain and craniofacial development as well as lung hypoplasia (Fan et al., 2000; 
Ringvall et al., 2000; Grobe et al., 2005). In contrast, both Ndst2-/- and Ndst3-/- 
mutant mice are viable and display mild defects (Forsberg et al., 1999; Humphries et 
al., 1999; Pallerla et al., 2008). An Ndst4-null mouse has not been reported. 
 Several mutant mice have also been generated to target different O-
sulfotransferases, which I have analysed further during nervous system development 
in Chapter 4. The Hs2st-null mouse was generated using a gene trap approach; this 
mutation is perinatal lethal with kidney agenesis, skeletal and ocular defects as well 
as reduced cell proliferation in the cortex (Bullock et al., 1998; Merry et al., 2001; 
McLaughlin et al., 2003). Interestingly, the loss of 2-O-sulfotransferase, both in mice 
and Drosophila, increases levels of 6-O and N-sulfation (Merry et al., 2001; Dejima 
et al., 2013). Hs6st1-null mice are embryonic lethal due to abnormal placenta 
microvessels and also develop commissural axon defects (Pratt et al., 2006; Habuchi 
et al., 2007; Conway et al., 2011). On the other hand, Hs6st2 does not seem to be as 
essential for development, as Hs6st2-mice are viable and develop only metabolic 
defects (Sedita et al., 2004). Hs6st3 mutant mice have not been reported.  
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1.3.4 HSPG signalling interactions  
1.3.4.1 HSPGs and VEGF-A signalling 
HSPGs can interact with a variety of signalling pathways including FGFs, 
VEGF, glial cell-line derived neurotrophic factor (GDNF), hedgehog and SLITs by 
either forming functional signalling complexes or by affecting their tissue 
distribution (Hacker et al., 2005; Bishop et al., 2007). Studies in vitro have shown 
that heparin promotes VEGF165-binding to FLK1, FLT1 and NRP1 (Gitay-Goren et 
al., 1992; Tessler et al., 1994; Soker et al., 1998). Furthermore, VEGF-A also binds 
to heparin with high affinity through domains encoded in exons 6 and 7, which 
affects its distribution in vivo (section 1.2.1.2; (Park et al., 1993; Ruhrberg et al., 
2002; Gerhardt et al., 2003). Thus, mice expressing only the VEGF120 isoform, 
which lacks the heparin-binding domains and is consequently very diffusible, have 
impaired tip cell filopodia extension and reduced branch points in the brain 
vasculature (Ruhrberg et al., 2002). Vice versa, mice that only expressed the heparin 
binding isoform VEGF188 show excessive and ectopic vascular branching (Ruhrberg 
et al., 2002). This evidence shows that VEGF requires HSPGs to localise different 
isoforms in the ECM and thereby forms gradients in a tissue specific manner.  
One study has shown that VEGF can use HSPGs in a trans complex to signal 
correctly. Embryonic stem cells expressing FLK1 can form vessels upon VEGF 
induction, whilst in Ndst1/2-/- embryoid bodies there is a reduced response to VEGF 
(Jakobsson et al., 2006). However, mosaic embryoid bodies, containing Flk-/- and 
Ndst1/2-/- cells, can respond to VEGF and form vessels. The resulting vessels 
contained pericytes with normal HSPG content (derived from Flk-/- cells) and FLK1 
expressing endothelial cells (derived from Ndst1/2-/- cells). This suggests that in 
some situations VEGF requires HSPGs to signal through FLK1. 
Some HSPG modifications have been described as important for the 
interaction with VEGF. Interestingly, Ndst1-/- mice have reduced VEGF induced 
vascular hyperpermeability in vivo (Xu et al., 2011). Several studies have shown that 
VEGF requires the presence of 6-O-sulfated proteins to correctly signal in 
endothelial cells in vitro (Ashikari-Hada et al., 2005; Robinson et al., 2006). In vivo, 
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its been shown that Hs6st2 and Vegfa interact for correct caudal vein development in 
zebrafish (Chen et al., 2005).  
 
1.3.4.2 HSPGs and FGF signalling 
The interaction between FGFs and HSPGs has been thoroughly characterised 
(reviewed by (Mohammadi et al., 2005; Matsuo and Kimura-Yoshida, 2013). Early 
experiments showed that HS chains enable the formation of a ternary complex that is 
required for FGF2 to bind FGFR1 in cultured cells (Rapraeger et al., 1991; Yayon et 
al., 1991). Crystal structure analysis has shown that a unit consisting of a 1:1:1 
FGF:FGFR:HS dimer is required for correct FGF signalling, in this context HSPGs 
act as co-receptors (Schlessinger et al., 2000). In this dimer complex, each FGF 
binds both receptors, and the two receptors are also in direct contact. Furthermore, 
HSPGs have other functions during FGF signalling, as they can also determine the 
rate of FGF diffusion, act as a storage reservoir and also stabilise FGFs by lowering 
their degradation (Hacker et al., 2005; Sarrazin et al., 2011; Venero Galanternik et 
al., 2015).  
 Several in vitro studies have demonstrated that FGF signalling is mostly 
dependent on 2- and 6-O-sulfated groups as well as N-sulfation in HSPGs (Turnbull 
et al., 1992; Guimond et al., 1993; Maccarana et al., 1993). Interestingly, one study 
has shown that HS without 6-O-sulfation will bind FGF, but prevents it from forming 
a complex with FGFR (Lundin et al., 2000). Similarly to VEGF, evidence shows that 
FGFs require HSPGs with specific characteristics to signal appropriately in a tissue 
specific manner.  
The neuronal tissue-specific knockout of Ext1 in mice results in midbrain/hindbrain 
patterning defects caused by altered FGF8 distribution (Inatani et al., 2003). In 
Drosophila, both 2- and 6-O-sulfotransferases cooperate to control FGF signalling 
during tracheal development (Kamimura et al., 2006). In this case, deleting only one 
O-sulfotransferase does not cause tracheal defects, possibly because of compensation 
mechanisms. During lacrimal gland development, mice also require both HS2ST and 
HS6ST1 as well as NDST1/2 in a tissue specific manner for correct Fgf10-Fgfr2b. 
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Using a Cre targeting approach, it was shown that Hs2st1 and Hs6st1 are required in 
lacrimal gland epithelia, but dispensable in mesenchyme, whilst NDST1/2 are 
essential in both epithelia and mesenchyme (Pan et al., 2008; Qu et al., 2011a; Qu et 
al., 2012). Furthermore, Hs6st1-null mice have increase FGF8 levels in the corpus 
callosum, and Ndst1-/- mice have defective lens development because of disrupted 
FGF signalling (Pan et al., 2006; Clegg et al., 2014).  
  
 
56 
Gene/Mutation Proteoglycan Phenotype (reference) 
Sdc3-/- Syndecan 3 Enhanced long-term potentiation in the 
hippocampus (Kaksonen et al., 2002). 
Impaired neuronal migration leading to 
abnormal cortical laminar organisation 
(Hienola et al., 2006). 
Gpc1-/- Glypican 1 Impaired neurogenesis and reduced brain 
size (Jen et al., 2009). 
Gpc3-/- Glypican 3 Cardiac and vascular defects (Ng et al., 
2009). 
Gpc4-/- Glypican 4 Defects in the formation of excitatory 
synapses in the hippocampus (Allen et al., 
2012). 
Hspg2-/- Perlecan Neuromuscular junctions lacking 
acetylcholinesterase (Arikawa-Hirasawa et 
al., 2002). Cardiac flow tract defects 
(Costell et al., 2002). Defects in cephalic 
development (Arikawa-Hirasawa et al., 
1999). 
Agn-/- Agrin Defective number and formation of 
synapses in the CNS (Serpinskaya et al., 
1999; Gingras et al., 2007). Small brain 
(Ksiazek et al., 2007). Reduction in the 
number, density and size of acetylcholine 
receptors in muscles (Gautam et al., 1996).  
Nsdt1-/- N-deacetylase/N-
sulfotransferase 1 
Abnormal craniofacial and forebrain 
development (Grobe et al., 2005). Lung 
hypoplasia (Fan et al., 2000). 
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Hs2st-/- 2-O-
sulfotranferase 
Kidney agenesis (Bullock et al., 1998). 
Reduced proliferation during cortical 
development (McLaughlin et al., 2003). 
Hs6st1-/- 6-O-
sulfotranferase 1 
Commissural axon guidance defects (Pratt 
et al., 2006; Habuchi et al., 2007; Conway 
et al., 2011). 
Hs6st2-/- 6-O-
sulfotranferase 2 
Metabolic defects (Sedita et al., 2004). 
Extfl/fl Nestin-
Cre 
Exotosin 1 Midline axon guidance defects and brain 
structure malformations (Inatani et al., 
2003). 
Table 1.2 Mutation in HSPGs affecting neuronal development in the mouse. 
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1.4 AIMS OF THIS STUDY 
For the correct development of the nervous system neurons must find their 
appropriate location in the brain and make synaptic connections with their targets. A 
combinatorial use of several different signalling molecules is required during cranial 
axon guidance and vertebrate neuronal migration. However, the way in which these 
different signalling pathways collaborate or differ is not well understood. I used 
mouse genetic models to analyse the individual and combinatorial signal of different 
signalling molecules required during FBM neuron migration and cranial axon 
guidance.  
 
! The NRP1 binding properties of the VEGF165 and VEGF121 isoforms have 
been extensively studied, while the longer isoform VEGF189 has been 
neglected. In Chapter 3 I aim to investigate VEGF189 binding and signalling 
through NRP1 in the developing nervous system.  
! In Chapter 4 I aim to investigate the role of HSPG modifying enzymes 2- and 
6-O-sulfotransferases in FBM neuron migration and cranial axon guidance. I 
also aim to analyse the interaction between HSPG modifiers and other 
signalling pathways. 
! In Chapter 5 I aim to characterise different Cre lines under the control of 
neuronal promoters by targeting new and known pathways important during 
FBM neuron development. 
  
 
59 
Chapter 2 MATERIALS AND METHODS 
 
2.1 MATERIALS 
2.1.1 General laboratory materials 
All reagents were obtained form Sigma Aldrich, besides where indicated. 
Glassware was obtained from VWR international. Plasticware was obtained from 
Corning or Nunc. 
 
2.1.2 General laboratory solutions 
Water was purified using a MilliRo 15 Water Purification System 
(Millipore). Where necessary water was further purified using a Milli-Q reagent 
Grade Water Ultrafiltration system (Millipore). DNAse- and RNAse-free water was 
obtained from Sigma Aldrich. Absolute ethanol, methanol and isopropanol were 
obtained from Fischer Scientific.  
1X PBS 137mM NaCl, 3mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4, pH 7.2 
1X PBT 1X PBS + 0.1% Triton X100 (for immunolabelling) 
1X PBT 1X PBS + 0.1% Tween 20 (for in situ hybridisation) 
1X TAE 40mM Tris-acetate, 1mM EDTA, pH 8.0 
1X TBS 10mM Tris-HCl pH 8.0, 150mM NaCl (for immunolabelling) 
1X TBS 25mM Tris pH 7.5, 150mM NaCl, 3mM KCl (for in situ 
hybridisation) 
1X TBST 1X TBS + 1% Tween 20 
1X TE  10mM Tris-HCl, 1mM EDTA, pH 8.0 
4% PFA 4% formaldehyde, made freshly from paraformaldehyde, in PBS 
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2.2 ANIMAL METHODS 
 All animal research was conducted under the ethical approval of the United 
Kingdom Home Office. 
 
2.2.1 Animal maintenance and husbandry 
 Mice were mated in the evening and checked for vaginal plugs the following 
morning. The morning of vaginal plug formation was counted as 0.5 days post 
coitum. Females were culled by cervical dislocation and embryos were harvested in 
ice cold PBS. All mice were on CD1 or C57Bl/6 genetic backgrounds.  
 
2.2.2 Genetic mouse strains 
 See Table 2.1 for details of mouse strains used. 
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Gene/Mutation Provider Reference 
Nrp1 Knockout Dr Hajime Fujisawa (Kitsukawa et al., 1997) 
Nrp1 floxed Dr David Ginty (Gu et al., 2003) 
Nrp2 floxed Dr Alex Kolodkin (Walz et al., 2002) 
Vegfa120/120 Knockin Dr David Shima (Carmeliet, 1999) 
Vegfa188/188 Knockin Dr Peter Carmeliet (Stalmans et al., 2002) 
Hs6st1 LacZ Knockin Dr Tom Pratt (Leighton et al., 2001; 
Mitchell et al., 2001) 
Hs6st2 LacZ Knockin Lexicon Pharmaceuticals (Sugaya et al., 2008) 
Hs2st LacZ Knockin Dr Valerie Wilson (Bullock et al., 1998) 
Ext1 floxed Dr Yu Yamaguchi (Inatani et al., 2003) 
Sdc1 Knockout Dr Michael Simons (Alexander et al., 2000) 
Sdc2 Knockout Dr Michael Simons (Skarnes et al., 2011) 
Sdc4 Knockout Dr Michael Simons (Li et al., 2002) 
Vegfa floxed Dr Napoleone Ferrara (Gerber et al., 1999) 
VegfaHypo LacZ Knockin Dr Jody Haigh (Damert et al., 2002) 
Rosa26Yfp floxed Dr J. P. Barbera (Srinivas et al., 2001) 
Rosa26Dta floxed Dr J. P. Barbera (Ivanova et al., 2005) 
Nestin-Cre Dr Jody Haigh (Tronche et al., 1999) 
NesCre8 Dr Weimin Zhong (Petersen et al., 2002) 
Phox2b-Cre Dr Jean-Francois Brunet (D'Autreaux et al., 2011) 
Table 2.1 Mouse genetic strains, with source and reference. 
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2.2.3 Compound Hs6st1;Hs6st2 mutant mice 
To obtain compound Hs6st1;Hs6st2 mutants, mice heterozygous for the 
Hs6st1 null mutation were crossed with mice heterozygous for the Hs6st2 null 
mutation, and compound heterozygous mice were crossed to each other. This 
crossing resulted in mixtures of Hs6st1 and Hs6st2 heterozygous and homozygous 
mutations as well as wild types, and the Mendelian probability of obtaining a wild 
type or a compound homozygous Hs6st1;Hs6st2 mutant in these matings was 1/16.  
 
2.2.4 Vegfa isoform specific mice 
Mice expression only a single Vegfa specific isoform were used in this thesis 
termed Vegfa120/120, which expresses only the VEGF120 isoform and Vegfa188/188, 
which expressed only the VEGF188 isoform. Vegfa120/120 mice were generated using a 
Cre-LoxP system to remove Vegfa exons 6 and 7 in embryonic stem cells (Carmeliet 
et al., 1999). Vegfa188/188 mice were generated by replacing the Vegfa genomic 
sequence with Vegfa188 cDNA containing exons 4 to 8 (Stalmans et al., 2002).  
 
2.2.5 Tissue specific genetic targeting 
 The Cre-LoxP recombination system was used for tissue specific gene 
targeting (reviewed by (Nagy, 2000). This system uses the P1 phage CRE 
recombinase, a 38kDa enzyme that specifically recognises a 34bp sequence called 
LoxP. Inserting LoxP sites in flanking positions of a DNA target sequence allows 
CRE recombinase binding when present and leads to the excision or inversion of this 
sequence, depending on the orientation of the LoxP sites. For specific tissue targeting 
CRE recombinase can be inserted under the control of a selected tissue specific 
promoter. Depending on the choice of promoter to drive CRE expression, genetic 
deletions can occur somatic cells and consequently their entire progeny.  
 To evaluate the tissue targeting of different Cre lines, I used Rosa26 reporter 
mice that have a LoxP-flanked (floxed) stop cassette upstream of an enhance eYfp 
gene coding for enhanced yellow fluorescent protein (Rosa26Yfp) (Srinivas et al., 
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2001). I also used a Rosa26Dta line that is constructed in the same way as Rosa26Yfp 
but expresses the diphtheria toxin A (Dta) gene instead (Ivanova et al., 2005). This 
means that Cre targeting will excise the floxed stop cassette flanked by LoxP sites, 
which results in the expression of eYfp or Dta in the Cre expressing cells (Rosa26Yfp; 
Rosa26DTA). I analysed three Cre lines using this method, Phox2b-Cre (D'Autreaux 
et al., 2011); Nestin-Cre (Tronche et al., 1999); and NesCre8 (Petersen et al., 2002), 
to determine the level of targeting in migrating FBM neurons in the embryonic 
hindbrain.  
Phox2b-Cre; Nestin-Cre; and NesCre8 were used to target floxed Nrp1 (Gu 
et al., 2003) and Ext1 (Inatani et al., 2003) genes. The floxed Nrp1 and Ext1 mice 
were in some cases bred on a heterozygous null background to yield Nrp1fl/- and 
Ext1fl/- mice, respectively. I also targeted floxed Vegfa in neuronal progenitors; 
because crossing Vegfafl/fl (Gerber et al., 1999) mice to Nestin-Cre line results in 
offspring that is lethal during early embryonic development, I crossed a Vegfa 
hypomorphic strain (VegfaHypo/+) (Damert et al., 2002) and the floxed Vegfa line to 
create mice with one hypomorphic and one floxed Vegfa allele (VegfaHypo/fl). This 
approach was previously used successfully to substantially knock down Vegfa in the 
neural lineage without causing early embryonic lethality (Haigh et al., 2003). 
 
2.2.6 Genotyping 
Tissue biopsies were taken from mice, either ear punches from pre-weaning age mice 
or tail snips or yolk sacs from embryos. The biopsy tissue was incubated overnight at 
55°C in 500 µl of lysis buffer (100 mM Tris-HCl pH 8.5, 5 mM EDTA, 0.2% SDS, 
200 mM NaCl add 100 µg/ml proteinase K) for protein digestion. DNA was 
precipitated by adding 1 ml of ethanol and collect by centrifugation at 13000 rpm for 
5 minutes. The remaining pellet was washed with 70% ethanol, centrifuged as 
previously, and air-dried for 30 minutes before being resuspended in 100 µl of 0.2X 
TE buffer. All genotyping was carried out by Kathryn Davidson, Laura Denti, 
Valentina Senatore and Andy Joyce in the Ruhrberg lab. Polymerase chain reaction 
(PCR) amplification was performed using extracted genomic DNA on a MJ Research 
PTC-200 Peltier Thermal Cycler. A single reaction used 1 µl of genomic DNA with 
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10 µl Megamix Blue reaction mix (Microzone, contains Taq polymerase, dNTS, 
buffer loading dye) and 1 µg/µl of each oligonucleotide primer specific for the gene 
being targeted (synthesized by Sigma, see Table 2.2) using the relevant cycle and 
temperature program (Table 2.3). 
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Gene Primer Primer sequence 
Nrp1 
Nrp1fl 
NPneo 5’-CGTGATATTGCTGAAGAGCTTGGC-3’ 
NP-F 5’-CAATGACACTGACCAGGCTTATCATC-3’ 
NP-R 5’-GATTTTTATGGTCCCGCCACATTTGTC-3’ 
 
Nrp2fl 
Wt1 AGCTTTTGCCTCAGGACCCA 
Wt1 CAGGTGACTGGGGATAGGGTA 
loxP CCTGACTACTCCCAGTCATAG 
 
Hs6st1 
6OST-F 5’-ATGGTGACTGTGACCCACAA-3’ 
6OST-R 5’-GGGATATAGGGGACCTTGGA-3’ 
hPLAP-F 5’-ACAGCTGCCAGGATCCTAAA-3’ 
hPLAP-R 5’-CAAGCCAATGGTCTGGAAGT-3’ 
 
Hs6st2 
HS6ST2-34 5’- GTTCGGCCAGGTTTGTACC-3’ 
HS6ST2-35 5’- CAGCTGGTGAGCTCGGTC-3’ 
HS6ST2-neo 5’- GCAGCGCATCGCCTTCTATC-3’ 
HS6ST2-7 5’- CTAAGATAGGCTCTAGTGTCTAC-3’ 
 
Hs2st 
Hs2st1 5’-ATCAATGAATAATTGCCTAGGTC-3’ 
Hs2st2 5’-GGGAAGAAATTCACCCCAACA-3’ 
Hs2stV 5’-TACTCAGTGCAGTGCAGTCA-3’ 
 
Vegfa120 
120F2 5’-CAGTCTATTGCCTCCTGACCTTCAGGGTC-3’ 
120R2 5’-CTTGCGTCCACACCGTCACATTAAGTCAC-3’ 
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120E2 5’- 
TTCAGAGCGGAGAAAGCATTTGTTTGTCCA-3’ 
 
Vegfa188/164 
F 5’-CAAAGCCAGCACATAGGAGAGA-3’ 
E 5’-GTGGGTAGAGAAAGGAGGAGAA-3’ 
R 5’-TGGCTTGTCACATCTGCAAGTA-3’ 
Extfl Ext-11 5’- AAGGATTCTCGCTGTGACAG-3’ 
Ext-35 5’- CCAAAACTTGGATACGAGCC-3’ 
Vegfafl F 5’- CCTGGCCCTCAAGTACACCTT-3’ 
R 5’- TCCGTACGACGCATTTCTAG-3’ 
 
Rosa26Yfp/Dta 
WT-F1 5’-AAAGTCGCTCTGAGTTGTTAT-3’ 
WT-R1 5’-GGAGCGGGAGAAATGGATATG-3’ 
KO-F1 5’-GCGAAGAGTTTGTCCTCAACC-3’ 
 
VegfaHypo 
Stop 5’-GAGCATTTATTCCCATGTCTG-3’ 
Fusion 5’-CAGGCTTTCTGGATTAAGGAC-3’ 
Lac 5’-CATTACCAGTGGGTCTGGTG-3’ 
NesCre8 Nes8-F1 5’-GAATACCCTCGCTTCAGCTC-3’ 
Creb 5’-GCATTTTCCAGGTATGCTCAG-3’ 
Nestin-Cre 
Phox2b-Cre 
Cre1 5’-GCCTGCATTACCGGTCGATGCAACGA-3’ 
Cre2 5’-GTGGCAGATGGCGCGGCAACACCATT-3’ 
Table 2.2 Specific oligonucleotide primers used in genotyping. 
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Gene Start Denaturing Annealing Extension Cycles End 
Nrp1 94°C 
3 min 
94°C, 40 s 66°C, 1 min 72°C, 1.5 
min 
35 x 72°C, 
5 min 
Nrp1fl 95°C 
3 min 
95°C, 30 s 69°C, 30 s 72°C, 1 
min 
34 x 72°C, 
5 min 
Nrp2fl 95°C 
2 min 
94°C, 40 s 60°C, 1 min 72°C, 1 
min 
34 x 72°C, 
5 min 
Hs6st1 94°C 
4 min 
94°C, 20 s 58°C, 30 s 72°C, 30 s 29 x 72°C, 
1 min 
Hs6st2 94°C 
4 min 
94°C, 30 s 65°C, 1 min 72°C, 1 
min 
32 x 72°C, 
10 
min 
Hs2st 94°C 
3 min 
94°C, 40 s 60°C, 45 s 72°C, 2 
min 
36 x 72°C, 
5 min 
Vegfa120 94°C 
3 min 
94°C, 40 s 52°C, 1 min 72°C, 1.5 
min 
5 x  
  94°C, 40 s 60°C, 1 min 72°C, 1.5 
min 
28 x 72°C, 
5 min 
Vegfa188/164 94°C 
4 min 
94°C, 40 s 55°C, 1 min 72°C, 1.5 
min 
34 x 72°C, 
5 min 
Extfl 94°C 
2 min 
94°C, 45 s 56°C, 45 s 72°C, 2 
min 
32 x 72°C, 
5 min 
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Vegfafl 94°C 
3 min 
94°C, 40 s 52°C, 1 min 72°C, 1.5 
min 
5 x   
  94°C, 40 s 60°C, 1 min 72°C, 1.5 
min 
28 x 72°C, 
5 min 
Rosa26Yfp/Dta 94°C 
4 min 
94°C, 30 s 59°C, 45 s 72°C, 1 
min 
34 x 72°C, 
3 min 
VegfaHypo 94°C 
4 min 
94°C, 40 s 55°C, 1 min 72°C, 1.5 
min 
34 x 72°C, 
5 min 
NesCre8 94°C 
3 min 
94°C 1 min 67°C, 1 min 72°C, 1 
min 
32 x 72°C, 
3 min 
Cre 94°C 
3 min 
94°C, 1 min 67°C, 1 min 72°C, 1 
min 
40 x 72°C, 
3 min 
Table 2.3 Details of PCR cycling parameters used in genotyping. 
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2.3 TISSUE PROCESSING 
2.3.1 Tissue fixation 
 Pregnant mice at the appropriate day of gestation were culled in accordance 
with the Home Office Schedule 1 regulations. Embryos were removed from the 
pregnant uterus and the umbilical cord severed in ice-cold 1X PBS and fixed in 4% 
formaldehyde solution at 4°C for 2 hours (immunolabelling) or overnight (in situ 
hybridisation). For hindbrain experiments, the head was severed from the trunk 
above the limbs and fixed separately. Embryos required for wholemount TUJ1 
immunolabelling were fixed and maintained in Dents fixative (4:1 methanol:DMSO) 
at -20°C. 
 
2.3.2 Cryosectioning 
 Fixed samples washed twice in PBS, and incubated in 30% sucrose in PBS at 
4°C until the tissue was equilibrated, i.e. sank to the bottom of the tray holding the 
sucrose. Tissue for in situ hybridisation was fixed as described above, then washed 
twice in PBS and incubated in methanol overnight at -20°C. Tissue was then 
embedded in OCT (Sakura Tissue-Tek), frozen on dry ice and stored at -80°C. 
Frozen samples were cut at various thicknesses ranging from 10-40 µm using a 
histology cryostat (Leica CM 1850) and collected on Superfrost Plus slides (VWR 
International). Slides with cryosections were stored at -20°C. 
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2.4 IMMUNOLABELLING 
2.4.1 Immunolabelling of cryosections 
 Slides containing cryosections were allowed to air dry at room temperature 
for 1 hour. Cryosections were rehydrated and excess OCT was washed off with 2 
PBS washes. Cryosections were incubated for 10 minutes in PBT to permeabilise the 
tissue. Slides were incubated in blocking solution (10% normal goat serum in PBT; 
or 100% Dako serum free) for 30 minutes at room temperature. Slides were then 
incubated in a wet chamber overnight at 4°C with primary antibody and appropriate 
blocking solution (see Table 2.4 for antibody dilutions and blocking solutions). The 
next day slides were washed 3 times for 5 minutes each at room temperature in PBT. 
Cryosections were then incubated at room temperature with secondary antibody in 
blocking solution in the dark. The slides were then washed 3 times for 5 minutes 
each at room temperature in PBS and post-fixed for 5 minutes with 4% 
formaldehyde solution. Sections were mounted in Mowiol 4-88 (Calbiochem). For 
all experiments a minimum of three embryos were analysed for each genotype. All 
mutants analysed were compared to control littermates. 
 
2.4.2 Wholemount Immunolabelling 
 Samples were incubated at room temperature for 30 minutes in PBT to 
permeabilise the tissue. Wholemount samples were then incubated for 1 hour at room 
temperature in blocking solution (10% normal goat serum in PBT; or 100% protein 
block, serum free; Dako), then incubated overnight (anti-ISL1 antibody is incubated 
for 4 days) at 4°C with primary antibody and appropriate blocking solution (Table 
2.4). Samples were then washed at least 4 times in PBT for 30 minutes each and then 
incubated for 1-2 hours at room temperature with secondary antibody. Samples were 
then washed as described above and post-fixed for 15 minutes with 4% 
formaldehyde solution. 
 Fluorescently labelled wholemount hindbrains were mounted using SlowFade 
(Life Technologies). 
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 Wholemount immunolabelling of samples for TUJ1 staining was bleached 
using hydrogen peroxidase (10% H2O2 in Dents fixative) overnight hours at room 
temperature. Embryos were washed 3 times with TBS for 60 minutes each at room 
temperature, then incubated overnight in TUJ1 antibody dilute in blocking serum 
(normal goat serum with 20% DMSO and 0.12% thimerosal) at room temperature. 
The following day embryos were washed 5 times with TBS for 1 hour each at room 
temperature then incubated overnight in secondary antibody (peroxidase conjugated) 
dilute in blocking serum. Stained embryos were then incubated in DAB and 
hydrogen peroxide (SigmaFast, Sigma) until colour developed. To stop the reaction 
embryos were washed several times in TBS and postfixed in 4% formaldehyde 
solution.  
Wholemount HRP stained embryos were cleared before imaging using 
BAAB (1:2 benzyl alcohol:benzyl benzoate). Embryos were dehydrated in 100% 
methanol for 30 minutes, followed by 50% methanol 50% BAAB for 30 minutes, 
and finally 100% BAAB solution. For all experiments a minimum of three embryos 
were analysed for each genotype. All mutants analysed were compared to control 
littermates. 
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Primary antibody  
(dilution, supplier) 
Secondary antibody  
(dilution) 
Blocking solution 
Goat anti-NRP1 (1:100, 
R&D Systems) 
Alexa594-conjugated 
donkey anti-goat Fab 
fragment (1:200) 
Dako serum free protein 
block 
Rabbit anti-GnRH 
(1:1000, Immunostar) 
HRP-conjugated goat anti-
rabbit IgG (1:200) 
10% NGS/PBT 
Rabbit anti-TUJ1 (1:250, 
Millipore) 
Alexa488-conjugated 
donkey anti-rabbit Fab 
fragment (1:200)  
HRP-conjugated goat anti-
rabbit IgG (1:200) 
10% NGS/PBT or 
NGS and 20% DMSO 
Rabbit anti-GFP (1:500, 
Medical and Biological 
Laboratories) 
Alexa488-conjugated 
donkey anti-rabbit Fab 
fragment (1:200)  
10% NGS/PBT 
Bandeiraea simplicifolia 
Isolectin B4 (1:200, 
Sigma) 
Streptavidin-Alexa633 10% NGS/PBT 
Mouse anti-ISL1 (1:100, 
Developmental Studies 
Hybridoma Bank) 
Alexa488-conjugated 
donkey anti-mouse Fab 
fragment (1:200) 
10% NGS/PBT 
Table 2.4 List of antibodies and lectin used for immunolabelling.  
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2.5 IN SITU HYBRIDISATION (ISH) 
2.5.1 Bacterial culture of plasmid containing in situ probe 
 Chemical transformation competent bacteria were prepared by culturing a 
single colony of DH5" overnight at 37°C without shaking in 10 ml 2YT medium (16 
g/l bacto tryptone, 10 g/l bacto yeast extract, 5 g/l NaCl, pH 7.2). The culture was 
then used to inoculate 100 ml of P-media (50 ml 10X P-buffer (6.92 g K2HPO4, 2.15 
g KH2PO4, 4.96 g NH4SO4 in 250 ml distilled water), 50 ml 10% (w/v) casamino 
acids, 5 ml 1 M MgSO4, 0.5 ml 1.8 mM FeSO4, 6.25 ml 20% glucose (w/v) in 500 
ml distilled water) and grown at 37°C with shaking until the O.D600 reached 0.4. 
The bacteria was centrifuged at 6000 rpm for 10 minutes at 4°C, the pellet was 
washed once in ice cold 10mM NaCl, suspended in 100 ml ice cold 50 mM CaCl2 
and incubated on ice for 15 minutes. The bacteria was centrifuged again at 6000 rpm 
for 10 minutes at 4°C, resuspended in 10 ml ice cold 50 mM CaCl containing 16% 
glycerol (w/v), aliquoted and stored at -80°C.  
 Chemically competent cells were used to transform plasmids containing 
cDNA. Competent cells were thawed on ice and 1 ng of plasmid DNA was incubated 
on ice with 100 µl of competent cells. The bacteria were heat-shocked for 90 seconds 
at 42°C and then placed on ice for 10 seconds. 600 µl of L-broth medium (10g/l 
bacto tryptone, 5 g/l yeast extract, 5 g/l NaCl) were added and the bacterial 
suspension was allowed to grow for 30 minutes at 37°C. The bacterial culture was 
then spread on L-agar plates containing the appropriate antibiotic (L-broth, 100 
µg/ml ampicillin, 15 g/l agar) and incubated overnight at 37°C. A single colony was 
picked and grown in L-broth with the appropriate antibiotic (100 µg/ml ampicillin) 
overnight with shaking at 37°C. 
 
2.5.2 RNA probe synthesis 
 Plasmids were isolated with the QIAprep Spin Miniprep kit (Qiagen), 
according to manufacturer’s instructions. The isolated plasmid was linearized using 
the appropriate restriction enzyme (New England Biolabs) (see Table 2.5 for 
individual probe details) for 2 hours at 37°C in a reaction mixture according to 
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manufacturer’s instruction: 5 µl plasmid DNA, 2 µl 10X buffer, 1 µl enzyme, 12 µl 
water. Phenol/chloroform was used to extract linearized plasmid DNA. RNA for in 
situ hybridisation was synthesized by reverse transcription using the appropriate 
polymerase (Roche) (Table 2.5) for 2 hours at 37°C in a reaction mixture according 
to manufacturer’s instruction: 14.5 µl DNA, 2 µl 10X buffer, 2 µl 10X DIG labelling 
mixture (Roche), 1 µl polymerase and 0.5 µl RNAse inhibitor (Roche). RNA was 
precipitated by adding 80 µl of water, 8 µl 5 M lithium chloride, 1 µl GlycoBlue 
(Life Technologies) and 300 µl ethanol. The mixture was incubated overnight at -
80°C followed by centrifugation for 15 minutes at 13000 rpm and 4°C, the pellet was 
washed in 70% ethanol and allowed to air dry for 5 minutes before suspension in 40 
µl of water.  
 
2.5.3 Wholemount in situ hybridisation 
 As described previously tissue was fixed overnight at 4°C in 4% 
formaldehyde solution and stored at -20°C in methanol. Wholemount samples were 
then bleached with 6% hydrogen peroxide in methanol for 1 hour at room 
temperature. Samples were then rehydrated in serial dilutions of methanol and PBT. 
Rehydrated samples were permeabilised with 10 µg/ml Proteinase K in PBT at room 
temperature, 10 minutes for E10.5-12.5 hindbrains and 1 hour for E15.5 hindbrains. 
Samples were incubated in hybridisation solution (50% formamide (Roche), 5X SSC 
pH 4.5 (Sigma; sodium citrate, sodium chloride, citric acid), 50 µg/ml tRNA 
(Sigma), 50 µg/ml heparin (Sigma), 1% sodium dodecyl sulphate (Sigma) for 30 
minutes at 70°C and then incubated with RNA probe solution (3.5 µl in 1 ml 
hybridisation solution) overnight at 65°C. The next day samples were washed 3 
times in solution 1 (50% formamide, 5X SSC pH 4.5, 1% SDS) and 3 times in 
solution 3 (50% formamide, 2X SSC pH 4.5) at 65°C for 30 minutes each. I then 
washed the samples briefly twice with TBST (1X TBS, 1% Tween 20) at room 
temperature and blocked the tissue using 10% sheep serum in TBST for 30 minutes 
are room temperature, then incubated overnight at 4°C with anti-digoxigenin alkaline 
phosphatase antibody (Roche) at 1:5000 in 1% sheep serum in TBST. The following 
day, the samples were washed with TBST at least 5 times for 1 hour each at room 
temperature and left washing overnight at 4°C. Samples were washed 3 times for 10 
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minutes at room temperature in NTMT buffer (100 mM NaCl, 100 mM Tris-HCl pH 
9.5, 1% Tween20, 50 mM MgCl2), then incubated in developing solution containing 
(3.5 µl BCIP and 4.5 µl NBT (Roche) per ml of NTMT) at room temperature until 
alkaline phosphatase develops. The reaction was stopped by washing in TBST and 
the tissue stored in 4% formaldehyde solution at 4°C. For all experiments a 
minimum of three embryos were analysed for each genotype. All mutants analysed 
were compared to control littermates. 
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Probe Anti-sense 
restriction 
enzyme 
Polymerase Source Reference 
Isl1 NcoI Sp6 Dr Tom Jessel (Ericson et al., 1992) 
Nrp1 NotI T7 Dr Marcus Fruttiger (He and Tessier-
Lavigne, 1997) 
Nrp2 XhoI T3 Dr Marc Tessier-
Lavigne 
(Chen et al., 1997) 
Hs6st1 EcoRI T3 Dr Xin Zhang (Sedita et al., 2004) 
Hs6st2 EcoRI T3 Dr Xin Zhang (Sedita et al., 2004) 
Hoxb1 EcoRI T3 Dr Linda Ariza-
McNaughton 
(Gavalas et al., 2003) 
Fgfr1 HindIII T3 Dr Siew-Lan Ang (Trokovic et al., 2003) 
Fgfr2 NdeI T7 Dr Quenten Schwarz  
Fgfr3 XhoI T3 Dr Siew-Lan Ang (Pringle et al., 2003) 
Fgfr4 ApaI Sp6 Dr Quenten Schwarz  
Erm Sal1 T7 Dr Siew-Lan Ang (Trokovic et al., 2005) 
Table 2.5 Restriction enzyme and polymerase specific to anti-sense in situ 
hybridisation probes. 
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2.6 LABELLING TECHNIQUES 
2.6.1 X-gal assay 
 !-galactosidase activity was visualised in samples containing a lacZ inserted 
in the locus of a specific gene. Embryos were dissected and fixed with 4% 
formaldehyde solution for 30 minutes at 4°C and then processed for wholemount 
staining or frozen for cryosections. Tissue was then washed in 0.02% NP-40 in PBS 
three times for 15 minutes at room temperature. Samples were incubated at 37°C in 
X-gal (stock: 40 mg/ml in dimethylformamide) diluted 1:40 in staining solution 
(5mM K3Fe(CN)6, 5mM K4Fe(CN)6.3H2O, 2mM MgCl2, 0.01%  sodium 
deoxycholate) until sufficient blue colour developed. The reaction was stopped by 
washing with PBS, and tissue was stored in 4% formaldehyde solution at 4°C. 
 
2.6.2 Alkaline phosphatase (AP)-binding assay 
 To generate VEGF121, VEGF165 and VEGF189 isoform-specific AP probes, 
the open reading frames for each VEGF isoform was amplified from pBluescript 
plasmid containing the relevant cDNA sequences by PCR with the oligonucleotides 
5’-AATAATGGATCCGCACCCATGGCAGAAGGAG-3’ and 5'-
TATATGCTCGAGCTCACCGCCTCGGCTTGTC-3'. The PCR products were 
cloned into pAG3-AP containing an upstream in-frame AP cassette, which was 
kindly donated by Dr Jonathan Raper, University of Pennsylvania. For this, the 
pAG3-AP plasmid was cut using the restriction enzymes BglII and XhoI (New 
England Biolabs) and ligated using T4 ligase (New England Biolabs) to the PCR 
product digested with BamHI and XhoI. The ligation products were transformed 
using chemically competent bacteria and the plasmid was isolated with a HiSpeed 
Plasmid Maxi kit (Qiagen) according to the manufacturer’s instructions.  
 AP expression vectors were transfected into HEK-293T or Cos cells using 
Lipofectamine 2000 (Life Technologies). Briefly, cells were transfected using 1 ml 
of Opti-MEM (Life Technologies) containing 31 µl of Lipofectamine 2000 and 13 
µg of plasmid DNA which was mixed with cells cultured in DMEM and incubated at 
37°C in 5% CO2for 4-6 hours. The medium was then replaced with DMEM 
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supplemented with 10% FBS and PenStrep. Cells were incubated at 37°C in 5% CO2 
for 48 hours and the conditioned media containing AP-fusion protein was collected 
and stored in aliquots at -80°C. AP activity was checked by spotting conditioned 
media on nitrocellulose filters and incubating in NTMT buffer (100 mM NaCl, 100 
mM Tris-HCl pH 9.5, 1% Tween20, 50 mM MgCl2) with BCIP and NBT.  
 For wholemount AP assays, freshly dissected E12.5 hindbrains were 
incubated in PBS containing 10% FBS for 30 minutes at room temperature, then 
incubated overnight with conditioned media containing AP-fusion protein at 4°C. 
The following day, tissue was washed with PBS 3 times for 10 minutes at room 
temperature, then fixed with 4% formaldehyde solution for 1 hour at room 
temperature, and washed with PBT 3 times for 10 minutes also at room temperature. 
The samples were incubated for 3 hours at 65°C in order to heat-inactivate 
endogenous AP. After that the samples were washed 2 times in PBS for 10 minutes 
and incubated in NTMT buffer containing BCIP and NBT at room temperature until 
colour developed. To stop the developing reaction samples were washed in PBS and 
kept at 4°C in formaldehyde solution. 
 
2.6.3 DiI labelling 
DiI labelling was performed with fixed tissues as described (Erskine et al., 2011). A 
DiI crystal (Life Technologies) was placed over the optic disc of one eye for 
anterograde labelling. After 3 days at 37˚C, dissected brains were imaged ventral 
side up. ImageJ was used to determine the pixel intensity in defined areas of the 
ipsilateral and contralateral optic tracts, and the ipsilateral index calculated as the 
ratio of fluorescent intensity in the ipsilateral relative to the ipsilateral plus 
contralateral tracts. For retrograde labelling, the cortex was removed unilaterally and 
DiI crystals placed in a row over the dorsal thalamus for 15 weeks at room 
temperature; we imaged flatmounted retinas as above and determined the percentage 
of labelled ipsilateral RGCs relative to the ipsilateral plus contralateral RGCs. A 
minimum of three embryos were analysed for each genotype. Tissue was collected 
and fixed by Miguel Tillo and DiI labelling was performed by Professor Lynda 
Erskine, University of Aberdeen. 
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2.7 HINDBRAIN EXPLANTS 
 Culture inserts with 8-micrometer pore size (Corning) were washed in sterile 
PBS and incubated in Neurobasal (Life Technologies) supplemented with 20 µg/ml 
laminin (Life Technologies) for at least 1 hour at 37°C in 5% CO2. Hindbrains were 
dissected from E11.25 embryos in ice cold L15 (Life Technologies), meninges were 
removed and hindbrains left in an open-book preparation. After dissection, 1-3 Affi-
Gel heparin beads (Biorad), soaked overnight in 100 µg/ml VEGF (Peprotech) or 10 
µg/ml FGF2 (Sigma), were implanted on one side of the hindbrain at the level of 
rhombomere 6. Each hindbrain was placed ventral side up in one previously coated 
culture insert and dried using a paper towel. The embryos were cultured in 
Neurobasal medium supplemented with 20 µl/ml 50X B-27 (Life Technologies) and 
6 ng/ml glucose and incubated for 30 hours at 37°C in 5% CO2. FBM neuron 
migration was measured with ImageJ (NIH) as the distance travelled from r5 to the 
leading group of cells in r6 in each hindbrain and normalised to the control side of 
each hindbrain. This protocol has been published in (Tillo et al., 2014) (a copy of the 
publication is appended to this thesis).  
 
2.8 GnRH NEURON (GN11) CULTURE AND SURVIVAL ASSAY 
GN11 cells were grown in standard conditions (Dulbecco’s MEM containing 1 
mM sodium pyruvate, 100 mg/ml streptomycin, 100 U/ml penicillin and 10% FBS; 
Life Technologies). The cells were then seeded in 24-well plates at a density of 5000 
cells/well and grown for 24 hours in same standard conditions. For survival assays, 
cells were serum starved for 72 h and treated for 12 h with media containing 10% 
FBS, 10 ng/ml VEGF120, VEGF164 or VEGF188. Cells were labelled with propidium 
iodide (PI) (Life Technologies) and Hoechst fluorochrome (Life Technologies). The 
number of non-viable cells was determined as the relative number of PI-labelled cells 
compared to the total number of Hoechst fluorochrome-positive cells.  
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2.9 GnRH NEURON QUANTIFICATION IN VIVO 
E14.5 heads were fixed in 4% PFA for 4-8 hours at room temperature. The 
tissue was cryoprotected in 30% sucrose in PBS and embedded in Tissue-Tek OCT. 
Using a cryostat the heads were sectioned sagitally in 20 µm sections. The sections 
were then incubated in 3% H2O2 for 1 hour at room temperature before 
immunolabelling with anti-GnRH antibody as previously described in Section 2.4. A 
minimum of three embryos were analysed for each genotype. The total number of 
GnRH-positive cells was counted across every section in each head.  
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2.10 IMAGING 
 Fluorescently labelled samples were imaged using a laser scanning confocal 
microscope (LSM510, LSM700, LSM710, Zeiss). HRP labelled tissue and in situ 
hybridisation were photographed using an Olympus SZX16 equipped with a camera 
(QImaging Micropublisher 3.3 RTV) and the imaging software OpenLab 5.5.2 
(Improvision Ltd.). Images were processed using Adobe Photoshop CS4 (Adobe 
Systems, Inc.). 
 
2.11 RT-PCR 
 Tissue was homogenised using a 23G needle syringe and RNA was extracted 
with 1 ml of Tri-Reagent (Sigma) according to manufacturers instructions. 250 µl of 
chloroform were added to each sample, shaken vigorously, and centrifuged at 12000 
rpm for 15 minutes at 4°C. Samples separated into 3 phases and the upper aqueous 
phase was transferred to a new tube and 500 µl of isopropanol were added. The 
mixture was incubated for 10 minutes at room temperature and then centrifuged at 
12000 rpm for 10 minutes at 4°C. The remaining pellet was washed with 70% 
ethanol, air dried and resuspended in 20 µl of water. The concentration of RNA was 
quantified and quality was assessed using a NanoDrop Spectrophotometer ND-1000 
(Thermo Scientific).  
cDNA was synthesised using Superscript Reverse Transcriptase III kit (Life 
Technologies). The mixture contained 1 µg of RNA, 3 µg of random primers and 1 
µl of dNTPs made up with water to a total volume of 12 µl, and was heated to 65°C 
for 5 minutes then rapidly chilled on ice. Following this, 4 µl of 5X First Strand 
Buffer, 2 µl of 0.1 M dithiothreitol (DTT) and 1 µl of RNAse OUT (40 units/µl), 1 µl 
of Superscript Reverse Transcriptase III was added and the mixture was incubated at 
25°C for 10 minutes, 50°C for 1 hour and lastly at 70°C for 15 minutes to stop the 
reaction. All cDNA was stored at -20°C. 
RT-PCR was carried out using Megamix Blue reaction mix (Microzone) and 
oligonucleotides (see Table 2.6 for sequences) (Sigma).  
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Gene Primer Sequence 
Fgfr1 Forward 5’-AACCTCTAACCGCAGAAC-3’ 
Reverse 5’-GAGACTCCACTTCCACAG-3’ 
Fgfr2 Forward 5’-AATCTCCCAACCAGAAGCGTA-3’ 
Reverse 5’-CTCCCCAATAAGCACTGTCCT-3’ 
Fgfr3 Forward 5’-GGAGGACGTGGCTGAAGAC-3’ 
Reverse 5’-GGAGCTTGATGCCCCCAAT-3’ 
Fgfr4 Forward 5’-ATGACCGTCGTACACAATCTTAC-3’ 
Reverse 5’-TGTCCAGTAGGGTGCTTGC-3’ 
Vegfa 120 Forward 5’-GTAACGATGAAGCCCTGGAG-3’ 
Reverse 5’-CCTTGGCTTGTCACATTTTTC-3’ 
Vegfa 164 Forward 5’-AGCCAGAAAATCACTGTGAGC-3’ 
Reverse R 5’-GCCTTGGCTTGTCACATCT-3’ 
Vegfa 188 Forward 5’-AGTTCGAGGAAAGGGAAAGG-3’ 
Reverse 5’-GCCTTGGCTTGTCACATCT-3’ 
Table 2.6 Oligonucleotide sequences for RT-PCR. 
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Chapter 3 VEGF189 BINDS TO NRP1 IN THE DEVELOPING 
NERVOUS SYSTEM 
 
3.1 INTRODUCTION 
VEGF-A is a potent inducer of blood vessel growth, but also has essential 
roles in neurodevelopment (Mackenzie and Ruhrberg, 2012). In humans, VEGF is 
encoded by a single gene (VEGFA) of eight exons that is alternatively spliced into 
isoforms, the major ones containing 121, 165 and 189 amino acid residues in humans 
and therefore termed VEGF121, VEGF165 and VEGF189, respectively (Figure 3.1 A; 
(Koch et al., 2011). The alternatively spliced exons 6 and 7 encode domains enable 
ECM binding, with VEGF121 being the most diffusible and VEGF189 the least 
soluble, whilst VEGF165 has intermediate properties. Furthermore, these exons 
additionally mediate differential binding to VEGF receptors. All VEGF isoforms 
bind the receptor tyrosine kinases VEGFR1 and VEGFR2, whereas the non-catalytic 
receptors NRP1 and NRP2 are VEGF isoform-specific receptors that preferentially 
bind VEGF165 over VEGF121 (Figure 3.1 A; (Soker et al., 1998; Gluzman-Poltorak et 
al., 2000). Unexpectedly, recent studies from our lab and others showed that VEGF 
binding to NRP1 is largely dispensable for embryonic angiogenesis (Fantin et al., 
2014; Gelfand et al., 2014). In contrast, VEGF signalling through NRP1 has multiple 
roles in neurodevelopment, including guiding FBM neurons in the hindbrain 
(Schwarz et al., 2004), promoting the survival of migrating gonadotropin-releasing 
hormone (GnRH) neurons (Cariboni et al., 2011) and enhancing the contralateral 
projection of RGC axons across the optic chiasm (Erskine et al., 2011).  
To demonstrate roles for VEGF binding to NRP1 in neurons, prior studies 
used Vegfa120/120 mice, which express VEGF120, the murine equivalent of VEGF121, 
but lack VEGF164 and VEGF188, corresponding to human VEGF165 and VEGF189, 
respectively (Carmeliet et al., 1999). Vegfa120/120 mice phenocopy the defects of 
NRP1 knockouts in FBM neuron migration, GnRH neuron survival and RGC axon 
guidance (Schwarz et al., 2004; Cariboni et al., 2011; Erskine et al., 2011). In all 
three systems, VEGF signalling was attributed to the activity of VEGF164, because it 
evokes appropriate neuronal responses in in vitro models including neuronal 
migration in hindbrain explants; axon outgrowth in RGC explants; survival in GnRH 
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neuron cultures (Schwarz et al., 2004; Cariboni et al., 2011; Erskine et al., 2011), and 
because NRP1’s ability to bind VEGF165 is well established (Soker et al., 1998; 
Parker et al., 2012) However, Vegfa120/120 mutants lack VEGF188 in addition to 
VEGF164. Yet, it has never previously been examined if VEGF189 can also function 
as a NRP1 ligand in vivo. Moreover, it is not known if VEGF121 can bind NRP1 in a 
physiologically relevant context, even though it has been suggested that the exon 8 
domain, present in all major VEGF isoforms including VEGF121, can mediate NRP1 
binding in vitro (Jia et al., 2006; Pan et al., 2007; Parker et al., 2012).   
I have generated alkaline phosphatase (AP)-conjugated VEGF isoforms for in 
situ ligand binding assays (Fantin et al., 2014) to examine if VEGF121 or VEGF189 
can bind NRP1 in vivo, as previously reported for VEGF165. In this chapter, I 
demonstrate that VEGF189 binds NRP1-expressing axon tracts in intact hindbrain 
tissue, but that VEGF121 is unable to do so. I further show that VEGF188 is co-
expressed with the other isoforms during VEGF/NRP1-dependent FBM neuron 
migration, GnRH neuron survival and RGC axon guidance. In collaboration with Dr 
Anna Cariboni and Dr Lynda Erskine, I further show that VEGF188 is sufficient to 
control FBM migration, GnRH neuron survival and RGC axon guidance, whilst 
VEGF120 is not. I conclude that VEGF188 effectively binds NRP1 and has the 
capacity to evoke NRP1-dependent signalling events, similar to VEGF164. This work 
has been published in (Tillo et al., 2015) (a copy of the publication is appended to 
this thesis). Considering that VEGF189 has the highest affinity for ECM and therefore 
tissue retention amongst the VEGF isoforms, future research may therefore wish to 
consider the mechanistic contribution and therapeutic potential of this understudied 
VEGF isoform. 
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3.2 RESULTS 
3.2.1 VEGF188 is co-expressed with VEGF120 and VEGF164 in developing 
hindbrain, nose and diencephalon 
Because prior studies implicated VEGF signalling through NRP1 in FBM 
neuron migration in the hindbrain, GnRH neuron survival in the nose and RGC axon 
guidance in the diencephalon (Schwarz et al., 2004; Cariboni et al., 2011; Erskine et 
al., 2011), I asked which Vegfa isoforms were expressed in these developmental 
contexts. For this experiment, I collaborated with Dr Alessandro Fantin, who 
designed isoform specific primers that can distinguish the most Vegfa120, Vegfa164 
and Vegfa188 mRNA species by reverse transcription (RT)-PCR (Figure 3.1 A, B). 
The isoform specific primers were sometimes required to span across two exons and 
target exons 3 to 5/8 to amplify Vegfa120 (size 179 bp), exons 5/7 to 7/8 to amplify 
Vegfa164 (size 159 bp), and exons 6 to 7/8 to amplify Vegfa188 (size 215 bp) (red 
arrows in Figure 3.1 A). I validated the specificity of each isoform specific primer in 
collaboration with Dr Fantin and Ms Laura Denti using a pBlueScript vectors 
containing mouse Vegfa120, Vegfa164 and Vegfa188 cDNA. Results showed that 
each isoform specific primer was specific and only amplified its corresponding Vegfa 
isoform vector (Figure 3.1 B). I also prepared cDNA from the isoform-specific 
mouse strains Vegfa120/120 and Vegfa164/164 for further validation of the specificity of 
the designed isoform specific primers (Figure 3.1 C). Using these primers for RT-
PCR of cDNA derived from mouse embryo nose, hindbrain and diencephalon tissue, 
I then demonstrated that all 3 isoforms were co-expressed at relevant periods of 
VEGF/NRP1-dependent neurodevelopment (Figure 3.1 D). 
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Figure 3.1 VEGF189 is expressed in developing mouse tissues. 
(A) Current knowledge of VEGF isoform binding to their receptors. All isoforms 
bind VEGFR1/2, whilst only VEGF165 is known to bind NRP1. VEGF121 can bind 
NRP1 with low affinity in vitro, but whether this association occurs in vivo has not 
been shown. Moreover, it is not known whether VEGF189 binds NRP1 in vivo. Red 
arrows indicate the position of oligonucleotide primers used for RT-PCR in (B). 
(B) Vegfa isoform-specific oligonucleotide primers for RT-PCR were validated with 
pBlueScript vectors (pBS) containing mouse Vegfa120, Vegfa164 or Vegfa188 
cDNA, respectively. Unspecific amplification was not observed using any of the 
isoform specific primers. 
(C) The specificity of oligonucleotide primers for Vegfa isoform expression analysis 
was validated by RT-PCR using cDNA derived from Vegfa120/120, Vegfa164/164 or wild 
type E12.5 mouse embryo trunks, respectively. Note that a molecular weight 
standard confirmed the predicted sizes of each isoform as 179, 159 and 215 bp, 
respectively.  
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(D) RT-PCR analysis of the indicated tissues shows that Vegfa120 (179 bp), 
Vegfa164 (159 bp) and Vegfa188 (215 bp) are co-expressed in E11.5 hindbrain, 
E13.5 nose and E14.5 diencephalon mouse tissue.  
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3.2.2 VEGF189 binds axons in a NRP1-dependent fashion 
Because prior studies of VEGF binding to NRP1 have not examined if 
VEGF189 or VEGF121 can bind NRP1 in vivo, I used the mouse hindbrain as a 
physiologically relevant model to compare the ability of the three major VEGF 
isoforms to bind NRP1 in a tissue context. I first performed immunostaining on 
wholemount E12.5 hindbrains with a validated antibody for NRP1 (Fantin et al., 
2010) to confirm that NRP1 localises to blood vessels in wild type, but not NRP1 
knockout hindbrains (Figure 3.2 A; note unspecific staining of blood in the dilated 
vessels of mutants). Immunolabelling also confirmed NRP1 is expressed in TUJ1-
positive dorsolateral axons on the pial side of wild type, but not mutant hindbrains 
(Figure 3.2 A). Nrp1-/- hindbrains showed some defasciculation of these dorsolateral 
axons, but they were still clearly present in the mutant, as shown by TUJ1 staining. 
Overall, these observations suggest that the hindbrain dorsolateral axons are a 
suitable model to examine VEGF-A isoform binding to NRP1.  
To compare the binding properties of VEGF121, VEGF165 and VEGF189, I 
fused the cDNA for each isoform to an expression cassette encoding alkaline 
phosphatase (AP). I then transfected these expression plasmids into Cos cells and 
used the cell supernatants containing the fusion proteins to perform in situ ligand 
binding assays on E12.5 hindbrains. By visualising alkaline phosphate activity, this 
technique allowed me to analyse in vivo, which VEGF isoforms can bind to tissues 
expressing the different VEGF receptors. As expected from previous work, all 3 
isoforms bound vessels (Figure 3.3 A), correlating with their expression of the pan-
VEGF isoform receptor VEGFR2 (Lanahan et al., 2013). I next examined binding to 
the dorsolateral axons, because they express NRP1, but lack VEGFR2 or VEGFR1 
(Lanahan et al., 2013), which makes them an ideal model to study VEGF/NRP1 
binding. Both VEGF165 and VEGF189 bound these axons, whilst VEGF121 did not 
(Figure 3.3 A). These observations indicate that all VEGF isoforms are capable of 
binding VEGFR2/NRP1-positive vessels. In contrast, only VEGF165 and VEGF189, 
but not VEGF121, bound NRP1-expressing axons lacking VEGFR2.  
I next confirmed that axonal VEGF189 binding is NRP1-dependent, similar to 
VEGF165 binding. For this experiment, I performed in situ ligand binding assays on 
Nrp1-/- hindbrains that have no NRP1 expression in any tissue. This assay showed 
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that VEGF189 bound vessels (Figure 3.3 B) in Nrp1-null mutant hindbrains with their 
characteristic vascular tufts (Fantin et al., 2013). This correlates with the retention of 
VEGFR2 in Nrp1-null mutants. In contrast, AP-VEGF189 failed to bind axons in 
Nrp1-null hindbrains, similar to AP-VEGF165, because these axons do not express 
NRP1 or any other VEGF receptor type (Figure 3.3 B). This shows that VEGF189 can 
bind axons in a NRP1-dependent fashion. To further confirm that AP-VEGF189 
binding was specific to NRP1, I also performed binding assays in Nrp2-null mutant 
hindbrains. NRP2 is expressed in a subpopulation of dorsolateral axons, but loss of 
NRP2 (Giger et al., 2000) did not abolish VEGF189 binding (Figure 3.3 B). Taken 
together, the ligand binding assays of intact hindbrain tissue show that NRP1 serves 
as a neuronal receptor for VEGF165 and VEGF189, but not VEGF121. 
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Figure 3.2 NRP1 is expressed in the developing hindbrain. 
(A) Wholemount staining of E12.5 wild type hindbrains for NRP1 and TUJ1 
together with IB4; single NRP1 channels are shown in grey scale adjacent to each 
panel. The white arrow indicates IB4-positive vessels, the arrowhead unspecific 
NRP1 staining of blood cells inside mutant vessels and the red wavy arrow TUJ1-
positive axons; open triangles indicate absent NRP1 staining in subventricular plexus 
(SVP) vessels and pial axons. Asterisks indicate most medial section of the 
hindbrain, towards the midline. Scale bar: 200 µm.  
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Figure 3.3 VEGF189 binds NRP1 in the developing hindbrain. 
(A, B) AP-VEGF121, AP-VEGF165 and AP-VEGF189 binding to E12.5 wild type 
hindbrains (A) and AP-VEGF189 binding assay on E12.5 Nrp1-/- and Nrp2-/- 
hindbrains (B). The white arrows indicate VEGF binding to vessels, the red wavy 
arrows binding to axons; the open triangles indicate absence of VEGF121 binding to 
wild type axons in (A) and absence of VEGF189 binding to axons in Nrp1-/- 
hindbrains in (B). The arrowhead indicates vascular tufts. Scale bar: 25 µm.  
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3.2.3 VEGF188 is sufficient for the NRP1-dependent migration of FBM neurons 
Vegfa is a haploinsufficient gene, as deletion of just one allele causes early 
embryonic lethality due to a complete failure of blood vessel formation (Carmeliet et 
al., 1996; Ferrara et al., 1996). However, retention of any one of the major VEGF 
isoforms rescues this severe phenotype and instead gives rise to more subtle vascular 
and neuronal phenotypes (Ruhrberg et al., 2002; Stalmans et al., 2002). I first 
examined if VEGF188 can substitute for VEGF164 in NRP1-dependent FBM neuron 
guidance with an established hindbrain explant assay. In this assay, implanted beads 
provide exogenous VEGF and FBM neuron migration is visualised by 
immunolabelling with the motor neuron marker ISL1 (Schwarz et al., 2004; Tillo et 
al., 2014). As had been previously observed, FBM neurons were attracted to 
VEGF164, but not to control beads soaked in PBS only (Figure 3.4 A). I then used 
VEGF188 soaked beads and observed that these also attracted FBM neurons in similar 
manner to VEGF164 (Figure 3.4 A). Quantification of the distance travelled by FBM 
neurons confirmed that migration was significantly enhanced on the hindbrain side 
containing a VEGF164- or VEGF188-soaked bead relative to the control side of the 
same hindbrain (Figure 3.4 B). VEGF188 can therefore promote NRP1-dependent 
neuronal migration similar to VEGF164.  
I next examined FBM neuron migration in vivo by wholemount Isl1 ISH. As 
previously shown (Schwarz et al., 2004), Vegfa120/120 hindbrains demonstrated 
abnormal split stream of FBM neurons on the ventricular side and dumbbell-shaped 
nuclei on the pial side (Figure 3.4 C). This is similar but less severe to the phenotype 
observed in Nrp1-/- mice (Schwarz et al., 2004). In contrast, Vegfa188/188 mice, which 
express only VEGF188 at the expense of other isoforms, showed normal FBM neuron 
migration similar to what was previously described in Vegfa164/164 mice (Schwarz et 
al., 2004) (Figure 3.4 C). Heterozygous Vegfa120/+ mice display normal FBM neuron 
migration and replacing one Vegfa120 allele in Vegfa120/120 mutants with the Vegfa188 
allele (Vegfa120/188) was also sufficient to prevent FBM neuron migration defects 
(Figure 3.4 C). Altogether these results show that unlike VEGF120, VEGF188 is 
therefore sufficient to direct NRP1-dependent neuronal migration. 
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Figure 3.4 VEGF188 is sufficient for FBM neuron migration. 
(A) ISL1 staining of E12.5 hindbrain explants containing implanted heparin beads 
soaked in PBS (n=10) or PBS containing VEGF164 (n=10) or VEGF188 (n=6). Red 
dotted circles indicate the position of heparin beads; white arrowheads indicate 
normal migration; red arrows indicate migration towards heparin beads; asterisks 
indicate the midline. Scale bar 200 µm. 
(B) Distance migrated by FBM neurons. Migration distance was quantified as 
migration away from r5 territory on the hindbrain side with a bead relative to the 
control half of the same hindbrain; mean ± s.e.m. control 1 ± 0.09 vs. VEGF164 bead 
1.39 ± 0.05 and control 1 ± 0.11 vs. VEGF188 bead 2.04 ± 0.17; asterisks indicate 
**p<0.01 VEGF compared to control (t-test). 
(C) Wholemount Isl1 ISH of E12.5 hindbrains of the indicated genotypes detects 
migrating FBM neurons (VIIm) (control n=10, Vegfa120/120 n=6, Vegfa188/188 n=4, 
Vegfa120/188 n=5) Brackets indicate the width of the neuronal stream on the 
ventricular side; red arrowheads indicate dumbbell-shaped nuclei on the pial side; 
asterisks indicate the midline. Scale bar 25 µm. 
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3.2.4 VEGF188 is sufficient to guide NRP1-dependent axons at the optic chiasm 
 Professor Lynda Erskine and I (herein referred to as “we”) next investigated 
if VEGF188 can evoke neuronal responses similar to VEGF164 in the developing 
visual system. To establish binocular vision, RGC axons project through the optic 
chiasm to both the ipsilateral and contralateral brain hemispheres (Erskine and 
Herrera, 2007). VEGF164, but not VEGF120, promotes RGC axon guidance in a 
NRP1-dependent fashion in vitro (Erskine et al., 2011). Furthermore Nrp1-null mice 
have an abnormal chiasm with too many ipsilateral projecting axons, and a similar 
defect is seen in Vegfa120/120 mice (Erskine et al., 2011). To examine if VEGF188 can 
also promote RGC axon guidance, we performed DiI labelling in VEGF isoform 
mutants in a similar way to the experiments to study FBM neuron migration. 
Anterograde DiI labelling of RGC axons from one Vegfa188/188 eye at E14.5 
demonstrated that VEGF188 was sufficient for NRP1-mediated chiasm patterning 
(Figure 3.5 A). Thus, Vegfa120/120 mice had a significantly increased ipsilateral 
projection index as well as defasciculation of the ipsilateral and contralateral optic 
tracts (Erskine et al., 2011), but the ipsilateral index and shape of the optic chiasm 
appeared unaffected in Vegfa188/188 mice (Figure 3.5 B, C). Moreover, replacing one 
Vegfa120 with the Vegfa188 allele was sufficient to prevent chiasm defects observed in 
Vegfa120/120 mutants (Figure 3.5 B, C).  
We next performed retrograde DiI labelling of RGC axons from the dorsal 
thalamus in VEGF isoform mice and compared the number of labelled RGCs in 
flatmounted ipsilateral and contralateral retina (Figure 3.6 A). Quantitation showed 
that the proportion of DiI-labelled ipsilateral RGCs was significantly increased in 
Vegfa120/120 compared to control mice, but was normal in Vegfa188/188 and Vegfa120/188 
mice (Figure 3.6 B). Flatmount images also revealed the preferential origin of 
ipsilaterally projecting neurons from the ventrotemporal retina in wild types (Figure 
3.6 C). Their distribution is affected in Vegfa120/120 mice, which contain ipsilaterally 
projecting RGCs throughout the nasal retina (Erskine et al., 2011), but this defect 
was rescued by the introduction of a single Vegfa188 allele (Figure 3.6 C). Therefore 
VEGF188 is sufficient to promote NRP1-dependent aspects of optic chiasm 
development. All mouse tissue was collected and processed by me and subsequently 
DiI labelled and quantified by Professor Lynda Erskine.   
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Figure 3.5  VEGF188 is sufficient to guide anterogradely labelled commissural 
axons across the optic chiasm. 
(A) Schematic illustration of the method used to anterogradely label RGC 
projections. DiI crystals were placed onto the retina in one eye to label axons 
extending through the optic chiasm into the ipsilateral and contralateral optic tracts.  
(B) Ipsilateral index in the indicated genotypes (mean ± s.e.m.): control 0.095 ± 0.01, 
n=11; Vegfa120/120 0.15 ± 0.03, n=5; Vegfa188/188 0.083 ± 0.01, n=3; Vegfa120/188 0.09 
± 0.01, n=3; t-test, *p<0.05 compared to control.  
(C) Representative wholemount views of RGC axons at the optic chiasm from 
embryos of the indicated genotypes, labelled anterogradely with DiI at E14.5; ventral 
view, anterior up; optic nerve (on), contralateral optic tract (otc) and ipsilateral optic 
tract (oti). Red arrows indicate the normal position of the ipsilateral projection, red 
arrowheads the secondary tract and axon defasciculation in Vegfa120/120 mutants. 
Scale bar: 500 !m. High magnifications of each boxed areas are shown beneath the 
respective panels. 
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Figure 3.6 VEGF188 is sufficient to guide retrogradely labelled commissural 
axons across the optic chiasm. 
(A) Schematic illustration of the method used to retrogradely label RGC projections. 
DiI crystals were placed unilaterally into the optic tract in the dorsal thalamus.  
(B) Proportion of ipsilaterally projecting RGCs relative to total number of RGCs in 
both eyes of the indicated genotypes at E15.5 (mean ± s.e.m): control 3.28 ± 0.44%, 
n=8; Vegfa120/120 19.64 ± 3.89%, n=4; Vegfa188/188 2.16 ± 0.42%, n=4; Vegfa120/188 
2.12 ± 0.14%, n=2; t-test, ***=p<0.001 compared to control. 
(C) Representative examples of flatmounted ipsilateral retinas from E15.5 embryos 
of the indicated genotypes after retrograde labelling from the optic tract in the right 
thalamus. DT, dorsotemporal; VN, ventronasal; DN, dorsonasal; VT, 
ventrotemporal. Scale bar: 500 !m. 
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3.2.5 VEGF188 is sufficient to ensure normal GnRH neuron survival 
As a third model to study VEGF188 in neurodevelopment, Dr Anna Cariboni 
and I (herein referred to as “we”) investigated GnRH neuron survival. GnRH 
neurons are born in the nasal placode and travel along olfactory and vomeronasal 
axons to reach the forebrain (Figure 3.7 A; (Cariboni et al., 2007). The Ruhrberg lab 
has previously shown that VEGF164 signals through NRP1 to promote the survival of 
migrating GnRH neurons by demonstrating that Nrp1-/- and Vegfa120/120 mice have 
significantly fewer GnRH neurons in the embryonic nose (Cariboni et al., 2011). 
This study further used GN11 cells as an in vitro model that recapitulates many 
features of migratory GnRH neurons to show that VEGF164 signals through NRP1 to 
promote GnRH neurons survival (Cariboni et al., 2011).  
We first examined if VEGF188 promotes GN11 survival, similar to VEGF164. 
Whilst 72h of serum withdrawal caused the death of over half of the GN11 cells, the 
inclusion of serum, VEGF164 or VEGF188 for the last 12h of culture significantly 
reduced cell death, and VEGF188 was as effective as VEGF164 in preventing cell 
death; in contrast, and as expected, VEGF120 did not promote survival (Figure 3.7 B; 
percentage of propidium iodide positive cells, mean ± s.e.m: control 44 ± 3%; serum 
2 ± 1%; VEGF120 37 ± 3%; VEGF164 11 ± 2%, VEGF188 11 ± 2%). These 
observations suggest that VEGF188, similar to VEGF164, can promote GnRH neuron 
survival.  
In agreement with the in vitro findings, the GnRH neuron number was 
normal in Vegfa188/188 mice that express VEGF188, but lack VEGF164 (Figure 3.7 C, 
D). Moreover, replacing one Vegfa120 allele in Vegfa120/120 mutants with the Vegfa188 
allele (Vegfa120/188) was sufficient to prevent the GnRH survival defect seen in 
Vegfa120/120 mice (Figure 3.7 C, D; number of GnRH positive cells, mean ± s.e.m: 
control 1246 ± 46; Vegfa120/120 854 ± 21; Vegfa188/188 1335 ± 63; Vegfa120/188 1314 ± 
58). Together, these data show that VEGF188 is sufficient to promote NRP1-
dependent GnRH neuron survival.  
All tissue was collected, processed and immunostained by Miguel Tillo; cell 
counting and GN11 cell culture experiments were performed by Dr Anna Cariboni.   
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Figure 3.7 VEGF188 is sufficient to promote GnRH neuron survival. 
(A) Schematic illustration of GnRH neuron migration (blue dots) in a mouse embryo 
head. The neurons are born in the nasal placodes that give rise to the olfactory and 
vomeronasal epithelia (OE, VNO) and migrate along olfactory and vomeronasal 
axons (purple, Olf/VN) through the nasal compartment (NC) to reach the forebrain 
(FB).  
(B) Serum-starved GN11 cells were treated with DMEM or DMEM containing 10% 
FBS, VEGF120, VEGF164 or VEGF188; cell death was visualised by propidium iodide 
staining (red); counterstaining with Hoechst (blue) was used to determine the 
proportion of PI+ cells in the total number of cells. Scale bar 25 µm. 
(C) Sagittal sections of E14.5 mouse heads of the indicated genotypes, 
immunolabelled for GnRH. Arrows indicate migrating neurons, arrowheads blood 
vessels, open triangles absence of migrating neurons, dotted lines indicate the FB 
boundary; OB, olfactory bulb. Scale bar 100 µm.  
(D) GnRH neuron number in E14.5 heads of the indicated genotypes (mean ± 
s.e.m.): control 1246 ± 46, n=6; Vegfa120/120 854 ± 21, n=5; Vegfa188/188 1335 ± 63, 
n=3; Vegfa120/188 1314 ± 58, n=3; t-test, *=p<0.05 compared to control. 
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3.3 DISCUSSION 
Understanding the precise binding affinities of the VEGF-A isoforms for 
their various receptors has become a priority in the field. It was originally proposed 
that the VEGF domain encoded by exon 7 is responsible for VEGF binding to NRP1 
(Soker et al., 1997), and that it binds the NRP1 b1 domain (Mamluk et al., 2002). 
However, it was subsequently shown that the exon 8-encoded C-terminus present in 
all VEGF isoforms also contributes to NRP1 binding (Jia et al., 2006). Thus, the 
most recent model of VEGF binding to NRP1 predicts that a C-terminal arginine 
residue encoded by exon 8 mediates high affinity binding of the b1 domain, whilst 
exon 7-encoded residues engage NRP1 for enhanced and selective receptor binding 
(Parker et al., 2012). In agreement with this model, VEGF121 lacking exon 7 residues 
binds NRP1 in vitro, but with almost 10-fold lower affinity than VEGF165 (Pan et al., 
2007; Parker et al., 2012). The low affinity of VEGF121 for NRP1 may explain why 
some experiments using plasmon resonance with immobilised NRP1 confirmed 
binding to NRP1 (Pan et al., 2007), whilst others did not observe it (Herve et al., 
2008). However, none of these previous studies had examined the binding affinity of 
VEGF121 for NRP1 in a tissue context.  
Here, I have combined AP-ligand binding assays with intact hindbrains, 
neuronal tissue culture assays and the analysis of genetically modified mice to 
compare the ability of the three major VEGF isoforms to bind NRP1 and regulate 
NRP1-dependent-neurodevelopmental processes. Ligand binding assays showed that 
VEGF121, lacking the exon 7 domain, does not bind endogenous neuronal NRP1 in 
situ at detectable levels. This is consistent with the previously reported 10-fold lower 
affinity of VEGF121 for NRP1 in vitro (Parker et al., 2012). The finding that VEGF121 
does not bind endogenous neuronal NRP1 at detectable levels also agrees with prior 
genetic studies, which showed that VEGF120 is unable to compensate for VEGF164 in 
FBM neuron migration, RGC axon guidance and GnRH neuron survival (Schwarz et 
al., 2004; Cariboni et al., 2011; Erskine et al., 2011). Thus, low affinity binding of 
VEGF121 to NRP1 shown in vitro is unlikely to be relevant in vivo, at least in a 
neuronal context.  
In contrast, VEGF189, which carries the exon 7 domain, was able to bind 
endogenous NRP1-expressing axons in the hindbrain AP-ligand binding assay. 
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Moreover, these experiments demonstrated that binding relied on NRP1, not NRP2. 
Similar studies had not previously been carried out with either blood vessels or 
neurons. Importantly, our findings agree with prior in vitro studies performed with 
VEGF165, which demonstrated that exon 7-encoded residues interact well with 
NRP1, but not NRP2 (Parker et al., 2012).  
Consistent with human VEGF189 binding NRP1 in neurons, I observed that 
mouse VEGF188 expressed from the endogenous Vegfa locus was able to evoke 
NRP1-dependent neuronal responses in vitro and in vivo, similar to VEGF164. 
Extending prior knowledge that VEGF188 contains the NRP1 binding domains 
encoded by exons 6-8, I have therefore demonstrated for the first time that VEGF188 
binds NRP1 in a tissue context.  
Future work on the role of VEGF signalling in neurons, especially studies 
utilising Vegfa120/120 or tissue-specific Vegfa null alleles, should therefore address 
which endogenous VEGF isoform is the predominant regulator for each neuronal 
process under investigation. This may be done through isoform expression profiling 
at relevant developmental stages. Some studies have suggested that VEGF164 is most 
abundant in neuronal tissues, whilst VEGF188 is relatively more abundant in highly 
vascular tissues such as the lung (Ng et al., 2001; Ruiz de Almodovar et al., 2010). 
By extension, studies on the role of VEGF in bone development or vascular 
physiology have previously largely focused on VEGF164, but if the pathways under 
investigation involve NRP1, should consider that VEGF188 has similar signalling 
capacity. 
 Our finding that the relatively understudied VEGF189 is capable of evoking 
VEGF isoform-specific signalling events may also have broad implications for the 
therapeutic use of VEGF. Thus, VEGF application has been considered in many 
studies as a tool for pro-angiogenic, pro-neurogenic and neuroprotective therapies 
e.g. amyotrophic lateral sclerosis treatment (reviewed by (Storkebaum et al., 2011). 
Most prior studies used VEGF165 to ensure comprehensive receptor targeting; 
however, the retention of VEGF165 in tissues is inferior to that of VEGF189 due to the 
presences of only one versus two heparin/matrix-binding domains. Our work 
demonstrating that VEGF189 is fully capable of engaging NRP1, in the context of its 
known ability to bind the alternative VEGF receptors VEGFR1 and VEGFR2, 
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therefore suggests that VEGF189 may be better suited than VEGF165 to induce 
localised tissue effects. 
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3.4 SUMMARY 
VEGF-A regulates both vascular and neuronal patterning. Alternative 
splicing of the Vegfa gene gives rise to three major isoforms termed VEGF121, 
VEGF165 and VEGF189 in reference to their amino acid length. VEGF165, the most 
widely studied isoform, binds NRP1 to promote the migration, survival and axon 
guidance of subsets of neurons, whereas VEGF121 cannot activate NRP1-dependent 
neuronal responses. In contrast, the role of VEGF189 in NRP1-mediated signalling 
pathways has not yet been examined. Here, I combined expression studies and in situ 
ligand binding assays to demonstrate that VEGF189 can bind NRP1. Furthermore, we 
analysed genetically altered mice containing single VEGF isoforms and in vitro 
models to demonstrate that VEGF189, similarly to VEGF165, is sufficient to control 
NRP1-dependent neuronal responses in neuronal migration, survival and axon 
guidance. 
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Chapter 4 2- AND 6-O-SULFATED PROTEOGLYCANS HAVE 
DISTINCT AND COMPLEMEMTARY ROLES IN CRANIAL 
AXON GUIDANCE MOTONEURON MIGRATION 
 
4.1 INTRODUCTION 
HSPGs are polymerised by exotosin enzymes and further modified by 
sulfation, epimerisation or deacetylation through modifying enzymes to generate vast 
structural and functional heterogeneity (Bishop et al., 2007; Sarrazin et al., 2011). 
These HSPG modifying enzymes are expressed and utilised throughout development 
in a tissue dependent manner. Two modifying enzymes have previously been 
implicated in brain development, the 2- and 6-O-sulfotransferases, which regulate 
axon guidance in the Xenopus and mouse brain (Irie et al., 2002; Pratt et al., 2006; 
Conway et al., 2011; Clegg et al., 2014). Both enzymes also control neuronal 
migration in C. elegans (Kinnunen et al., 2005). However, it is not known whether 
these enzymes regulate neuronal migration in the vertebrate brain. 
The proper positioning of neurons along the dorsoventral and anterior-
posterior axes in the developing brain and spinal cord and the correct extension of 
their neurites to suitable targets are fundamental processes for the appropriate wiring 
and therefore function of the nervous system. The VIIth and Vth cranial nerves are 
useful models to define molecular mechanisms that regulate axon guidance 
(Kitsukawa et al., 1997). Whilst the trigeminal motor neurons arise in two paired 
columns adjacent to the midline in the ventricular zone of hindbrain r2, the FBM 
neurons arise in r4, and both types of neurons extend their axons dorsally into the 
branchial arches by following stereotypical trajectories relative to the cranial ganglia 
and branchial arches (reviewed by (Chandrasekhar, 2004; Wanner et al., 2013). 
Many molecular signals that control axon guidance and neuronal migration 
have been identified and shown to depend on an overlapping set of guidance cues 
(Dickson, 2002; Cooper, 2013). For example, the secreted extracellular matrix 
protein reelin and members of the WNT/PCP pathway promote correct FBM neuron 
migration (Rossel et al., 2005; Vivancos et al., 2009; Qu et al., 2010; Glasco et al., 
2012). VEGF-A also guides FBM neuron migration by acting via its receptor NRP1; 
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interestingly, NRP1 also serves as a receptor for repulsive SEMA3A signals during 
FBM axon guidance (Taniguchi et al., 1997; Schwarz et al., 2004).  
HSPGs can interact with a variety of other signalling molecules by either 
binding directly through singling complexes, presenting other molecules so these can 
bind to receptors, or sequestering and reducing the diffusion of other cues (Bishop et 
al., 2007; Aman and Piotrowski, 2008; Sarrazin et al., 2011; Venero Galanternik et 
al., 2015). O-sulfotransferases have previously been implicated in VEGF, FGF and 
WNT signalling (Ai et al., 2003; Kamimura et al., 2006; Mitsi et al., 2006). For 
example, the 6-O-sulfotransferases HS6ST1 and HS6ST2 promote the formation of 
VEGF/VEGFR and FGF/FGFR signalling complexes in vascular endothelial cells 
(Ferreras et al., 2012). HS6ST2 was also reported to be required for VEGF signalling 
during zebrafish vascular development (Chen et al., 2005). Moreover, FGFs interact 
with both 2- and 6-O-sulfated HSPGs for correct lacrimal gland and tracheal 
development (Kamimura et al., 2006; Qu et al., 2011b). WNT signalling is also 
regulated by HS2ST during zebrafish epiboly and by HS6STs for muscle 
development (Bink et al., 2003; Cadwalader et al., 2012).  
Here, I show that mice lacking HS6ST1 and HS6ST2 have defective axon 
extension of specific branches of the Vth and VIIth cranial nerves, but normal FBM 
neuron migration. Inversely, I found that mice lacking HS2ST showed normal 
patterning of cranial nerve axons, but defective FBM neuron migration. I identified 
FBM neuron migration defects in HS2ST-deficient mice that were similar to those 
previously observed in mice lacking VEGF-A signalling through NRP1. However, 
HS2ST was not required for VEGF-A signalling in these neurons. Instead, HS2ST 
enabled FGF-mediated FBM neuron migration in an explant model, consistent with 
the expression of FGF receptors in migrating FBM neurons. Moreover, the 
expression of Erm, a genetic readout of FGF signalling (Firnberg and Neubuser, 
2002), was altered in these mutants. Thus, our study has revealed a hitherto 
unrecognised role for HSPG-mediated FGF signalling in neuronal migration and 
demonstrated distinct and complementary roles for 2- and 6-O-sulfotransferases 
during cranial nerve development.  
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4.2 RESULTS 
4.2.1 HSPGs are require for FBM neuron migration 
 To examine if HSPGs regulate FBM neuron migration, I used an ex vivo 
hindbrain culture assay (Figure 4.1 A). In this model, FBM neurons migrate rostrally 
from their site of origin in r4 to the site of nucleus formation in r6, similar to the 
migration they undergo in vivo (Schwarz et al., 2004; Tillo et al., 2014). The 
inclusion of heparitinase in the culture medium to remove heparan sulfate side chains 
from HSPGs (Linhardt et al., 1990) prevented FBM neuron migration beyond r5 
(Figure 4.1 B). This observation suggested that HSPGs are important for FBM 
neuron migration. 
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Figure 4.1 Heparitinase treatment induces FBM neuron migration defects. 
(A) Schematic representation of hindbrain ex vivo culture. E11.5 hindbrains were 
cultured in the absence of presence of inhibitors in the culture medium (indicated 
with a pipette). In some experiments, I implanted agarose beads soaked in growth 
factors. 
(B) Heparitinase treatment impairs FBM migration. Wild type hindbrains were 
cultured ex vivo and treated with PBS or heparitinase. White arrow indicates arrested 
FBM neuron migration at the level of r5; asterisks indicate the midline. Scale bar 200 
µm.  
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4.2.2 Hs6st1 and Hs6st2 cooperate in cranial axon guidance, but are dispensable 
for FBM neuron migration 
With the knowledge that HSPGs are required for FBM neuron migration, I 
therefore asked if 6-O-sulfotransferases played a role in this process. I first used ISH 
to establish the expression pattern of Hs6st1 and Hs6st2 in the mouse hindbrain at 
E12.5, when both the trigeminal and facial nuclei have formed. Both Hs6st1 and 
Hs6st2 were expressed in r5- and r6-derived hindbrain territories, where Isl1-
expressing FBM neurons migrate (Figure 4.2 A). However, Hs6st1-/- and Hst6s2-/- 
single mutants showed normal FBM neuron migration, and 2/5 double mutant 
Hs6st1-/-;Hs6st2-/- hindbrains only showed minor displacement of a small proportion 
of FBM neurons (Figure 4.2 B).  
Because 6-O-sulfotransferases have previously been implicated in axon 
guidance (Irie et al., 2002; Pratt et al., 2006; Conway et al., 2011; Clegg et al., 2014) 
I next examined cranial nerve axon guidance in Hs6st1 and Hs6st2 mutants by TUJ1 
wholemount immunostaining at E11.5. I observed that Hs6st1-/- and Hst6s2-/- mutant 
heads both showed normal guidance of facial nerve axons, including those in the 
facial branchiomotor nerve (VIIbm), the chorda tympani (VIIct) and the greater 
superficial petrosal nerve (VIIgspn) (Figure 4.2 C). These mutants also had normal 
guidance of trigeminal axons, including the mandibular nerve (Vmd), the maxillary 
nerve (Vmx) and the ophthalmic nerve (Vop). Interestingly, however, Hs6st1-/-;Hs6st2-
/- double mutants had severe defects in both cranial nerves. Thus, the VIIbm, VIIct and 
VIIgspn and the Vmx nerve failed to extend normally (symbols, Figure 3.1 C), and 
both the Vmd and Vop nerves were absent (symbols, Figure 4.2 C). Taken together, 
these results demonstrate that 6-O-sulfotransferases are dispensable for FBM neuron 
migration, but essential for cranial nerve axon guidance.   
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Figure 4.2 Hs6st1 and Hs6st2 are essential for cranial axon guidance, but not 
required for FBM neuron migration. 
(A) Hs6st1 and Hs6st2 expression during FBM neuron migration. ISH of E12.5 
hindbrains shows the expression pattern of Hs6st1 and Hs6st2 relative to motor 
neurons identified by Isl1. VIIm indicates the migrating FBM neurons, VIIn the 
facial motor nuclei. Scale bar 100 µm. 
(B) FBM neuron migration in Hs6st1 and Hs6st2 mutants. Isl1 ISH of Hs6st1-/- (n=3) 
and Hs6st2-/- (n=10) hindbrains at E12.5 relative to controls; a minor defect in FBM 
neuron migration in a Hs6st1-/-;Hs6st2-/- hindbrain (arrow). Scale bar 100 µm. 
(C) Cranial axon patterning in Hs6st1 and Hs6st2 mutants. Lateral view of E11.5 
Hs6st1-/-, Hs6st2-/- and Hs6st1-/-;Hs6st2-/- mutant (n=3 each) relative to control heads, 
immunolabelled with TUJ1. Double mutants have misplaced facial nerve branches 
(red arrow), delayed extension of the mandibular (Vmd) and maxillary (Vmx) nerves 
(green arrow), lack the ophthalmic nerve (Vop), the chorda tympani (VIIct) and the 
facial branchiomotor nerve (VIIbm) (open triangles). VIIg, geniculate ganglion; Vg, 
trigeminal ganglion, VIIgspn, greater superficial petrosal nerve. Scale bar 200 µm.   
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4.2.3 Hs2st is expressed in rhombomere 4 at the onset of FBM neuron migration 
Because 6-O-sulfotransferases have been shown to cooperate with 2-O-
sulfotransferase during Drosophila tracheal and mouse lacrimal gland development 
(Kamimura et al., 2006; Qu et al., 2011b), I next asked if HS2ST also regulates 
cranial nerve guidance, or if it instead controlled neuronal migration. To determine 
the expression pattern and function of HS2ST during hindbrain development, I used 
mice carrying an Hs2stLacz knock-in allele that faithfully recapitulates the expression 
of the endogenous Hs2st gene when visualised as !-galactosidase X-gal staining 
(Bullock et al., 1998). Hs2stLacz/+ hindbrains showed prominent X-gal staining in r4 
at E10.5, close to the domain in which the Isl1-positive FBM neurons differentiate 
(Figure 4.3 A). X-gal staining of cryosections through Hs2stLacz/+ hindbrains, 
followed by immunolabelling for ISL1, showed that this expression domain was 
adjacent to, but did not overlap with the FBM neurons (Figure 4.3 B). At later stages 
of FBM neuron development, Hs2st expression appeared to be restricted to an area 
adjacent to the midline (Figure 4.3 C). This expression pattern suggested that HS2ST 
is involved in modifying proteoglycans that act in trans to regulate FBM neuron 
development. 
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Figure 4.3 Hs2st is transiently expressed near migrating FBM neurons. 
(A-C) Hs2st expression was visualised as X-gal staining in Hs2stLacz/+ hindbrains. In 
wholemount hindbrains at E10.5 (A), expression was prominent in rhombomere 4 
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(r4) near the Isl1-positive motor columns (compare the position of the red arrowhead 
and red arrow). Asterisks indicate the midline. Scale bar 200 µm. In sections through 
r4 at E10.5 (B), X-gal staining (arrow) was present just outside the motor column, 
which was visualised by ISL1 immunolabelling. X-gal staining was pseudocoloured 
red in the right hand panel. VIIm indicates migrating FBM neurons. Scale bar 50 µm. 
In wholemount hindbrains at E12.5 (C), during FBM neuron migration, X-gal 
staining (red arrow) is observed in the midline in an area between the migrating Isl1-
positive FBM streams. Scale bar 200 µm.  
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4.2.4 Hs2st is essential for FBM neuron migration, but dispensable for cranial 
axon guidance 
To determine whether HS2ST is required for FBM neuron migration, I 
examined E12.5 hindbrains from Hs2st-null mutants (Hs2stLacz/Lacz) using Isl1 ISH. I 
observed splitting of the migratory stream in all mutants examined (Figure 4.4 A). In 
contrast, wholemount TUJ1 immunolabelling at E11.5 showed that Hs2st mutants 
had normal axon extension of all branches of the facial (VII) and trigeminal (V) 
nerves (Figure 4.4 B). Together, these results imply that 2-O-sulfotransferase is 
important for FBM neuron migration, whilst 6-O-sulfotransferases are essential for 
cranial axon guidance.  
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Figure 4.4 Hs2st is essential for FBM neuron migration, but dispensable for 
cranial axon guidance. 
(A) Isl1 wholemount ISH at E12.5 shows abnormal FBM neuron migration in 
Hs2stLacz/Lacz (n=6) homozygous compared to Hs2stLacz/+ heterozygous hindbrains. 
Brackets indicate the width of the neuronal stream. Scale bar 200 µm. 
(B) Normal cranial axon patterning in Hs2st mutants. Lateral views of E11.5 
Hs2stLacz/Lacz (n=3) wholemount heads and Hs2stLacz/+ controls, immunolabelled with 
TUJ1. Note normal cranial nerve extension of the mandibular (Vmd), maxillary (Vmx) 
and ophthalmic (Vop) nerves, the chorda tympani (VIIct), facial branchiomotor nerve 
(VIIbm) and the greater superficial petrosal nerve (VIIgspn). VIIg, facial ganglion; Vg, 
trigeminal ganglion. Scale bar: 200 µm.  
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4.2.5 Hs2st is dispensable for VEGF-mediated FBM neuron migration 
HSPGs have been shown to interact with VEGF and its receptor NRP1 
(Sarrazin et al., 2011), which have previously been implicated in FBM neuron 
migration (Schwarz et al., 2004). I therefore asked if loss of 2-O-sulfated HSPGs 
caused an FBM neuron defect that was similar to that of mice lacking Nrp1 
(Kitsukawa et al., 1997) or the NRP1-binding VEGF isoforms (Vegfa120/120) 
(Carmeliet et al., 1999). ISL1 immunostaining of cryosections from E12.5 hindbrains 
showed that migrating FBM neurons split into two main streams in Hs2st-null mice, 
as observed in Nrp1-/- mice or Vegfa120/120 mice lacking NRP1-binding VEGF 
isoforms (Figure 4.5 A). 
To examine if HS2ST-modified HSPGs were required for VEGF-induced 
FBM neuron migration, I again used the hindbrain explant model. Thus, I 
unilaterally implanted VEGF165-coated heparin beads into explanted Hs2st-null and 
littermate control hindbrains. As expected, FBM neurons migrated towards the beads 
in controls (Figure 4.5 B), as previously shown (Schwarz et al., 2004). Unexpectedly, 
these neurons also still migrated towards the VEGF165-coated beads in the Hs2st-null 
hindbrains (Figure 4.5 D). Quantitation confirmed that VEGF165-coated heparin 
beads promoted FBM neuron migration in both genotypes (Figure 4.5 C, E). These 
results suggest that the similar in vivo phenotypes of mutants lacking HS2ST or 
NRP1-binding VEGF isoforms cannot be explained by a requirement for HS2ST-
modified HSPGs in VEGF-induced FBM neuron migration.   
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Figure 4.5 Hs2st FBM neuron migration defect is similar to but not required 
for VEGF/NRP1 dependent FBM migration phenotype. 
(A) Hs2st mutants show a FBM neuron migration phenotype similar to Nrp1-/- and 
Vegfa120/120 mice. Transverse sections through E12.5 hindbrains at r6 level were 
immunolabelled for ISL1, TUJ1 and IB4. White arrows indicate split stream of 
migrating FBM neurons in Hs2stLacz/Lacz, Nrp1-/- and Vegfa120/120 mice. Scale bar 200 
µm. 
(B, D) HS2ST is not essential for VEGF165-mediated FBM migration. E12.5 
Hs2stLacz/Lacz and littermate control hindbrain were cultured ex vivo with heparin 
beads soaked in VEGF165. Red dotted circles indicate the heparin bead position; 
asterisks indicate the midline. (C, E) The corresponding quantification of the 
distance migrated by FBM neurons are shown adjacent to each experiment. Scale bar 
200 µm. The quantification of the distance migrated by FBM neurons (mean ± 
s.e.m.) are shown adjacent to each experiment: Hs2st+/+ +VEGF165 bead, n=15; 
Hs2stLacz/Lacz +VEGF165 bead, n=7. P-values: *=p<0.05, **=p<0.01 compared to 
control (t-test).  
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4.2.6 FGF receptors are expressed in the hindbrain during FBM neuron migration 
HSPGs act as FGF co-receptors in FGF:FGFR:HS complexes and regulate 
the distribution and degradation of FGFs (Schlessinger et al., 2000; Hacker et al., 
2005). I therefore examined if FGF signalling components are expressed during 
FBM neuron migration and whether loss of HS2ST affects FGF signalling during 
this process. RT-PCR showed that all four FGF receptors (Fgfr1-4) were expressed 
in the E11.5 hindbrain (Figure 4.6 A). ISH demonstrated that Fgfr1-4 were expressed 
widely in the hindbrain at E10.5, the onset of FBM neuron migration, and that Fgfr1-
3 were expressed near the midline and Fgfr4 in the same are as FBM neurons at 
E12.5 (Figure 4.6 C). The Allen Brain Atlas, a database of transcripts expressed in 
the mouse brain, showed expression of FGF1, FGF8, FGF9 and FGF15 in the 
hindbrain at E11.5. Work by others has also shown that FGFR1, FGFR2 and FGFR3 
are differentially expressed in the hindbrain during chick development, whilst FGF3 
and FGF8 signalling are required for normal zebrafish rhombomere patterning in the 
developing hindbrain (Walshe and Mason, 2000; Walshe et al., 2002). These 
findings are consistent with a role for FGF signalling in regulating FBM neuron 
migration.  
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Figure 4.6 FGF receptor expression in the hindbrain 
(A) RT-PCR analysis shows expression of Fgfr1 (148bp), Fgfr2 (142bp), Fgfr3 
(197bp) and Fgfr4 (141bp) in E11.5 hindbrain tissue, when FBM neurons migrate. 
(B, C) ISH of E10.5 (B) and E12.5 (C) mouse hindbrains demonstrate the expression 
of Fgf receptors during FBM neuron development. Red arrowhead indicates Fgfr4 
expression in the same area as! migrating FBM neurons at E12.5. Scale bar 200 µm. 
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4.2.7 FGF promotes FBM neuron migration and is requires HS2ST for FBM 
neuron migration ex vivo 
To examine whether FBM neurons can in principle respond to FGF ligands, I 
performed hindbrain explants with FGF-coated beads. Because I did not know which 
of the 22 FGF ligands were expressed in the hindbrain during FBM neuron 
migration, I tested FGF2, because it is known to require HSPGs for appropriate 
signalling (Matsuo and Kimura-Yoshida, 2013). I observed that FBM neurons in 
wild type brains were strongly attracted by FGF2-coated beads (Figure 4.7 A), whilst 
attraction was abolished in Hs2st-null hindbrains (Figure 4.7 C). Quantitation 
confirmed that loss of HS2ST significantly impaired FGF2-induced FBM neuron 
migration (Figure 4.7 B, D). These results raise the possibility that FGFs promote 
FBM neuron migration in a mechanism that requires 2-O-sulfated HSPGs. However, 
these experiments do not define which endogenous FGF ligand or receptor may 
regulate FBM neuron development. 
Because Hs2st is prominently expressed in r4 at E10.5, I next considered the 
possibility that HSPGs modulate FGF-induced signalling events in this rhombomere 
to regulate the subsequent process of FBM neuron migration. I therefore examined 
the expression pattern of Erm, a member of the ETS transcription factor family that 
is positively regulated by FGF (Firnberg and Neubuser, 2002). Erm was expressed 
along the midline of E10.5 wild type hindbrains in the posterior hindbrain (Figure 
4.7 E; r6-r8). ISH at E10.5 unexpectedly showed that Erm was ectopically expressed 
in the midline region of r2 and r4, the rhombomeres in which trigeminal and facial 
branchiomotor neurons arise, respectively (Figure 4.7 E). This finding agrees with 
prior observations that HSPGs can spatially restrict the diffusion or degradation of 
FGF ligands in the zebrafish embryo to modulate FGF signalling (Venero 
Galanternik et al., 2015). In contrast to Erm, the master regulator of r4 identify, 
Hoxb1, was expressed normally in Hs2st-null mice at E10.5 (Figure 4.7 F). This 
finding suggests that r4 had been specified normally in Hs2st-null mutants, and that 
the observed ectopic Erm expression is more likely caused by HS2ST-dependent 
alterations in FGF signalling. 
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Figure 4.7 FGF2 requires Hs2st to control FBM neuron migration. 
 (A, C) HS2ST promotes FGF2-stimulated FBM migration. E12.5 Hs2stLacz/Lacz and 
littermate control hindbrain were cultured ex vivo with heparin beads soaked in 
FGF2. Red dotted circles indicate the position of the heparin bead in each hindbrain; 
asterisks indicate the midline. Scale bar 200 µm. (B, D) The quantification of the 
distance migrated by FBM neurons (mean ± s.e.m.) are shown adjacent to each 
experiment: Hs2st+/+ +FGF2 bead, n=16; Hs2stLacz/Lacz +FGF2 bead, n=5. P-value 
***=p<0.001 compared to control (t-test); n.s., not significant.  
(E) Ectopic Erm expression in Hs2st mutant hindbrains. Wholemount ISH of E10.5 
Hs2st mutant and littermate control hindbrains for Erm, a target of FGF signalling. 
Scale bar 200 µm.  
(F) Hindbrain architecture in Hs2st mutants (n=2). Wholemount ISH for the r4 
marker Hoxb1 at E10.5 shows normal rhombomere formation in the hindbrain at the 
level of FBM neurons. Scale bar 200 µm. 
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4.2.8 Syndecans 1, 2 and 4 are not essential for FBM neuron migration 
Because O-sulfotransferases are modifiers of various HSPGs, I wanted to 
investigate which core HSPG was essential for the FBM migration phenotype 
observed. I focused on the syndecan (SDC) family because several members have 
been shown to interact with FGF (Tkachenko et al., 2005), and in C. elegans Sdc has 
a similar role to Hs2st during neuronal migration (Rhiner et al., 2005). To determine 
whether Syndecans are required for FBM neuron migration, I examined E12.5 and 
E13.5 hindbrains from various Sdc-null mice (in the laboratory of Professor Michael 
Simons, Yale University). I observed that Sdc1-/- and Sdc2-/- mice had normal FBM 
neuron migration (Figure 4.8 A, B). More over, Sdc4-/- mice also form normal facial 
nuclei (unpublished observation by Charlotte Maden). I also analysed Sdc2-/-;Sdc4-/- 
double mutants and observed these also had normal FBM migration (Figure 4.8 B). 
This data indicates that syndecans 1, 2 and 4 do not mimic the phenotype observed in 
Hs2st-null mice and therefore are not essential for FBM migration. 
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Figure 4.8 Syndecans are non-essential HSPGs for FBM neuron migration 
(A, B) Isl1 wholemount ISH at E12.5 (A) and E13.5 (B). VIIn, facial nucleus; 
brackets indicate the width of the neuronal stream; asterisks indicate the midline. 
Scale bar 200 µm. (A) Normal FBM neuron migration in Sdc1-/- mutants (n=2) 
hindbrains. (B) Normal facial nuclei in Sdc2-/- mutants (n=2) and Sdc2-/-;Sdc4-/- 
double mutants (n=2). 
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4.3 DISCUSSION 
Previous work described roles for Hs6st1 in commissural axon guidance 
(Pratt et al., 2006; Conway et al., 2011; Clegg et al., 2014). My observations agree 
with an important role for this gene in axon guidance and additionally demonstrate 
that Hs6st1 synergises with Hs6st2 during cranial axon extension. Interestingly, 
Hs6st1-/-;Hs6st2-/- double mutants have similar cranial nerve defects to Slit/Robo 
mutants (Hammond et al., 2005; Ma and Tessier-Lavigne, 2007), raising the 
possibility that 6-O-sulfotransferases regulate SLIT function during cranial nerve 
development. In agreement, Hs6st1 interacts with Slit2 during commissural axon 
guidance (Conway et al., 2011). However, this is only a hypothesis driven section of 
the chapter. In order to strengthen the results section and dissect the pathway 
downstream of Hs6st1 and Hs6st2 would require more experiments. To test the 
possible interaction between SLITs and HS6STs during cranial axon patterning, I 
might analyse mice with compound mutations in the Slit and Hs6st genes to look for 
an epistatic interaction, and also test explants of cranial ganglia from Hs6st1 and 
Hs6st2 mutants for their responsiveness to exogenous SLIT protein.  
SEMA3A is another guidance cue important for cranial nerve patterning, 
with both Sema3a-/- and Nrp1-/- mice showing severe defasciculation of these axons 
(Fujisawa et al., 1997; Taniguchi et al., 1997; Schwarz et al., 2004). In contrast, 
Hs6st1-/-;Hs6st2-/- double mutants did not fully extend their cranial axons. The 
opposing phenotypes seen in SLIT and HS6ST versus SEMA3A mutants suggest 
that the two pathways are independent, but that their correct balance is essential for 
normal cranial axon guidance. Interestingly, SEMA3A binds to CSPGs in mouse 
perineuronal nets, and in Drosophila SEMA5A binds to HSPGs or CSPGs in 
neurons to evoke attractive versus repulsive axon guidance responses, respectively 
(Kantor et al., 2004; Vo et al., 2013). This raises the question of whether CSPGs 
rather than HSPGs might be required for SEMA3A-mediated aspects of cranial axon 
guidance. To analyse if CSPGs are essential for cranial axon guidance, I might 
analyse different CSPG mouse mutants. 
I have also uncovered a requirement of HS2ST in FBM neuron migration. 
Despite the fact that Hs2st-null mice had very similar FBM migration defects to 
Nrp1-/- and Vegfa120/120 mice, a hindbrain explant assay showed that VEGF signalling 
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was not perturbed by loss of HS2ST. Even though O-sulfotransferase-modified 
HSPGs are dispensable for VEGF/NRP1-induced FBM neuron migration, VEGF and 
NRP1 may still interact with HSPGs modified by other enzymes, a possibility which 
I have not investigated. Interestingly, perlecan enhances VEGF binding to NRP1, has 
been implicated in VEGF-induced endothelial migration and influences Vegfa 
expression levels (Zoeller et al., 2009; Muthusamy et al., 2010; Ishijima et al., 2012). 
Furthermore, the gene encoding perlecan (trol) interacts with Sema1a in Drosophila 
to control axonal guidance. I might analyse perlecan (Hspg2)-deficient mice to 
investigate whether it is involved in FBM neuron migration or cranial axon guidance.  
Prior work has suggested that a lack of 2-O sulfation increased 6-O- or N-
sulfation within the chain location where 2-O-sulfation is lost, raising the possibility 
of compensation (Merry and Wilson, 2002). However, my results indicate that 
modifications induced by 6-O-sulfotransferases are unlikely to compensate for the 
loss of HS2ST-induced modifications during FBM neuron migration, as the 6-O-
sulfotransferases do not seem to play an essential role in this process. Nevertheless, 
the possibility that N-sulfation may be required for FBM neuron migration remains 
to be studied. In order to confirm if any genetic compensation is taking place, it 
would be interesting to perform qPCR to compare the levels of the Hs6st and Ndst 
family members in Hs2st-null hindbrains relative to wild type hindbrains. Moreover, 
I could analyse mice lacking NDSTs for possible FBM neuron migration defects.  
I have further shown that FGF can promote FBM neuron migration in an 
HS2ST-dependent manner. I have not examined which HS2ST-modifed HSPG may 
be involved in FGF-dependent FBM migration, but my results exclude the syndecans 
1, 2 and 4. Syndecan 3 is an interesting candidate, because it is mainly expressed in 
the nervous system to promote radial migration of cortical neurons and can also 
interact with FGFs during chick limb development (Dealy et al., 1997; Hienola et al., 
2006). Therefore, I should next analyse the expression pattern of syndecan 3 during 
FBM neuron migration and analyse Sdc3-/- mice for possible defects in FBM neuron 
migration. 
 My results show the expression of Hs2st in a domain adjacent to FBM 
neurons, thus suggesting that HS2ST acts in trans to regulate FBM neuron migration. 
To understand what cell type adjacent to the r4 FBM neuron domain expresses 
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Hs2st, I would have to perform co-expression studies with other r4 markers and then 
target a floxed Hs2st mouse with appropriate Cre drivers (Stanford et al., 2010). In 
the first instance, I could use Hoxb1-Cre (Arenkiel et al., 2003) to target the entire r4 
territory to confirm that r4-derived Hs2st expression is indeed essential for FBM 
migration. Moreover, I could use a Nestin-Cre transgene, which would target all 
neuronal progenitors. Ideally, I would also seek to identify a Cre line that could 
specifically delete Hs2st in the as yet unidentified Hs2st-expressing cell type. In 
Chapter 5, I describe experiments that further investigated further the possibility of 
trans and/or cis role of HSPGs during FBM neuron migration. 
Previous work using zebrafish shows that disrupting HSPGs by targeting 
exotosins in extl3/ext2 double mutants increases FGF diffusion and impairs FGF 
signal transduction (Venero Galanternik et al., 2015). In these mutants, cells that 
require HSPGs and FGF for collective migration stop expressing the FGF target pea3 
and instead show increased expression of pea3 in surrounding tissues, suggesting 
that HSPGs restrict FGF ligand localisation. Furthermore, loss of HSPGs in zebrafish 
also leads to ectopic WNT activation, which is normally repressed by FGF 
signalling, and thereby causes cell polarity defects, ultimately resulting in abnormal 
collective migration (Venero Galanternik et al., 2015). The authors suggest that 
HSPGs are required both for FGF signalling and to spatially restrict FGF ligand 
localisation (Venero Galanternik et al., 2015). Similar to these findings, I observed 
that the expression of the FGF target gene Erm is altered in Hs2st-null hindbrains. It 
would be important to test how other signalling pathways, besides FGF and VEGF, 
cooperate with the HS2ST-dependent FBM neuron migration. I should investigate 
whether other molecules that control FBM migration non-cell autonomously, such as 
cadherins and PCP pathway components, also rely on HS2ST (Vivancos et al., 2009; 
Qu et al., 2010; Stockinger et al., 2011; Zakaria et al., 2014). 
Altogether, my findings suggest an important role for the HSPG-modifying 
enzyme HS2ST in FBM neuron migration through roles in FGF-mediated neuronal 
guidance and/or hindbrain patterning. In contrast, the HSPG-modifying enzyme 
HS6ST1 and HS6ST2 regulate cranial axon development. In conclusion, HS6ST1/2 
and HS2ST have distinct, but complementary roles in cranial nerve development.   
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4.4 SUMMARY 
The correct migration and axon extension of neurons in the developing brain is 
essential for the appropriate wiring and function of neural networks. Here, I showed 
that O-sulfotransferases, a class of enzymes that modify HSPGs, are essential to 
regulate neuronal migration and axon development. I found that the 6-O-
sulfotransferases HS6ST1 and HS6ST2 are essential for cranial axon patterning, 
whilst the 2-O-sulfotransferase HS2ST is important for the normal migration of FBM 
neurons in the hindbrain. Furthermore, I showed that FGF signalling regulates FBM 
neuron migration in an HS2ST-dependent manner.  
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Chapter 5 CRE-LOXP-MEDIATED TARGETING OF FACIAL 
BRANCHIOMOTOR NEURONS 
 
5.1 INTRODUCTION 
The Cre-LoxP recombinase system is a valuable tool to bypass the embryonic 
lethality of certain constitutive knockout mouse strains and to target genes in a cell 
type specific fashion to explore cell autonomous versus non-cell autonomous roles in 
the processes under investigation (reviewed by (Nagy, 2000). Most published studies 
describing developmental defects in FBM neurons use full-knockout mice 
(Chandrasekhar, 2004; Wanner et al., 2013). However, this approach does not 
distinguish whether the observed phenotypes are caused by defects in these neurons 
themselves or are instead caused by defects in cell types they interact with or 
secondary to general deficiencies in hindbrain development. Identifying a Cre line 
suitable for FBM neuron targeting would therefore empower mechanistic studies of 
neuronal migration and axon guidance in the hindbrain.  
I explored the efficiency of three different Cre lines in targeting migrating 
FBM neurons. The first one was Phox2b-Cre (D'Autreaux et al., 2011), a transgene 
in which Cre is expressed under the control of the promoter of the gene encoding 
PHOX2B, a well-described transcription factor in migrating FBM neurons and other 
subtypes of neurons in the developing hindbrain. The Phox2b-Cre line was generated 
using a BAC construct that introduced the Cre sequence together with the exon 2 
coding sequence of Phox2b. This resulted in a fusion protein that contained the first 
82 amino acids of PHOX2B. The transgene construct was then knocked into the 
endogenous Phox2b exon 2 locus, as previously described for generating the 
Phox2b-null mice (Pattyn et al., 1999; D'Autreaux et al., 2011).  
I also studied the targeting efficiency of two different transgenes, in which Cre 
expression is controlled by the promoter for Nestin, which is expressed in neural and 
glial progenitors: the Nestin-Cre transgene (Tronche et al., 1999) and the NesCre8 
transgene (Petersen et al., 2002). The Nestin-Cre transgene was generated to express 
Cre under the control of the rat Nestin promoter and enhancer and is reported to 
recombine well in the neural tube from E10.5 onwards (Tronche et al., 1999). The 
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NesCre8 transgene also expresses Cre under the control of the Nestin promoter, but 
starts recombining neural progenitors from E8.5 onwards (Petersen et al., 2002). 
To analyse the targeting efficiency of each Cre transgene, I used Rosa26Yfp and 
Rosa26Dta knockin mice (Srinivas et al., 2001; Ivanova et al., 2005), designed to 
express enhanced yellow fluorescent protein (eYFP) or diphtheria toxin a (DTA), 
respectively, whereby both the eYfp and Dta sequences contain a stop cassette 
flanked by LoxP sites. Therefore, when targeted by a CRE recombinase, the stop 
cassette will be excised and the green fluorescent protein or diphtheria toxin 
fragment, respectively, will be expressed. When combined with ISL1 
immunostaining, YFP-labelled FBM neurons and the death of FBM neurons due to 
DTA expression can therefore be observed in the embryonic hindbrain targeted with 
the three Cre lines described above.  
To analyse the efficiency of each Cre line, I also targeted the Nrp1fl (Gu et al., 
2003) and the Ext1fl (Inatani et al., 2003) alleles. These target genes were chosen, 
because the Ruhrberg lab has previously shown that Nrp1-null mice have FBM 
neuron soma migration defects and altered cranial axon guidance (Schwarz et al., 
2004). Further to that, in Chapter 4, I have shown that mice with defects in the 
enzymes acting downstream of EXT in the HSPG synthesis pathway also have 
hindbrain neuronal defects. Thus, Hs2st-null mice have defective FBM migration, 
whilst the Hs6st1-/-;Hs6st2-/- have cranial axon guidance abnormalities. Moreover, 
conditionally knocking out Ext1fl in the nervous system with Nestin-Cre was 
previously shown to cause midline commissure guidance defects (Inatani et al., 
2003). Therefore, targeting either the floxed Nrp1 or Ext1 lines successfully in 
hindbrain neurons was expected to cause FBM defects similar to Nrp1-null and 
Hs2st-null mice, respectively, and thereby indicate successful CRE-mediated gene 
targeting in FBM neurons. 
The aim of this chapter was therefore to characterise the Phox2b-Cre line as a 
tool for targeting FBM neurons, and also to investigate if the neural targeting lines 
Nestin-Cre and NesCre8 can be used as alternative tools for FBM neuron studies. 
Ultimately, I wanted to identify a Cre line suitable for future studies of FBM neuron 
development, including NRP1 co-receptors and downstream targets. In addition, 
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such a Cre line would help to isolate FBM neurons for molecular biology and 
biochemistry assays using FACS methodology with the Rosa26Yfp reporter.   
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5.2 RESULTS 
5.2.1 Phox2b-Cre targets migrating FBM neurons and other areas of the 
developing hindbrain 
Previous work from D’Autreaux and colleagues showed that the Phox2b-Cre 
line targets FBM neurons by E13.5 and that the facial motor nuclei are lost in the 
Phox2b-null mouse (Pattyn et al., 1999; Pattyn et al., 2000; D'Autreaux et al., 2011). 
I analysed the CRE recombinase-mediated targeting of the Rosa26Yfp reporter with 
Phox2b-Cre at earlier stages, because genes regulating FBM neuron migration would 
have to be deleted before E12.5 to affect the migratory process. 
I analysed a wholemount hindbrain at E12.0 using an antibody against GFP 
that recognised the YFP protein and an ISL1 antibody that labels motor neuron cell 
bodies. At this stage in development, FBM neurons are midway through their 
migration from r4 to r6, and neurons are distributed along the whole path of 
migration. In agreement with D’Auxtreaux and colleagues, I observed effective YFP 
expression in migrating FBM neurons (VIIm) as well as the facial motor nuclei 
(VIIn, Figure 3.1 A). I also observed that Phox2b-Cre targeted the most superficial 
layer of cells in r4 and r2 on the ventricular side of the hindbrain, in agreement with 
observation made by D’Auxtreaux and colleagues (Jean-Francois Brunet, personal 
communication). Furthermore, there were high levels of YFP in ISL1 negative cells 
along the midline as well as in the trigeminal motor neurons (Vm). I noted that ISL1 
staining also unspecifically visualised blood vessels, probably due to the cross 
reaction of the secondary antibody (anti-mouse IgG) with IgG-containing blood 
cells.  
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Figure 5.1 Rosa26Yfp/+ Phox2b-Cre is expressed in migration FBM neurons. 
(A) Wholemount E12.0 hindbrain showing Phox2b-Cre targeting. The top panels 
show ventricular (v) and the bottom panels pial (p) views of the hindbrain. YFP 
(green) indicates Rosa26Yfp targeting and ISL1 (red) indicates migrating FBM 
neurons (VIIm) and the paired facial motor nuclei (VIIn). YFP and ISL1 are show as 
single channels in the adjacent panels. ISL1/anti-mouse IgG unspecifically binds to 
blood vessels, indicated by red arrowhead. Rhombomeres are indicated as r2-r6. Vm, 
trigeminal motor neurons. Scale bar: 100 µm. 
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5.2.2 Phox2b-Cre mediated targeting of floxed Nrp1 and Ext1 alleles does not 
cause FBM neuron defects 
Previous work in the lab has shown that Nrp1 is expressed by and essential 
for FBM neuron migration (Schwarz et al., 2004). I therefore used a floxed Nrp1 
allele to investigate the efficiency of Phox2b-Cre to target FBM neurons. I analysed 
E12.5 hindbrains from Nrp1fl/fl Phox2b-Cre mice using Isl1 ISH and observed 
normal FBM migration (Figure 5.2 A). This was surprising, as I had confirmed with 
the Rosa26Yfp reporter that Phox2b-Cre targets migrating FBM neurons, and Nrp1-/- 
mice have split migrating streams of FBM neurons and dumbbell shaped nuclei on r6 
with complete penetrance. I also immunolabelled E11.5 Nrp1fl/fl Phox2b-Cre 
embryos with TUJ1 to visualise cranial nerve extension and observed some nerve 
defasciculation in these mutants (Figure 5.2 C). There was mild defasciculation of 
every branch of the facial nerve, including the chorda tympani (VIIct), facial 
branchiomotor nerve (VIIbm) and the greater superficial petrosal nerve (VIIgspn) 
(green arrowheads, Figure 5.2 C). The sensory nerves, at a more superficial level, 
were severely defasciculated and appeared to merge with the VIIbm (red arrowheads, 
Figure 5.2 C). The trigeminal nerve branches and the ophthalmic nerve extended 
normally. The defects observed are milder than those in Nrp1-null mice. Taken 
together, the absence of FBM defects and the mild axon defects compared to Nrp1-
null mutants indicates that Nrp1 was not efficiently deleted by Phox2b-Cre. 
 To analyse Phox2b-Cre targeting of FBM neurons using a different floxed 
gene target, I combined this transgene with a floxed allele of Ext1, an essential gene 
for HSPG synthesis upstream of Hs2st, which is important for FBM neuron 
migration (Chapter 4). I analysed E12.5 hindbrains from Ext1fl/fl Phox2b-Cre using 
an Isl1 ISH and observed normal FBM neuron migration (Figure 5.2 B). This result 
may indicate inefficient targeting of the Ext1 gene in FBM neurons by the CRE 
recombinase expressed under the control of the Phox2b promoter. Alternatively, the 
lack of an FBM neuron defect in Ext1fl/fl Phox2b-Cre mice is consistent with a non-
cell autonomous function for EXT1 in FBM neurons, which would agree with Hs2st 
expression in a domain adjacent to FBM neurons (Chapter 4). I therefore needed to 
also target Ext1 with a Cre line that targets hindbrain neural lineages more widely, 
i.e. a Cre controlled by the Nestin promoter.   
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Figure 5.2 Phox2b-Cre targeted Nrp1fl/fl and Ext1fl/fl have normal FBM 
neuron migration and cranial axon guidance. 
(A, B) Wholemount Isl1 ISH of E12.5 hindbrains of the indicated genotypes detects 
migrating FBM neurons (VIIm) on the ventricular (v) and facial motor nuclei (VIIn) 
on the pial side (p). Note normal FBM migration in Nrp1fl/fl Phox2b-Cre (n=3) and 
Ext1fl/fl Phox2b-Cre (n=2) mutant hindbrains compared to heterozygous controls. 
Scale bar: 200 µm. 
(C) Cranial axon patterning in Nrp1fl/fl Phox2b-Cre embryos. Lateral view of E11.5 
wholemount heads immunolabelled with TUJ1. All Nrp1fl/fl Phox2b-Cre mutants 
(n=3) showed axon defasciculation of the sensory nerves (Sn) and the facial nerve 
branches, including the chorda tympani (VIIct), facial branchiomotor nerve (VIIbm), 
and the greater superficial petrosal nerve (VIIgspn). Red arrowheads indicate severe 
and green arrowheads indicate mild defasciculation. The trigeminal nerve branches, 
including the mandibular nerve (Vmd), the maxillary nerve (Vmx) and the ophthalmic 
nerve (Vop) extend normally. VIIg, facial ganglion; Vg, trigeminal ganglion. Scale 
bar: 200 µm. 
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5.2.3 Phox2b-Cre efficiently targets some floxed genes, but not floxed Nrp1 in 
migrating FBM neurons 
To confirm that Phox2b-Cre can target FBM neurons effectively and to show 
that NRP1 was indeed expressed in FBM neurons, I used the Rosa26Dta mice, as they 
express DTA when targeted by a Cre line, which should result in death of the 
targeted cells (Ivanova et al., 2005). I performed an Isl1 ISH on an E11.5 Rosa26Dta/+ 
Phox2b-Cre hindbrain and observed that there were no FBM neurons remaining 
(Figure 5.3 A). These hindbrains still maintained their abducens motor neurons 
(VIm) in r5 (Sharma et al., 1998), but had disorganised hypoglossal motor neurons 
(VIIm) at the level of the midline compared to control Rosa26+/+ Phox2b-Cre 
hindbrains (Figure 5.3 A). This suggests that Phox2b-Cre can target migrating FBM 
neurons effectively, as observed using the Rosa26Yfp/+ reporter. Using an ISH probe 
for Nrp1, I observed that Nrp1 mRNA was no longer present in an E12.5 
wholemount Rosa26Dta/+ Phox2b-Cre hindbrain in the location where all FBM 
neurons had died (compare Figure 5.3 A and B). This result implies that Nrp1 is 
indeed expressed in FBM neurons that were targeted by the Phox2b-Cre. 
 I had observed that Nrp1 targeting did not result in any FBM neuron 
migration phenotype, but this does not confirm that there was no targeting by 
Phox2b-Cre. I therefore explored the efficiency of Phox2b-Cre-mediated Nrp1 
targeting in the Nrp1fl/fl Phox2b-Cre hindbrain. Once more I used an Nrp1 ISH probe 
to analyse the levels of Nrp1 mRNA in control vs. mutant hindbrain. At E12.5, there 
was only a small decrease in the overall level of Nrp1 mRNA in the hindbrain, and 
migrating FBM neurons were still expressing high levels of Nrp1, similar to control 
heterozygous Nrp1fl/+ Phox2b-Cre hindbrains (Figure 5.3 C). 
To investigate if the Phox2b-Cre can target genes other than Nrp1 in FBM 
neurons, I next targeted Nrp2, a gene that is highly expressed in migrating FBM 
neurons, but is not required for their migration (Schwarz et al., 2004). I used a Nrp2 
ISH probe to compare the levels of Nrp2 mRNA in Nrp2fl/fl Phox2b-Cre to 
heterozygous control in the same way as previously done for floxed Nrp1. 
Interestingly, the Phox2b-Cre targeting was very efficient in Nrp2fl/fl mice, as there 
was no Nrp2 mRNA in FBM neurons and the general levels of Nrp2 were 
dramatically reduced in most of the E12.5 hindbrain tissue (Figure 5.3 D).   
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Figure 5.3 Phox2b-Cre does not efficiently target floxed Nrp1 in migrating 
FBM neurons. 
(A) Isl1 ISH of E11.5 wholemount hindbrains after Phox2b-Cre targeting of 
Rosa26Dta/+. Most migrating FBM neurons (VIIm) are missing, indicated by open 
triangle. The abducens motor neurons (VIm) are still present in r5, and the 
hypoglossal motor neurons (XIIm) are disorganised. Rhombomeres are indicated as 
r4-r6. Scale bar: 200 µm. 
(A) Nrp1 ISH of E12.5 wholemount hindbrains after Phox2b-Cre targeting of 
Rosa26Dta/+. Loss of Nrp1 expression in the area where the facial motor nucleus 
(VIIn) is missing is indicated by an open triangle. The red arrowheads indicate 
misplaced Nrp1-expressing motor neurons at the midline. Scale bar: 200 µm. 
(C) Nrp1 ISH of E12.5 wholemount hindbrains shows that Phox2b-Cre does not 
delete Nrp1fl/fl in migrating FBM neurons or the facial motor nuclei (red arrow). (D) 
Nrp2 ISH shows that Phox2b-Cre targets Nrp2fl/fl in migrating FBM neurons (open 
triangle). Scale bar: 200 µm. 
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5.2.4 Nestin-Cre targets most neuronal cells in the developing hindbrain 
Previous work showed that the Nestin-Cre line effectively targets neural 
progenitors by E12.5 (Haigh et al., 2003). To analyse the CRE recombinase-
mediated targeting with the Nestin-Cre line, I again used the Rosa26Yfp reporter. I 
analysed a wholemount hindbrain at E12.0 using an antibody against GFP that 
recognised the YFP protein, and an ISL1 antibody that labels motor neuron cell 
bodies. I observed YFP expression in most neuronal hindbrain tissue, including the 
majority of migrating FBM neurons (VIIm) from r4 to r6 and the facial motor nuclei 
(VIIn, Figure 5.4 A). I also noticed that Nestin-Cre did not activate YFP expression 
in blood vessels, either in the ventricular or the pial side of the hindbrain, where the 
characteristic pattern of vessel networks was observed in between areas of YFP 
expression. 
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Figure 5.4 Rosa26Yfp/+ Nestin-Cre targeting of FBM neurons. 
(A) Wholemount E12.0 hindbrain showing Nestin-Cre-mediated targeting of 
Rosa26Yfp. The top panels show ventricular (v) and the bottom panels pial (p) views 
of the hindbrain. YFP (green) indicates Rosa26Yfp targeting and ISL1 (red) indicates 
migrating FBM neurons (VIIm) and the paired facial motor nuclei (VIIn). YFP and 
ISL1 are shown as single channels in the adjacent panels. ISL1/anti-mouse IgG 
unspecifically binds to blood vessels, indicated by red arrowheads. Rhombomeres 
are indicated as r2-r6. Scale bar: 200 µm. 
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5.2.5 Nestin-Cre does not efficiently target floxed Nrp1 during migration of FBM 
neurons and cranial axon guidance 
I next investigated if Nestin-Cre, which seems to target most neural 
progenitors in the hindbrain, is a better tool than Phox2b-Cre to target Nrp1 in FBM 
neurons. For this, I generated mice that contained one floxed allele and a null allele 
of Nrp1 to make Nrp1fl/- Nestin-Cre mice. Given the disappointing experience I had 
with deleting Nrp1 with the Phox2b-Cre transgene, this approach was used to 
maximise the targeting of Nrp1. I analysed E12.5 Nrp1fl/- Nestin-Cre wholemount 
hindbrains with an Isl1 ISH probe and observed normal FBM neuron migration in 
mutant hindbrains (Figure 5.5 A). I also immunolabelled E11.5 Nrp1fl/- Nestin-Cre 
embryos with TUJ1 to visualise cranial nerve extension and observed no defects in 
these mutants (Figure 5.5 B). These results were unexpected, because my analysis 
using the Rosa26Yfp reporter had suggested that Nestin-Cre targets most neural 
progenitors in the embryonic hindbrain, and because loss of NRP1 in hindbrain 
neurons should result in cranial axon guidance defects. 
To evaluate targeting efficiency, I compared Nrp1 expression in Nrp1fl/- 
Nestin-Cre mutant and control hindbrain. I observed there was no reduction of Nrp1 
expression in mutant hindbrains compared to heterozygous control (Figure 5.5 C). 
Migrating FBM neurons and the facial nuclei express normal levels of Nrp1 in 
Nrp1fl/- Nestin-Cre mutant hindbrains. This implies that floxed Nrp1 is not efficiently 
targeted by Nestin-Cre in the hindbrain. 
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Figure 5.5 Nestin-Cre does not efficiently target floxed Nrp1 during FBM 
neuron migration or cranial axon guidance. 
(A) Wholemount Isl1 ISH of E12.5 hindbrains of the indicated genotypes detects 
migrating FBM neurons (VIIm) on the ventricular (v) and the paired facial motor 
nuclei (VIIn) on the pial side (p). Brackets indicate the width of the neuronal stream 
on the ventricular side. FBM neuron migration appeared normal in Nrp1fl/- Nestin-
Cre hindbrains (n=4) compared to control. Scale bar: 200 µm. 
(B) Cranial axon patterning in Nrp1fl/- Nestin-Cre embryos. Lateral views of E11.5 
wholemount heads immunolabelled with TUJ1. Nrp1fl/- Nestin-Cre mutants (n=2) 
showed normal cranial nerve extension of the trigeminal nerve branches, including 
the mandibular nerve (Vmd), the maxillary nerve (Vmx) and the ophthalmic nerve 
(Vop); and of the facial nerve branches, including the chorda tympani (VIIct), facial 
branchiomotor nerve (VIIbm) and the greater superficial petrosal nerve (VIIgspn). VIIg, 
facial ganglion; Vg, trigeminal ganglion. Scale bar: 200 µm.  
(C) E12.5 wholemount hindbrain showing Nestin-Cre does not target Nrp1fl in 
migrating FBM neurons. The red arrow indicates a facial motor nucleus (VIIn) 
expressing Nrp1 by ISH in both control and Nrp1fl/- Nestin-Cre hindbrains. Scale bar: 
200 µm. 
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5.2.6 Nestin-Cre targets efficiently some neuronal tissue but not migration of FBM 
neurons. 
To establish whether Nestin-Cre can target other floxed alleles in the 
hindbrain, I generated mice that contained one floxed allele and a null allele of Ext1 
to make Ext1fl/- Nestin-Cre mice. My results showed that Nestin-Cre targets floxed 
Ext1 inconsistently, resulting in variable phenotype penetrance. Thus, I observed that 
one in four Ext1fl/- Nestin-Cre mutant mice displayed anencephaly and brain 
abnormalities at E12.5 (Figure 5.6 A), in accordance with a role for HSPGs in spinal 
neurulation and general brain development (Yip et al., 2002; Inatani et al., 2003). 
Due to the severe defect, I was unable to dissect and analyse Ext1fl/- Nestin-Cre 
hindbrains with neural closure defects. I next analysed the other Ext1fl/- Nestin-Cre 
mutants, which had formed a hindbrain, using an Isl1 ISH probe and observed 
normal FBM neuron migration (Figure 5.6 B). Thus, Nestin-Cre can target the Ext1fl 
allele with some efficiency, but does not result in FBM neuron migration defects. 
To further analyse the efficiency of Nestin-Cre in hindbrain tissue, I also 
targeted floxed Vegfa, which is a haploinsufficient gene and deletion of just one 
allele results in a complete failure of blood vessel formation and consequently 
embryonic lethality (Carmeliet et al., 1996; Ferrara et al., 1996). Furthermore, 
combining the Vegfafl/fl genotype (Gerber et al., 1999) with Nestin-Cre line causes 
early embryonic lethality. To bypass this problem, I bred mice with one Vegfa 
hypomorphic allele (VegfaHypo/+) (Damert et al., 2002) to mice carrying Nestin-Cre, 
and then crossed the resulting double heterozygous mice with Vegfafl/fl mice to 
generate VegfaHypo/fl Nestin-Cre mutants with severe neural VEGF deficiency, as 
previously described (Haigh et al., 2003). ISL1 wholemount ISH of VegfaHypo/fl 
Nestin-Cre E12.5 hindbrains showed a split in the migrating stream of FBM neurons 
(Figure 5.6 C). This phenotype resembled that seen in Vegfa120/120 hindbrains, but 
was less severe than in Nrp1-/- mice. In addition to the migration phenotype, the 
VegfaHypo/fl Nestin-Cre hindbrains appear to have fewer motor neurons, indicating 
that there might be a role for VEGF in neuronal survival or proliferation, as 
previously observed for GnRH and cortical neural progenitors, respectively (Zhu et 
al., 2003; Cariboni et al., 2011).  
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Figure 5.6 Nestin-Cre does not efficiently target floxed alleles of genes 
regulating FBM neuron migration. 
(A) One in four E12.5 Ext1fl/- Nestin-Cre embryos showed brain malformations, 
including anencephaly. 
(B) Wholemount Isl1 ISH of E12.5 hindbrains shows similar migrating FBM 
neurons (VIIm) and the facial motor nuclei (VIIn) on the pial side (p) in Ext1fl/- 
Nestin-Cre embryos (n=3) and controls. Brackets indicate the width of the neuronal 
stream on the ventricular side (v).  
(C) Abnormal migration of FBM motor neurons in mice with neural VEGF 
deficiency. Split track of migrating FBM neurons in VegfaHypo/fl Nestin-Cre mutant 
hindbrains (n=6) compared to control VegfaHypo/fl heterozygous hindbrains. The 
larger bracket on the ventricular hindbrain side indicates the wider span of migrating 
FBM neurons in mutants compared to control. Scale bar: 200 µm. 
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5.2.7 NesCre8 targets most neuronal cells in the developing hindbrain 
To analyse CRE recombinase targeting with NesCre8, I used once more the 
Rosa26Yfp reporter. Previous analyses of the NesCre8 line using a similar approach 
had reported appropriate targeting of neural progenitors starting from E8.5 (Petersen 
et al., 2002). I analysed E11.5 Rosa26Yfp/+ NesCre8 cryosections and observed that 
most neuronal cells were YFP labelled at the r5 level. High magnification images 
showed that the majority of migrating FBM neuron nuclei labelled by ISL1 were also 
YFP positive, whilst the YFP reporter did not label blood vessels (Figure 5.7 A). I 
also analysed wholemount Rosa26Yfp/+ NesCre8 hindbrains at E12.0. I observed YFP 
expression in most neuronal hindbrain tissue, including the majority of migrating 
FBM neurons (VIIm) and the facial motor nuclei (VIIn, Figure 5.7 B). NesCre8 did 
not recombine in blood vessels, neither on the ventricular nor the pial sides of the 
hindbrain (red arrowhead, Figure 5.7 B). 
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Figure 5.7 Rosa26Yfp/+ NesCre8 is expressed in migration FBM neurons. 
(A,B) NesCre8-mediated targeting of the Rosa26Yfp reporter in the hindbrain at E11.5 
(A) and E12.0 (B). YFP staining (green) indicates Rosa26Yfp targeting by NesCre8 
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and ISL1 staining (red) indicates migrating FBM neurons. The YFP and ISL1 
staining patterns are shown as single channels in the adjacent panels. YFP is 
observed in most neuronal cells in hindbrain tissue except for the characteristic blood 
vessel pattern, indicated by a red arrow. V, ventricular; p, pial. (A) Section through 
E11.5 hindbrain at r5 level. Scale bar: 100 µm. The higher magnification image of 
the squared region shows migrating FBM neurons positive for YFP. Scale bar: 20 
µm.  
(B) Wholemount E12.0 hindbrain. ISL1/anti-mouse IgG unspecifically binds to 
blood vessels, indicated by red arrowhead. Rhombomeres are indicated as r2-r6. 
Scale bar: 200 µm 
  
  
157 
5.2.8 NesCre8 does not efficiently target floxed Nrp1 and Ext1 alleles during the 
migration of FBM neurons or cranial axon guidance. 
I investigated the efficiency of NesCre8, which is expressed from an earlier 
developmental stage (E8.5) than Nestin-Cre, in targeting the floxed Nrp1 and Ext1 
alleles. I generated mice that contained a floxed allele and a null allele of Nrp1 to 
make Nrp1fl/- NesCre8 mice, and used the same approach to generate Ext1fl/- NesCre8 
mice. At E12.5, I observed that most Nrp1fl/- NesCre8 mutants had normal FBM 
neuron migration (first Nrp1fl/- NesCre8, Figure 5.8 A), but 1 out of 4 mutants 
analysed had a small disruption in the formation of the facial motors nuclei (second 
Nrp1fl/- NesCre8, red arrowhead, Figure 5.8 A). However, this did not phenocopy the 
defect of Nrp1-/- mice. TUJ1 staining to visualise cranial axons at E11.5 showed 
defasciculation of several branches of the facial and the trigeminal nerve in Nrp1fl/- 
NesCre8 mutants (Figure 5.8 C). These defects were similar to those observed in 
Nrp1-null mice (Kitsukawa et al., 1997; Schwarz et al., 2004). I analysed the 
knockdown level of Nrp1 by ISH in Nrp1fl/- NesCre8 mutants and observed normal 
Nrp1 levels in FBM neurons in the hindbrain at E10.5 (Figure 5.8 D). However, I did 
not analyse the levels of Nrp1 in extending cranial axons. This raises the possibility 
that NesCre8 is more active in FBM neuron axons than in their somata, or that FBM 
neurons required different levels of Nrp1 in somata compared to axons.  
I analysed FBM neuron migration in Ext1fl/- NesCre8 mutants and observed 
varying penetrance in phenotypes. In most mutants, FBM neurons migrated normally 
(first Ext1fl/- NesCre8, Figure 5.8 B), but one out of four Ext1fl/- NesCre8 mutant 
hindbrains analysed had very small facial motor nuclei (second Ext1fl/- NesCre8, red 
arrowhead, Figure 5.8 B). Interestingly, this phenotype is not similar to that observed 
in Chapter 4. As a percentage of Ext1fl/- NesCre8 mutants develop anencephaly 
(unpublished observation by Charlotte Maden, a previous PhD student in the 
Ruhrberg lab), similar to the Ext1fl/- Nestin-Cre analysed (Figure 5.6 A), it is likely 
that targeting of neuronal tissue surrounding the FBM neurons contributes o the 
phenotype. 
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Figure 5.8 NesCre8 partially targets Nrp1fl and Ext1fl during migration of 
FBM neurons and cranial axon guidance. 
(A, B) Wholemount Isl1 ISH of E12.5 hindbrains of the indicated genotypes detects 
migrating FBM neurons (VIIm) on the ventricular side (v) and facial motor nuclei 
(VIIn) on the pial side (p). (A) A small defect in FBM migration was observed in 
some Nrp1fl/- NesCre8 mutants (n=2/4), as indicated by larger bracket on the 
ventricular side and red arrowhead pointing at split stream. (B) Small defect in FBM 
neuron migration and possibly survival was observed in the other two Ext1fl/- 
NesCre8 mutants (n=2/4), as indicated by a smaller bracket on the ventricular side 
and red arrowheads. Scale bar: 200 µm. 
(C) Cranial axon patterning in Nrp1fl/- NesCre8 embryos (n=3). Lateral view of 
E11.5 wholemount heads, immunolabelled with TUJ1. All Nrp1fl/- NesCre8 mutants 
showed severe axon defasciculation compared to control. All nerve branches appear 
to have formed correctly but branched excessively in mutants compared to controls. 
Red arrowheads indicate severe defasciculation and green arrowheads indicate mild 
defasciculation. The trigeminal nerve branches, including the mandibular nerve 
(Vmd), the maxillary nerve (Vmx) and the ophthalmic nerve (Vop); and of the facial 
nerve, including the chorda tympani (VIIct), facial branchiomotor nerve (VIIbm), and 
the greater superficial petrosal nerve (VIIgspn). VIIg, facial ganglion; Vg, trigeminal 
ganglion. Scale bar: 200 µm.  
 (D) E10.5 wholemount hindbrain showing that NesCre8 does not delete Nrp1 in 
migrating FBM neurons. Expressing of Nrp1 by ISH can be seen in r4 in both control 
and Nrp1fl/- NesCre8 hindbrains. Scale bar: 200 µm. 
 
  
  
160 
5.3 DISCUSSION 
Using a Cre transgene controlled by the Phox2b promoter that was generated 
using the same approach as the Phox2b-null mouse, which is essential for FBM 
migration, seemed a suitable approach to target migrating FBM neurons (Pattyn et 
al., 1997; Pattyn et al., 2000; D'Autreaux et al., 2011). The fact that Phox2b-Cre was 
unable to target floxed Nrp1 in FBM neurons, but could target other floxed lines 
such as Nrp2, Rosa26Dta or Rosa26Yfp, raises several questions. One possible 
explanation for the lack of floxed Nrp1 targeting could be the delayed onset of 
Phox2b-Cre relative to Nrp1 expression in FBM neurons. ISH showed that Phox2b is 
expressed by E9.0 in r4 neural progenitors (Pattyn et al., 1997), whilst Nrp1 starts 
being expressed around E10.5 (Schwarz et al., 2004), but I only analysed the 
expression of Phox2b-Cre using a Rosa26Yfp reporter at E12.0. If Phox2b-Cre were 
not expressed at E10.5, then floxed Nrp1 would not be targeted early enough to 
impair NRP1-mediated FBM neuron migration. To address this issue, I could repeat 
the Phox2b-Cre analysis with the Rosa26Yfp reporter at E10.5 or even earlier to 
confirm that Cre expression occurs at the same time as or before Nrp1 starts being 
expressed in FBM neurons.  
Unexpectedly, however, floxed Nrp1 was also not fully targeted by either 
Nestin-Cre or NesCre8, as high levels of Nrp1 mRNA remained in each conditional 
mutant, and accordingly, they displayed normal FBM neuron migration. Both these 
lines should target most neuronal cells in the hindbrain, especially as NesCre8 is 
already expressed from E8.5 onwards, before motor neurons are specified. This 
raises the possibility that floxed Nrp1 may not be targeted easily by any CRE 
recombinase in migrating FBM neurons. In contrast, previous work from the 
Ruhrberg lab has shown that NesCre8 (Cariboni et al., 2011; Fantin et al., 2013) and 
two other Cre lines, Wnt1Cre and Tie2-Cre, are efficient in targeting floxed Nrp1 in 
other cell types (Schwarz et al., 2009; Fantin et al., 2013). This means that floxed 
Nrp1 is readily targeted by CRE recombinase in principle, even though it was not 
effectively targeted in FBM neurons. Moreover, previous work showed that targeting 
Tbx20fl/- with NesCre8 resulted in defective tangential migration of FBM neurons, 
which demonstrates that NesCre8 can target genes in FBM neurons (Song et al., 
2006). 
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Interestingly, Nrp1fl/- NesCre8 mutants showed defective cranial axon guidance 
similar to Nrp1-null mice, and Nrp1fl/fl Phox2b-Cre mice also have mild facial nerve 
defasciculation, even though both mutants retained Nrp1 expression in FBM neuron 
somata. This raises the possibility that very low levels of NRP1 are sufficient in the 
FBM soma to ensure their normal migration, whereas low levels of NRP1 may not 
be sufficient to ensure its function in the distal axon. In agreement with low NRP1 
levels being sufficient for FBM neuron migration, I have never been able to identify 
NRP1 in the somas of FBM neurons using previously tested antibodies in the 
Ruhrberg lab, but I have seen NRP1 in some hindbrain axons and other neuron types 
(e.g. Figure 3.2). In addition, axon guidance has been shown to involve local 
translation at the axonal growth cone (Shigeoka et al., 2013), and if cranial axons 
require such a mechanism, then perhaps this would explain why axons are more 
sensitive to small changes in Nrp1 levels. In future experiments, I should therefore 
compare NRP1 levels in the cranial axons of controls and mutants.  
 In Chapter 4, I identified a non-cell autonomous role for Hs2st in FBM 
neurons, because Hs2stLacz/+ was expressed in a neuronal cell-type adjacent to FBM 
neurons. I was unsuccessful at targeting floxed Ext1 mice with Phox2b-Cre, which in 
some ways is not unexpected, because this line should target migrating FBM neurons 
and not adjacent cells. It was surprising that Nestin-Cre, which others have shown to 
cause neural defects in Ext1fl/fl mice (Inatani et al., 2003) and also targets Vegfa in 
VegfaHypo/fl mice to disrupt FBM neuron migration, was not able to cause defects in 
FBM neuron migration in Ext1fl/fl mice. It was even more surprising that NesCre8 
was also not able to disrupt FBM neuron migration in Ext1fl/fl mice, given that it 
recombines very efficiently throughout the hindbrain (Fantin et al., 2013). 
Nevertheless, I observed that Ext1fl/- Nestin-Cre mice developed a low penetrance 
anencephaly phenotype, whilst others have described full penetrance midline axon 
guidance defects in these mice (Inatani et al., 2003). Moreover, Ext1fl/- NesCre8 also 
have anencephaly (observation by Charlotte Maden and Christiana Ruhrberg). It 
would therefore be interesting to further analyse these mutants using wholemount 
TUJ1 staining at E11.5 and determine if they phenocopy the defects observed in 
Hs6st1-/-;Hs6st2-/- mice (Chapter 4). This could help determine if Ext1fl/- Nestin-Cre 
targeting causes axonal defects, in agreement with a previous report (Inatani et al., 
2003); Alternatively, the low penetrance neuronal phenotypes observed in Ext1fl/- 
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NesCre8 and Ext1fl/- Nestin-Cre might be explained by poor targeting of the Ext1 
floxed allele in general, since a recent paper using MMTV-Cre has reported variable 
targeting of floxed Ext1 in mammary glands (Garner et al., 2011). 
As an alternative to the Cre lines described this chapter, I could also target 
FBM neurons with CRE recombinase controlled under other promoters such as Isl1, 
which is expressed in all motor neurons. Two Cre lines under the control of the Isl1 
promoter have been published and described to target FBM neurons (Srinivas et al., 
2001; Yang et al., 2006; Qu et al., 2010). Another alternative would be to use to use 
a Hoxb1-Cre line that targets only r4, where the FBM neuron population is specified 
by E10.5 (Arenkiel et al., 2003; Yang et al., 2008; Di Bonito et al., 2013). In order to 
inactivate genes from an even earlier stage, I could use a Cre line under the control 
of the Nkx6.2 promoter, which is expressed in FBM neuron precursors (Vallstedt et 
al., 2001; Muller et al., 2003; Fogarty et al., 2007; Baudet et al., 2008). Using these 
lines to further target floxed Nrp1 and Ext1 may help establish whether the three Cre 
lines I have analysed so far are not appropriate to target FBM neurons, or whether 
instead the Nrp1 and Ext1 floxed alleles are not amenable to CRE recombination. 
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5.4 SUMMARY 
In this chapter, I have explored the suitability of existing genetic tools to study 
FBM neuron migration and axonal guidance. Thus, I have characterised the 
recombination pattern of three Cre transgenes in the developing embryonic 
hindbrain, Phox2b-Cre; Nestin-Cre; and NesCre8. I also investigated the efficiency 
of these Cre lines in targeting floxed genes in migrating FBM neurons and axons. I 
found that all Cre lines were unable to efficiently delete floxed alleles of Nrp1 in 
migrating FBM neurons. However, floxed Nrp2 was efficiently deleted by Phox2b-
Cre and NesCre8-mediated Nrp1 targeting efficiently phenocopied axonal defects in 
Nrp1-null mice. Further work should explore the idea that different levels of NRP1 
are required for FBM somata and axons to develop normal. Moreover, I found that 
all Cre lines did not efficiently target floxed Ext1 allele in the hindbrain and there 
was no phenocopy of FBM neuron migration defects observed in Hs2st-null mice 
(Chapter 4). On the other hand, lowering levels of Vegfa in the hindbrain using 
VegfaHypo/fl Nestin-Cre mice phenocopied FBM neuron migration defects in 
Vegfa120/120 mice. My results show that expression of reporter genes (Rosa26Yfp) is 
not always a faithful predictor of Cre targeting of other floxed alleles in every cell 
type, and none of the Cre lines are sufficient to target genes in migrating FBM 
neurons.  
  
  
164 
Chapter 6 FINAL CONCLUSIONS AND FUTURE WORK 
 
6.1 SUMMARY OF ACHIEVEMENTS AND FINAL REMARKS 
During embryonic development a variety of organs and systems, composed of 
different cell types and with different functions, will develop alongside each other in 
a timed manner. A wide variety of signalling pathways are involved in these various 
processes of development, but often each pathway appears to be required during 
various developmental processes. For example, VEGF signalling was initially 
thought to be mostly required during vascular development, but recent work, 
including results in this thesis, has shown that VEGF is important for neuronal 
development or cancer biology. Therefore, during development there must be more 
levels of complexity that allow a limited number of genes and molecules to be 
reiteratively used in varying systems. In this thesis I have focused on the use of 
combinatorial signalling pathways and the reuse of single pathways in various 
developmental processes.  
Alternative splicing is one way of creating a larger variety of possible 
signalling combinations using a limited pool of genes. Vegfa is alternatively spliced 
into different isoform that have varying diffusion properties and receptor binding 
affinities. My findings show that VEGF189, similar to VEGF165, can bind and signal 
through NRP1 during neuronal migration, axon guidance and neuronal survival. This 
shows that during some NRP1-dependend neuronal development events there can be 
compensation between VEGF isoforms. During vascular development this is not the 
case (Ruhrberg et al., 2002). The use of both VEGF165 and VEGF189 with similar 
functions in the same system could mean a more dynamic control of spatial and 
temporal expression of VEGF during development.  
Axon guidance and neuronal migration share several signalling molecules and 
occur simultaneously in the same cell type. The two processes occur in parallel and 
cell autonomously. During neuronal migration, in addition to guidance of the cell in 
a similar fashion to axons there is also the requirement to move the cell body and its 
nucleus (nucleokinesis) (Tsai and Gleeson, 2005; Marin et al., 2010). Therefore, 
there must be specific control of each compartment of the neuron that would allow it 
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to migrate the cell body and extend its axon. For example NRP1 controls both 
neuronal migration and axon guidance in FBM neurons. Interestingly it uses separate 
ligands, SEMA3A and VEGF, to control each event separately (Schwarz et al., 
2004). Furthermore, in addition to binding different ligands NRP1 can also signal 
through a variety of co-receptors and specifically uses PLXNA3/PLEXNA4 for 
cranial axon guidance (Schwarz et al., 2008). In this thesis I have explored how 
combinatorial signalling is important for axon guidance and neuronal migration and I 
have also focused on the importance of posttranslational modifications in these 
processes.  
 We know that different genes and molecules can affect different stages of 
FBM neuron migration. However, little is known about how various signalling 
pathways might integrate and converge during FBM migration to control the 
different stages of radial and tangential migration. Posttranslational modifications 
can greatly increase the diversity of signals available during nervous system 
development (Edwards et al., 2014). I have explored the role of HSPG 
posttranslational modifications, which results in immense protein heterogeneity, 
during neuronal migration and axon guidance. My results showed that 2-O-sulfation 
was important to control FBM neuron migration whilst 6-O-sulfation was required 
for correct cranial axon guidance. I also found that VEGF/NRP1-dependent 
migration does not require 2-O-sulfation whilst FGF-dependent chemoattraction was 
dependent on normal 2-O-sulfation. This demonstrates that different signals interact 
and are dependent on each other during FBM neuron migration. Interestingly, other 
signalling pathways required for FBM neuron migration, such as PCP pathway 
components and cadherins, have also been shown to associate with HPSGs and some 
of their specific posttranslational modifications (Ai et al., 2003; Vivancos et al., 
2009; Qu et al., 2010; Stockinger et al., 2011; Zakaria et al., 2014). In the future, new 
studies should investigate neuronal migration as a process that integrates a 
combination of genes and molecules that depend on each other. 
In brief summary, this project has identified novel combinatorial molecular 
mechanisms and examined which genetic tools might be useful for the study of 
hindbrain development. First, I found that the VEGF189 isoform can bind to axonal 
NRP1 in vivo and is sufficient to control VEGF/NRP1-dependent axon guidance, 
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neuronal migration and survival, in a similar manner to VEGF165. Secondly, I 
described a complementary function for 2- and 6-O-sulfotransferases during FBM 
neuron migration and cranial axon guidance. Moreover, I also found a novel role for 
HSPG/FGF signalling in regulating FBM neuron migration. Lastly, I have found that 
Cre lines under the control of the Phox2b or Nestin promoters can target some floxed 
genes during FBM neuron migration and cranial axon guidance, but are not ideal to 
target floxed Nrp1 in FBM neurons. 
My findings on the role of VEGF189 signalling through NRP1 in nervous 
system development have been published in the journal Development (Tillo et al., 
2015) and the explant method I used to study FBM neuron migration was published 
in the Journal of Visualized Experiments JoVE (Tillo et al., 2014). My work on the 
novel roles of O-sulfotransferases during cranial axon guidance and motor neuron 
migration has not yet been published, but has been submitted as a manuscript to 
undergo peer review. Altogether, the work presented in this thesis will advance our 
understanding of signalling pathways that regulate for neuronal migration in and 
axon extension from the developing hindbrain. 
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6.2 FUTURE WORK 
6.2.1 The role of HSPGs in VEGF signalling 
The ability of VEGF to bind NRP1 depends on exons 6 and 7, which are also 
responsible for VEGF binding to the extracellular matrix to create an isoform-
dependent diffusion gradient in vivo (Ruhrberg et al., 2002). VEGF requires heparin 
to signal appropriately in cultured endothelial cells (Ashikari-Hada et al., 2005), and 
HSPGs derived from pericytes can potentiate VEGF165 binding to VEGFR2 in trans 
during vessel sprouting in embryoid bodies (Jakobsson et al., 2006). However, it has 
not yet been demonstrated that HSPGs are required for VEGF signalling in either 
endothelial cells or neurons in vivo. Moreover, little is known about which native 
HSPGs might bind to VEGF for correct signalling and if different classes of HSPGs 
are required for VEGF binding in a tissue dependent manner, i.e. pericytes can 
interact with both endothelial cells and neurons. 
In vitro, human endothelial cell derived glypican 1 can bind VEGF165, but not 
VEGF121 (Gengrinovitch et al., 1999), and VEGF165 also binds shed syndecan 1 to 
promote endothelial invasion in a Boyden chamber-type assay (Purushothaman et al., 
2010). To further investigate VEGF/HSPG interactions in vivo, I could perform in 
situ AP-binding assays using tissue from HSPG mutant mice, e.g. Extfl/fl Nestin-Cre, 
syndecan or glypican mutants. Furthermore, I could use surface plasmon resonance 
assays to assess the affinity of VEGF to different HSPGs, and also compare the 
binding properties of VEGF121, which does not contain a heparin-binding domain, 
and VEGF165 or VEGF189 to various HSPGs. 
 
6.2.2 VEGF/NRP1 signalling during FBM neuron migration 
I showed that NRP1 signalling through VEGF is required for FBM neuron 
migration in a pathway that does not require HS2ST. However, no co-receptor has 
been identified for VEGF/NRP1 signalling during FBM neuron migration, even 
though PLXNA3/PLXNA4 have already been identified as NRP1 co-receptors for 
SEMA3A signalling during cranial axon guidance (Schwarz et al., 2004; Schwarz et 
al., 2008). It would therefore be interesting to identify the co-receptor required for 
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VEGF/NRP1 to control FBM neuron migration attraction by ablating floxed 
candidate NRP1 co-receptors, e.g. plexins, FLK1, FLT1, taking advantage of the 
knowledge on the Cre tools I have characterised. 
When analysing Cre recombination in migrating FBM neurons I observed 
that Phox2b-Cre could successfully target Rosa26Yfp/+, Rosa26Dta/+ and Nrp2fl/fl in 
these motor neurons. Furthermore, Nestin-Cre and NesCre8 also successfully target 
RosaYfp/+, which resulted in YFP expression in migrating FBM neurons. However, 
my results showed that none of these Cre lines could target floxed Nrp1 in migrating 
FBM neurons. This suggests that floxed Nrp1 mice are not an ideal target to use as a 
positive control for investigating Cre-targeting in FBM neurons; instead floxed Nrp2 
would be a more suitable control target gene. NRP2 is expressed but does not have a 
function in FBM neuron migration, therefore it could be important to use a floxed 
target gene known be required for FBM neuron development, e.g. Celsr1fl/fl (Qu et 
al., 2010). To investigate if floxed Nrp1 can be deleted with another Cre transgenic 
in these neurons, I could target floxed Nrp1 with Isl1-Cre, which has been shown by 
others to successfully delete genes in migrating FBM neurons (Qu et al., 2010). I 
also showed that targeting floxed Nrp1 with NesCre8 or Phox2b-Cre resulted in 
abnormal cranial axon guidance. My results show that it is most likely that floxed 
Nrp1 cannot be targeted by CRE recombinase in FBM neurons. The fact that Cre-
targeting floxed Nrp1 results in facial axon defects but normal neuronal migration 
might be explained by differences between NRP1 levels in each compartment. Axons 
are likely to have lower levels of Nrp1 than somata; therefore, even low-level CRE 
recombination might be enough to induce axonal defects. To examine levels of 
NRP1 in the somata versus axons of these mutants I could try to check local levels of 
NRP1 protein and mRNA in these compartments, although this would like be 
challenging.  
Using a hindbrain explant assay, I observed that VEGF-soaked beads are only 
capable of attracting the front of the FBM neuron migration stream. Similar to 
zebrafish, there might therefore be a leading population of FBM neurons or other cell 
types controlling collective migration, which express NRP1 and lead to VEGF 
chemoattraction. It is not clear if the Cre transgenes I used would target such a 
hypothetical leading front, as they may be somewhat genetically different from the 
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following neurons. To address this question and further understand the role of NRP1 
in FBM neuron migration and cranial axon guidance, I could use a new mouse line 
expressing a Nrp1-Cre transgene (personal communication from Dr. Quenten 
Schwarz) to target Rosa26Yfp/+ and thereby characterise Nrp1 expression across the 
FBM population in more detail. I could also combine Nrp1-Cre with Rosa26Dta/+, to 
investigate if Nrp1 targets most or only a subpopulation of migrating FBM neurons.  
 
6.2.3 The role of HSPGs in migrating FBM neurons 
To further understand the role of HSPGs in cranial axon guidance and FBM 
neuron migration, it would be interesting to use a ligand and carbohydrate 
engagement (LACE) assay to investigate in situ if FGF/FGFR complex formation 
depends on HSPGs in hindbrain tissue (Allen and Rapraeger, 2003; Pan et al., 2006). 
Briefly, tissue sections from wild type and Hs2st-null mice could be incubated with 
exogenous FGFs and AP-tagged FGFRs and AP signal would detect where 
FGF:FGFR complexes had formed. Thus, any changes in AP signal observed in wild 
type compared to Hs2st-null tissue would indicate a requirement for 2-O-sulfated 
HSPGs during FGF:FGFR complex formation.  
As my results show that FGFR4 is expressed in migrating FBM neurons, it 
would be interesting to analyse the hindbrain of Fgfr4-null mice for FBM neuron 
migration defects. However, this analysis may not be straightforward, because mouse 
mutant analyses have previously shown that there is a high level of redundancy 
between FGFRs. Specifically, Fgfr4-/- mice develop normally and some studies have 
suggested this is due to Fgfr3 compensation (Weinstein et al., 1998; Li et al., 2011). 
Thus, I might have to screen multiple combinations of Fgfr-null mice to identify 
which receptors are required for FBM neuron migration in vivo.  
To identify the endogenous FGF involved in FBM neuron migration I could 
use ISH and RT-PCR to characterise the expression pattern of candidate FGFs in the 
hindbrain. Once relevant candidate FGFs are identified I could use the hindbrain 
explant assay to investigate if FBM neurons are chemoattracted to these, and could 
also analyse the hindbrains of relevant Fgf-null mice during FBM neurons migration.  
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Other studies might focus on WNTs as candidate regulators in HS2ST-
dependent FBM neuron migration. Several components of the WNT/PCP pathway 
have been implicated in FBM neuron migration (Vivancos et al., 2009; Qu et al., 
2010; Glasco et al., 2012), and WNTs are known to require HSPGs for correct 
signalling, including O-sulfated HS (Ai et al., 2003; Hacker et al., 2005; Cadwalader 
et al., 2012).For example, Wnt5a is highly expressed in the caudal hindbrain starting 
from r5/6, and Wnt5a-/- mice have a split stream of migrating FBM neurons 
(Vivancos et al., 2009). Therefore, I could use a hindbrain explant model to analyse 
if migrating FBM neurons are still attracted to WNT5A in Hs2st-null mice (Vivancos 
et al., 2009), as performed for VEGF and FGF. I could also examine if WNT and 
FGF signalling regulate each other during FBM neuron development. For example, 
in the chick isthmus Wnt1 is required for maintenance of the Fgf8, which controls r1 
identity and the midbrain-hindbrain boundary (Canning et al., 2007).  
During collective cell migration in the zebrafish, FGF and WNT mutually 
repress each other by inducing the expression of dkk1b, a WNT inhibitor, and sef, an 
FGF inhibitor (Aman and Piotrowski, 2008). This mutual inhibition is required to 
maintain a boundary between FGF and WNT signalling domains. Interestingly, the 
distribution of FGFs in this system is controlled by HSPGs, thus, the inhibition of 
HS results in abnormal collective cell migration due to ectopic WNT and FGF 
activation (Venero Galanternik et al., 2015). My results show that there is also 
ectopic FGF activation in Hs2st-null hindbrains. I could therefore also examine 
whether the expression pattern of known WNT-pathway components required for 
FBM neuron migration, e.g. Wnt5a and Fz3, changes in Hs2st-null hindbrains. To 
study if the two pathways interact during hindbrain development, I could also 
analyse the role of WNT inhibitors on FGF signalling during FBM neuron migration 
and vice versa. 
 
6.2.4 Identifying novel signalling mechanisms during FBM neuron migration and 
cranial axon guidance. 
To identify additional signals required for FBM neuron migration and cranial 
axon guidance in the mouse, I could use two approaches, a candidate approach or an 
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unbiased search. In the case of a candidate approach, I suggest searching the 
literature for signals that are important during FBM neuron migration and cranial 
axon guidance in other model systems, such as zebrafish, and investigate if they also 
have a role in mice. Furthermore, one could also investigate signals known to 
interact with pathways that have already been shown to have a role in regulating 
neuron migration and axon guidance. Alternatively, I could use an unbiased 
approach to identify novel signals. For example, I could isolate RNA from E10.5 r4 
cells isolated by FACS from a Hoxb1-Cre Rosa26Yfp/+ hindbrain and use a DNA 
microarray to identify candidate genes that are highly expressed at the onset of FBM 
neuron migration and then validate them with expression studies. Combining both 
candidate and unbiased approaches in particular might identify an overlapping set of 
important target genes for future work on FBM neuron migration and cranial axon 
guidance. 
I could use the previously described hindbrain explant model (Tillo et al., 
2014) to screen for new molecules required during FBM neuron migration and 
functionally validate those identified in the approaches above. For example, I could 
treat hindbrain explants with chemical inhibitors or implant chemokine soaked beads 
to investigate new signalling pathways amenable to such manipulations. I could also 
attempt to live image FBM neuron migration using the hindbrain explant model on 
an Isl1-Egpf mouse, which has GFP-labelled cranial motor neurons (Shirasaki et al., 
2006; Song et al., 2006). Recently, the use of in utero and ex vivo electroporation in 
mouse has become more common when studying early development. This technique 
would allow me to electroporate small interfering RNA to knockout genes in the 
embryonic hindbrain during FBM neuron migration. Therefore, I could easily screen 
a large number of genes thought to be involved in FBM neuron migration before 
using knockout mice. This would also allow me to test the interaction between 
multiple pathways by targeting more than one gene at the same time. However, the 
fact that FBM neuron migration occurs during early embryonic development makes 
it challenging to electroporate the hindbrain. Some studies have successfully used 
electroporation to target the mouse hindbrain at E11.5 and E12.5 (Holland et al., 
2012; David et al., 2014), and this could be combined with the hindbrain culture 
assay used to study FBM neuron migration. Establishing a new protocol using in 
utero or ex vivo electroporation of hindbrains at early embryonic stages would help 
  
172 
advance the study of FBM neuron migration in the mouse. Any novel molecules 
essential for FBM neuron migration discovered using hindbrain explant assays or 
electroporation could then be confirmed by analysing mouse mutants in vivo.  
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VEGF189 binds NRP1 and is sufficient for VEGF/NRP1-dependent
neuronal patterning in the developing brain
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ABSTRACT
The vascular endothelial growth factor (VEGFA, VEGF) regulates
neurovascular patterning. Alternative splicing of theVegfa gene gives
rise to threemajor isoforms termed VEGF121, VEGF165 and VEGF189.
VEGF165 binds the transmembrane protein neuropilin 1 (NRP1)
and promotes the migration, survival and axon guidance of subsets
of neurons, whereas VEGF121 cannot activate NRP1-dependent
neuronal responses. By contrast, the role of VEGF189 in NRP1-
mediated signalling pathways has not yet been examined. Here, we
have combined expression studies and in situ ligand-binding assays
with the analysis of genetically altered mice and in vitro models to
demonstrate that VEGF189 can bind NRP1 and promote NRP1-
dependent neuronal responses.
KEY WORDS: Vascular endothelial growth factor (VEGF), VEGF189,
Neuron, Neuropilin, Mouse
INTRODUCTION
Vascular endothelial growth factor A (VEGFA, VEGF) is a potent
inducer of blood vessel growth, but also has essential roles in
neurodevelopment (Mackenzie and Ruhrberg, 2012). In humans,
VEGF is encoded by a single gene (VEGFA) of eight exons that is
alternatively spliced into isoforms, the major ones containing 121,
165 and 189 amino acid residues and therefore termed VEGF121,
VEGF165 and VEGF189, respectively (Fig. 1A; Koch et al., 2011).
The alternatively spliced exons 6 and 7 encode domains that enable
extracellular matrix (ECM) binding and additionally mediate
differential binding to VEGF receptors. All VEGF isoforms bind
the receptor tyrosine kinases VEGFR1 (FLT1) and VEGFR2 (KDR,
FLK1), whereas the non-catalytic receptors neuropilin (NRP) 1 and
NRP2 are VEGF isoform-specific receptors that preferentially bind
VEGF165 over VEGF121 (Fig. 1A; Gluzman-Poltorak et al., 2000;
Soker et al., 1998). Unexpectedly, recent studies showed that VEGF
binding to NRP1 is largely dispensable for embryonic angiogenesis
(Fantin et al., 2014). By contrast, VEGF signalling through NRP1
has multiple roles in neurodevelopment, including guiding
migrating facial branchiomotor (FBM) neurons in the hindbrain
(Schwarz et al., 2004), promoting the survival of migrating
gonadotropin-releasing hormone (GnRH) neurons (Cariboni et al.,
2011) and enhancing the contralateral projection of retinal ganglion
cell (RGC) axons across the optic chiasm (Erskine et al., 2011).
To demonstrate roles for VEGF binding to NRP1 in neurons,
prior studies used Vegfa120/120 mice, which express VEGF120, the
murine equivalent of VEGF121, but lack VEGF164 and VEGF188,
corresponding to human VEGF165 and VEGF189, respectively
(Carmeliet et al., 1999). Vegfa120/120mice phenocopy the defects of
NRP1 knockouts in FBM neuron migration, GnRH neuron survival
and RGC axon guidance (Cariboni et al., 2011; Erskine et al., 2011;
Schwarz et al., 2004). In all three systems, VEGF signalling was
attributed to the activity of VEGF165 because it evokes appropriate
neuronal responses in tissue culture models (Cariboni et al., 2011;
Erskine et al., 2011; Schwarz et al., 2004), and because the ability of
NRP1 to bind VEGF165 is well established (Fantin et al., 2014;
Soker et al., 1998). However, Vegfa120/120mutants lack VEGF188 in
addition to VEGF164. Yet, it has never previously been examined
whether VEGF189 can also function as a NRP1 ligand in vivo.
Moreover, it is not known whether VEGF121 can bind NRP1 in a
physiologically relevant context, even though it has been suggested
that the exon 8 domain, which is present in all major VEGF
isoforms, including VEGF121, can mediate NRP1 binding in vitro
(Jia et al., 2006; Pan et al., 2007; Parker et al., 2012).
Here, we have generated alkaline phosphatase (AP)-conjugated
VEGF isoforms for in situ ligand-binding assays (Fantin et al., 2014)
to examine whether VEGF121 or VEGF189 can bind NRP1 in vivo, as
previously reported for VEGF165. Our studies demonstrate that
VEGF189 binds NRP1-expressing axon tracts in intact hindbrain
tissue, but that VEGF121 is unable to do so. We further show that
VEGF188 is co-expressed with the other isoforms during VEGF/
NRP1-dependent FBM migration, GnRH neuron survival and RGC
axon guidance, and that VEGF188 is sufficient to control all three
processes, whereas VEGF120 is not. We conclude that VEGF188
effectively binds NRP1 and has the capacity to evoke NRP1-
dependent signalling events, similar to VEGF164. Considering that
VEGF189 has the highest affinity for ECM and therefore tissue
retention amongst the VEGF isoforms, future research may therefore
wish to consider the mechanistic contribution and therapeutic
potential of this understudied VEGF isoform.
RESULTS AND DISCUSSION
VEGF188 is co-expressed with VEGF120 and VEGF164 in
developing hindbrain, nose and diencephalon, and binds
axons in a NRP1-dependent fashion
Because prior studies implicated VEGF signalling through NRP1 in
FBM neuron migration in the hindbrain, GnRH neuron survival in
the nose and RGC axon guidance in the diencephalon (Cariboni
et al., 2011; Erskine et al., 2011; Schwarz et al., 2004), we asked
which Vegfa isoforms were expressed in these developmental
contexts. For this experiment, we designed isoform-specific primers
that can distinguish the Vegfa120, Vegfa164 and Vegfa188 mRNAReceived 1 August 2014; Accepted 26 November 2014
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species by reverse transcription (RT)-PCR (Fig. 1A,B;
supplementary material Fig. S1A). This analysis demonstrated that
all three isoforms were co-expressed during relevant periods of
VEGF/NRP1-dependent neurodevelopment in mice (Fig. 1C).
Because prior studies ofVEGFbinding toNRP1have not examined
whether VEGF189 or VEGF121 can bind NRP1 in vivo, we used the
mouse hindbrain as a physiologically relevant model to compare the
ability of the three major VEGF isoforms to bind NRP1 in a tissue
context.We first performed immunostaining with a validated antibody
for NRP1 (Fantin et al., 2010) to confirm that NRP1 localises to blood
vessels in wild-type, but not NRP1 knockout, hindbrains (Fig. 1D;
note unspecific staining of blood in the dilated vessels of mutants).
Immunolabelling also confirmed NRP1 expression in TUJ1-positive
dorsolateral axons on the pial side of wild-type, but not mutant,
hindbrains (Fig. 1D; supplementary material Fig. S1B). Nrp1−/−
hindbrains showed some defasciculation of these dorsolateral axons,
but they were still clearly present in the mutant, suggesting that this are
a suitable model to examine VEGFA isoform binding to NRP1.
To compare the binding properties of VEGF121, VEGF165 and
VEGF189, we fused each isoform to AP and performed in situ ligand
binding assays on E12.5 hindbrains. As expected, all three isoforms
bound vessels (Fig. 1E), because they express the pan-VEGF isoform
receptorVEGFR2 (Lanahan et al., 2013).Wenext examined binding to
dorsolateral axons, because they express NRP1, but lack VEGFR2
(Lanahan et al., 2013). Both VEGF165 and VEGF189 bound these
axons,whereasVEGF121 did not (Fig. 1E). These observations indicate
that all VEGF isoforms are capable of binding VEGFR2/NRP1-
positive vessels. By contrast, only VEGF165 and VEGF189, but not
VEGF121, boundNRP1-expressing axons lackingVEGFR2, consistent
with the previously reported 10-fold lower affinity of VEGF121 for
NRP1 in vitro (Parker et al., 2012). The finding that VEGF121 does not
bind endogenous neuronal NRP1 at detectable levels also agrees with
prior genetic studies, which showed that VEGF120 is unable to
compensate for VEGF164 in FBM, RGC andGnRH neurons (Cariboni
et al., 2011; Erskine et al., 2011; Schwarz et al., 2004). Thus, low-
affinity binding of VEGF121 to NRP1, even though previously
observed in vitro, is unlikely to be relevant in vivo, at least in a
neuronal context.
We next confirmed that axonal VEGF189 binding is NRP1
dependent. The AP ligand-binding assay showed that VEGF189
bound vessels (Fig. 1F) in Nrp1-null mutant hindbrains with their
characteristic vascular tufts (Fantin et al., 2013a). Strikingly, AP-
VEGF189 failed to bind axons in Nrp1-null hindbrains, similar to
AP-VEGF165 (Fig. 1F). VEGF189 can therefore bind axons in a
Fig. 1. VEGF189 is expressed indevelopingmouse tissues andbindsNRP1 in the developing hindbrain. (A) Current knowledge of VEGF isoformbinding to their
receptors. All isoforms bind VEGFR1/2, whereas only VEGF165 is known to bind NRP1. VEGF121 can bind NRP1 with low affinity in vitro, but whether this association
occurs in vivo has not been shown. Moreover, it has not been shown whether VEGF189 binds NRP1 in vivo. Red arrows below each isoform indicate the position of
oligonucleotide primers used for RT-PCR in B. (B)Vegfa isoform-specific oligonucleotide primers for RT-PCRwere validatedwith pBlueScript vectors (pBS) containing
mouse Vegfa120, Vegfa164 or Vegfa188 cDNA, respectively. (C) RT-PCR analysis of the indicated tissues shows that Vegfa120 (179 bp), Vegfa164 (159 bp) and
Vegfa188 (215 bp) are co-expressed. (D)Whole-mount staining of E12.5wild-typehindbrains forNRP1andTUJ1 togetherwith IB4; singleNRP1channelsare shown in
grey scale adjacent to each panel. The white arrows indicate IB4-positive vessels; the arrowhead indicates nonspecific NRP1 staining of blood cells inside mutant
vessels; the red wavy arrows indicate TUJ1-positive axons; open triangles indicate absent NRP1 staining in subventricular plexus (SVP) vessels and pial axons. Scale
bar: 200 μm. (E,F) AP-VEGF121, AP-VEGF165 and AP-VEGF189 binding to E12.5 wild-type hindbrains (E) and AP-VEGF189 binding to E12.5 Nrp1
−/− and Nrp2−/−
hindbrains (F).Thewhitearrows indicateVEGFbinding tovessels; the redwavyarrows indicatebinding toaxons; theopen triangles indicateabsenceofVEGF121binding
to wild-type axons in E and absence of VEGF189 binding to axons in Nrp1
−/− hindbrains in F. The arrowhead indicates vascular tufts. Scale bars: 25 μm.
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NRP1-dependent fashion. By contrast, loss of NRP2 (Giger et al.,
2000) did not abolish VEGF189 binding (Fig. 1F). Taken together, the
ligand binding assays of intact hindbrain tissue show that NRP1 serves
as a neuronal receptor forVEGF165 andVEGF189, but not forVEGF121.
VEGF188 is sufficient for the NRP1-dependent migration of
FBM neurons
Vegfa is a haploinsufficient gene for which deletion of just one allele
results in early embryonic lethality due to a complete failure of blood
vessel formation (Carmeliet et al., 1996; Ferrara et al., 1996).
However, retention of any one of the major VEGF isoforms rescues
this severe phenotype and instead gives rise to more subtle neuronal
and vascular phenotypes (Ruhrberg et al., 2002; Stalmans et al.,
2002). Understanding the receptor-binding properties of the VEGF
isoforms has therefore become a priority in the field. We first
examined if VEGF188 can substitute for VEGF164 in FBM neuron
guidance with an established hindbrain explant assay in which
implanted beads provide exogenous VEGF, and FBM neuron
migration is visualised by immunolabelling with the motor neuron
marker ISL1 (Schwarz et al., 2004; Tillo et al., 2014). Agreeing with
previous observations, FBM neurons were attracted to VEGF164, but
not to control beads lacking growth factors (Fig. 2B). VEGF188 beads
also attracted FBM neurons (Fig. 2B). Quantification confirmed that
FBM neuron migration was significantly enhanced on the hindbrain
side containing a VEGF164- or VEGF188-soaked bead relative to the
control side of the same hindbrain (Fig. 2C). VEGF188 can therefore
promote NRP1-dependent neuronal migration similar to VEGF164.
We next examined FBM neuron migration in vivo by Isl1
in situ hybridisation. As previously shown (Schwarz et al., 2004),
Vegfa120/120 hindbrains demonstrated abnormal streaming of FBM
neurons on theventricular side anddumbbell-shapednuclei on the pial
side (Fig. 2D). By contrast, Vegfa188/188 mice, which express only
VEGF188, showed normal FBM neuron migration (Fig. 2D).
Moreover, replacing one Vegfa120 allele in Vegfa120/120 mutants
with the Vegfa188 allelewas sufficient to prevent FBM neuron defects
(Fig. 2D). Unlike VEGF120, VEGF188 is therefore sufficient to direct
NRP1-dependent neuronal migration.
VEGF188 is sufficient to guide NRP1-dependent axon
crossing at the optic chiasm
Wenext investigatedwhether VEGF188 can evoke neuronal responses
similar to VEGF164 in the developing visual system. To establish
binocular vision, RGC axons project through the optic chiasm to both
the ipsilateral and contralateral brain hemispheres (Erskine and
Herrera, 2007). VEGF164, but not VEGF120, promotes RGC axon
guidance in aNRP1-dependent fashion in vitro, andVegfa120/120mice
therefore develop an abnormal chiasm (Erskine et al., 2011). To
examinewhether VEGF188 can also promote RGC axon guidance, we
performed DiI labelling in VEGF isoform mutants. Anterograde
labelling of RGC axons from one eye at E14.5 demonstrated that
VEGF188 was sufficient for NRP1-mediated chiasm patterning
(Fig. 3A). Thus, Vegfa120/120 mice had a significantly increased
ipsilateral projection index as well as defasciculation of the ipsilateral
and contralateral optic tracts (Erskine et al., 2011), but the ipsilateral
index and shapeof the optic chiasmappearedunaffected inVegfa188/188
mice (Fig. 3B,C). Moreover, replacing one Vegfa120with the Vegfa188
allele was sufficient to prevent chiasm defects in Vegfa120/120 mutants
(Fig. 3B,C).
Fig. 2. VEGF188 is sufficient for FBM neuron migration. (A) Schematic representation of FBM neuron migration in the mouse. (B) ISL1 staining of E12.5
hindbrain explants containing implanted heparin beads soaked in PBS (n=10) or PBS containing VEGF164 (n=10) or VEGF188 (n=6). Red dotted circles indicate
the position of heparin beads; white arrowheads indicate normal migration; red arrows indicate migration towards heparin beads; asterisks indicate the midline.
Scale bar: 200 µm. (C) Distance migrated by FBM neurons. Migration distancewas quantified as migration away from r5 territory on the hindbrain sidewith a bead
relative to the control half of the same hindbrain; mean±s.e.m. control 1±0.09 versus VEGF164 bead 1.39±0.05; control 1±0.11 versus VEGF188 bead 2.04±0.17;
**P<0.01, VEGF compared with control (t-test). (D) Whole-mount Isl1 in situ hybridisation of E12.5 hindbrains of the indicated genotypes detects migrating FBM
neurons (VIIm) (control, n=10; Vegfa120/120, n=6; Vegfa188/188, n=4; Vegfa120/188, n=5). Brackets indicate the width of the neuronal stream on the ventricular side;
red arrowheads indicate dumbbell-shaped nuclei on the pial side; asterisks indicate the midline. Scale bar: 25 µm.
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We next performed retrograde DiI labelling of RGC axons from
the dorsal thalamus in VEGF isoform mice and compared the
number of labelled RGCs in flatmounted ipsilateral and contralateral
retina (Fig. 3D). Quantitation showed that the proportion of DiI-
labelled ipsilateral RGCs was significantly increased in Vegfa120/120
compared with control mice, but was normal in Vegfa188/188 and
Vegfa120/188 mice (Fig. 3E). Flat-mount images also revealed the
preferential origin of ipsilaterally projecting neurons from the
ventrotemporal retina in wild types (Fig. 3F). Their distribution is
affected in Vegfa120/120 mice, which contain ipsilaterally projecting
RGCs throughout the nasal retina (Erskine et al., 2011), but this
defect was rescued by the introduction of a single Vegfa188 allele
(Fig. 3F). VEGF188 is therefore sufficient to promote NRP1-
dependent aspects of optic chiasm development.
VEGF188 is sufficient to ensure normal GnRH neuron survival
As a third model to study VEGF188 in neurodevelopment, we
investigated GnRH neuron survival. GnRH neurons are born in the
nasal placode and travel along nasal axons to reach the forebrain
(Fig. 4A; Cariboni et al., 2007). We have previously shown that
Vegfa120/120mice have significantly fewer migrating GnRH neurons
and demonstrated that VEGF164 signals through NRP1 to promote
the survival of GN11 cells, which recapitulate many features of
migratory GnRH neurons (Cariboni et al., 2011). We therefore
examined whether VEGF188 promotes GN11 survival, similar to
VEGF164. Whereas 72 h of serum withdrawal caused the death
of over half of the GN11 cells, the inclusion of serum, VEGF164
or VEGF188 for the last 12 h of culture significantly reduced cell
death, and VEGF188 was as effective as VEGF164 in preventing cell
death; by contrast, and as expected, VEGF120 did not promote
survival (Fig. 4B; percentage of propidium iodide-positive cells,
mean±s.e.m.: control, 44±3%; serum, 2±1%; VEGF120, 37±3;
VEGF164, 11±2%; VEGF188, 11±2%). These observations suggest
that VEGF188, similar to VEGF164, can promote GnRH neuron
survival. The ineffectiveness of VEGF120 agreed with the previously
observed NRP1-dependent neuroprotection of GN11 cells and the
Fig. 3. VEGF188 is sufficient to guide commissural axons across the optic chiasm. (A) Schematic illustration of the method used to anterogradely label
RGC projections. DiI crystals were placed onto the retina in one eye to label axons extending through the optic chiasm into the ipsilateral and contralateral optic
tracts. (B) Ipsilateral index in the indicated genotypes (mean±s.e.m.): control, 0.095±0.01, n=11; Vegfa120/120, 0.15±0.03, n=5; Vegfa188/188, 0.083±0.01, n=3;
Vegfa120/188, 0.09±0.01, n=3; t-test, *P<0.05 compared with control. (C) Whole-mount views of RGC axons at the optic chiasm from embryos of the indicated
genotypes, labelled anterogradely with DiI at E14.5; ventral view, anterior upwards; optic nerve (on), contralateral optic tract (otc) and ipsilateral optic tract (oti).
Red arrows indicate the normal position of the ipsilateral projection; red arrowheads indicate the secondary tract and axon defasciculation inVegfa120/120mutants.
Scale bar: 500 µm. Higher magnifications of each boxed areas are shown beneath the respective panels. (D) Schematic illustration of the method used to
retrogradely label RGC projections. DiI crystals were placed unilaterally into the optic tract in the dorsal thalamus. (E) Proportion of ipsilaterally projecting RGCs
relative to total number of RGCs in both eyes of the indicated genotypes at E15.5 (mean±s.e.m.): control, 3.28±0.44%, n=8; Vegfa120/120, 19.64±3.89%, n=4;
Vegfa188/188, 2.16±0.42%, n=4; Vegfa120/188, 2.12±0.14%, n=2; t-test, ***P<0.001 compared with control. (F) Flatmounted ipsilateral retinas from E15.5 embryos
of the indicated genotypes after retrograde labelling from the optic tract in the right thalamus. DT, dorsotemporal; VN, ventronasal; DN, dorsonasal; VT,
ventrotemporal. Scale bar: 500 µm.
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fact that Vegfa120/120 mice have fewer GnRH neurons (Cariboni
et al., 2011). Also in agreement with the in vitro findings, the GnRH
neuron number was normal in Vegfa188/188 mice that express
VEGF188 but lack VEGF164 (Fig. 4C,D). Moreover, replacing one
Vegfa120 allele in Vegfa120/120 mutants with the Vegfa188 allele was
sufficient to prevent their GnRH neuron survival defect (Fig. 4C,D).
Together, these data show that VEGF188 is sufficient to promote
NRP1-dependent neuronal survival.
Conclusions
Our study has demonstrated that human VEGF189, but not VEGF121,
binds NRP1 in a tissue context, that mouse VEGF188 is co-expressed
with VEGF164 in a neuronal context, and that mouse VEGF188
expressed from the endogenous Vegfa locus can evoke NRP1-
dependent neuronal responses in vitro and in vivo, similar to
VEGF164 and unlike VEGF121. Future work on the role of VEGF
signalling through NRP1, especially studies using Vegfa120/120 or
tissue-specific Vegfa-null alleles, should therefore consider the
possibility that VEGF188, similar to VEGF164, can regulate the
process under investigation. This consideration would be relevant for
both neural and vascular studies, or indeed any context inwhichVEGF
signalling through NRP1 is implicated. The finding that the relatively
understudied VEGF189 is capable of evoking VEGF isoform-specific
signalling eventsmayhavebroad implications for the therapeutic use of
VEGF. Thus, VEGF application has been considered in many studies
for pro-angiogenic, pro-neurogenic and neuroprotective therapies, e.g.
the treatment of amyotrophic lateral sclerosis (reviewed by Storkebaum
et al., 2011). Most prior studies have used VEGF165 to ensure
comprehensive receptor targeting; however, the retention of VEGF165
in tissues is inferior to that of VEGF189 due to the presence of only one
instead of two heparin/matrix-binding domains. Our work
demonstrating that VEGF189 is fully capable of engaging NRP1, in
addition to its known ability to bind VEGFR1 and VEGFR2, therefore
suggests that VEGF189 may be better suited than VEGF165 to induce
localised tissue effects in therapeutic applications.
MATERIALS AND METHODS
Animals
Animal procedures were preformed in accordance with institutional and UK
Home Office guidelines. The Vegfa120 and Vegfa188 alleles (Carmeliet et al.,
1999; Stalmans et al., 2002), and Nrp1−/− and Nrp2−/− mice have been
described previously (Giger et al., 2000; Kitsukawa et al., 1997).
RT-PCR and sequencing
Total RNAwas reverse transcribed using Superscript III (Life Technologies)
and Vegfa isoforms amplified by PCR using MegaMix (Microzone) and the
following oligonucleotide pairs: 120-F 5′-GTAACGATGAAGCCCTG-
GAG-3′ and 120-R 5′-CCTTGGCTTGTCACATTTTTC-3′; 164-F 5′-AG-
CCAGAAAATCACTGTGAGC-3′ and 164-R 5′-GCCTTGGCTTGTCA-
CATCT-3′; 188-F 5′-AGTTCGAGGAAAGGGAAAGG-3′ and 188-R
5′-GCCTTGGCTTGTCACATCT-3′.
AP-fusion protein binding assays
Open reading frames for the VEGF isoforms were amplified by PCR with
the oligonucleotides 5′-AATAATGGATCCGCACCCATGGCAGAAGG-
AG-3′ and 5′-TATATGCTCGAGCTCACCGCCTCGGCTTGTC-3′. The
PCR products were cloned into pAG3-AP containing an upstream in-frame
AP cassette. Binding assay were performed as described previously (Fantin
et al., 2013b).
Immunolabelling and in situ hybridisation
Primary antibodies used were: rabbit anti-mouse GnRH (Immunostar,
20075, 1:1000), goat anti-rat NRP1 (R&D Systems, AF566, 1:100), rabbit
anti-mouse TUJ1 (Covance, MRB-435p, 1:250) and mouse anti-rat ISL1
(DSHB, 39.4D5, 1:100). Secondary antibodies used were: Alexa594-
conjugated rabbit anti-goat Fab (Jackson ImmunoResearch, 305-587-003,
1:200), Alexa488-conjugated donkey anti-rabbit Fab (Jackson
ImmunoResearch, 711-547-003, 1:200), Alexa488-conjugated
goat anti-mouse (Life Technologies, A-110011, 1:200) and
biotinylated goat anti-rabbit (Vector Laboratories, BA-1000,
1:200). To detect blood vessels, we used biotinylated IB4 (Sigma)
followed by Alexa633-conjugated streptavidin (Life Technologies).
For in situ hybridisation, we used a digoxigenin-labelled Isl1 probe
(Schwarz et al., 2004).
Fig. 4. VEGF188 is sufficient to promote GnRH neuron survival. (A) GnRH neuron migration (blue dots). The neurons are born in the nasal placodes
that give rise to the olfactory and vomeronasal epithelia (OE, VNO) and migrate along olfactory and vomeronasal axons (purple, Olf/VN) through the
nasal compartment (NC) to reach the forebrain (FB). (B) Serum-starved GN11 cells were treated with DMEM or DMEM-containing serum, VEGF120,
VEGF164 or VEGF188; cell death was visualised by propidium iodide staining (red); Hoechst staining (blue) identified the total number of cells. Scale bar:
25 µm. (C) Sagittal sections of E14.5 mouse heads of the indicated genotypes, immunolabelled for GnRH. Arrows indicate migrating neurons;
arrowheads indicate blood vessels; open triangles indicate the absence of migrating neurons; dotted lines indicate the FB boundary. OB, olfactory bulb.
Scale bar: 100 µm. (D) GnRH neuron number in E14.5 heads of the indicated genotypes (mean±s.e.m.): control, 1246±46, n=6; Vegfa120/120, 854±21,
n=5; Vegfa188/188, 1335±63, n=3; Vegfa120/188, 1314±58, n=3; t-test; ***P<0.001 compared with control.
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Hindbrain explant culture
Hindbrain explants were cultured as previously described (Schwarz et al.,
2004; Tillo et al., 2014). Affi-Gel heparin beads (Bio-Rad) were soaked
overnight in 100 ng/ml of VEGF164 in PBS (Preprotech) or VEGF188
(Reliatech). FBM neuron migration was measured with ImageJ (NIH) as the
distance travelled from r5 to the leading group of cells in r6 in each hindbrain
and normalised to the control side of each hindbrain.
DiI labelling
DiI labelling was performed with fixed tissues as described previously
(Erskine et al., 2011). Briefly, a DiI crystal (Life Technologies) was placed
over the optic disc of one eye for anterograde labelling. After 3 days at 37°C,
dissected brains were imaged ventral side upwards. ImageJ was used to
determine the pixel intensity in defined areas of the ipsilateral and
contralateral optic tracts, and the ipsilateral index calculated as the ratio of
fluorescent intensity in the ipsilateral relative to the ipsilateral plus
contralateral tracts. For retrograde labelling, the cortex was removed
unilaterally and DiI crystals placed in a row over the dorsal thalamus for
15 weeks at room temperature; we imaged flatmounted retinas as above and
determined the percentage of labelled ipsilateral RGCs relative to the
ipsilateral plus contralateral RGCs.
GnRH neuron analysis and survival assays
Immunolabelled GnRH-positive cells were quantitated and GN11 survival
assays performed as described previously (Cariboni et al., 2011). For
survival assays, cells were serum starved for 72 h and treated for 12 h with
media containing 10% FBS, 10 ng/ml VEGF120, VEGF164 or VEGF188.
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Fig. S1. Specificity of Vegfa isoform PCR reagents and perseverance of the dorsolateral fascicles 
in Nrp1-null mutants.  
(A) The specificity of oligonucleotide primers for Vegfa isoform expression analysis was validated 
by RT-PCR using cDNA derived from Vegfa120/120, Vegfa164/164 or wildtype E12.5 mouse embryo 
trunks, respectively. Note that a molecular weight standard confirmed the predicted sizes of each 
isoform as 179, 159 and 215 bp, respectively.  
(B) Wholemount staining of E12.5 wildtype hindbrains for NRP1 and TUJ1; the single NRP1 and 
TUJ1 channels are shown in grey scale adjacent to each panel. Scale bar: 200 µm.  
??????????????????????????????????????????????????????? ???????
Development  |  Supplementary  Material
